Section 1 PE Tables – Results from the 2021 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ

220623

Table 1.1A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; Numbers in Thousands, 2021
Drug	Lifetime (2021)	Past Year (2021)	Past Month (2021)
ILLICIT DRUGS¹	138,790	61,203	39,995
Marijuana	128,016	52,454	36,363
Cocaine	40,901	4,765	1,833
Crack	10,640	996	527
Heroin	6,635	1,099	589
Hallucinogens	45,826	7,406	2,234
LSD	29,502	2,477	524
PCP	6,464	183	96
Ecstasy	21,122	2,199	594
Inhalants	25,596	2,178	830
Methamphetamine	16,830	2,549	1,617
Misuse of Prescription Psychotherapeutics	nr	14,284	4,263
Pain Relievers	nr	8,711	2,401
Stimulants	nr	3,733	1,104
Tranquilizers or Sedatives	nr	4,887	1,373
Tranquilizers	nr	4,317	1,184
Sedatives	nr	923	227
Benzodiazepines	--	3,941	--
Opioids	nr	9,236	2,791
Central Nervous System Stimulants	nr	9,177	4,126
Illicit Drugs Other Than Marijuana²	nr	23,249	9,030
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.1B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; Percentages, 2021
Drug	Lifetime (2021)	Past Year (2021)	Past Month (2021)
ILLICIT DRUGS¹	49.6	21.9	14.3
Marijuana	45.7	18.7	13.0
Cocaine	14.6	1.7	0.7
Crack	3.8	0.4	0.2
Heroin	2.4	0.4	0.2
Hallucinogens	16.4	2.6	0.8
LSD	10.5	0.9	0.2
PCP	2.3	0.1	0.0
Ecstasy	7.5	0.8	0.2
Inhalants	9.1	0.8	0.3
Methamphetamine	6.0	0.9	0.6
Misuse of Prescription Psychotherapeutics	nr	5.1	1.5
Pain Relievers	nr	3.1	0.9
Stimulants	nr	1.3	0.4
Tranquilizers or Sedatives	nr	1.7	0.5
Tranquilizers	nr	1.5	0.4
Sedatives	nr	0.3	0.1
Benzodiazepines	--	1.4	--
Opioids	nr	3.3	1.0
Central Nervous System Stimulants	nr	3.3	1.5
Illicit Drugs Other Than Marijuana²	nr	8.3	3.2
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.2A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 17; Numbers in Thousands, 2021
Drug	Lifetime (2021)	Past Year (2021)	Past Month (2021)
ILLICIT DRUGS¹	5,549	3,662	1,844
Marijuana	3,423	2,724	1,499
Cocaine	102	40	5
Crack	16	3	*
Heroin	6	*	*
Hallucinogens	591	347	78
LSD	419	249	41
PCP	30	20	4
Ecstasy	146	92	9
Inhalants	2,294	626	205
Methamphetamine	50	37	14
Misuse of Prescription Psychotherapeutics	nr	851	200
Pain Relievers	nr	497	115
Stimulants	nr	304	74
Tranquilizers or Sedatives	nr	225	44
Tranquilizers	nr	198	28
Sedatives	nr	41	19
Benzodiazepines	--	181	--
Opioids	nr	497	115
Central Nervous System Stimulants	nr	339	92
Illicit Drugs Other Than Marijuana²	nr	1,562	476
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.2B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 17; Percentages, 2021
Drug	Lifetime (2021)	Past Year (2021)	Past Month (2021)
ILLICIT DRUGS¹	21.3	14.1	7.1
Marijuana	13.2	10.5	5.8
Cocaine	0.4	0.2	0.0
Crack	0.1	0.0	*
Heroin	0.0	*	*
Hallucinogens	2.3	1.3	0.3
LSD	1.6	1.0	0.2
PCP	0.1	0.1	0.0
Ecstasy	0.6	0.4	0.0
Inhalants	8.8	2.4	0.8
Methamphetamine	0.2	0.1	0.1
Misuse of Prescription Psychotherapeutics	nr	3.3	0.8
Pain Relievers	nr	1.9	0.4
Stimulants	nr	1.2	0.3
Tranquilizers or Sedatives	nr	0.9	0.2
Tranquilizers	nr	0.8	0.1
Sedatives	nr	0.2	0.1
Benzodiazepines	--	0.7	--
Opioids	nr	1.9	0.4
Central Nervous System Stimulants	nr	1.3	0.4
Illicit Drugs Other Than Marijuana²	nr	6.0	1.8
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.3A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 or Older; Numbers in Thousands, 2021
Drug	Lifetime (2021)	Past Year (2021)	Past Month (2021)
ILLICIT DRUGS¹	133,241	57,542	38,152
Marijuana	124,593	49,730	34,864
Cocaine	40,798	4,725	1,828
Crack	10,623	993	526
Heroin	6,629	1,099	588
Hallucinogens	45,235	7,058	2,156
LSD	29,082	2,229	483
PCP	6,434	163	92
Ecstasy	20,976	2,107	586
Inhalants	23,302	1,552	625
Methamphetamine	16,780	2,512	1,603
Misuse of Prescription Psychotherapeutics	nr	13,433	4,063
Pain Relievers	nr	8,213	2,286
Stimulants	nr	3,429	1,029
Tranquilizers or Sedatives	nr	4,662	1,330
Tranquilizers	nr	4,119	1,155
Sedatives	nr	881	208
Benzodiazepines	--	3,760	--
Opioids	nr	8,738	2,676
Central Nervous System Stimulants	nr	8,838	4,034
Illicit Drugs Other Than Marijuana²	nr	21,687	8,554
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.3B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 or Older; Percentages, 2021
Drug	Lifetime (2021)	Past Year (2021)	Past Month (2021)
ILLICIT DRUGS¹	52.5	22.7	15.0
Marijuana	49.1	19.6	13.7
Cocaine	16.1	1.9	0.7
Crack	4.2	0.4	0.2
Heroin	2.6	0.4	0.2
Hallucinogens	17.8	2.8	0.8
LSD	11.5	0.9	0.2
PCP	2.5	0.1	0.0
Ecstasy	8.3	0.8	0.2
Inhalants	9.2	0.6	0.2
Methamphetamine	6.6	1.0	0.6
Misuse of Prescription Psychotherapeutics	nr	5.3	1.6
Pain Relievers	nr	3.2	0.9
Stimulants	nr	1.4	0.4
Tranquilizers or Sedatives	nr	1.8	0.5
Tranquilizers	nr	1.6	0.5
Sedatives	nr	0.3	0.1
Benzodiazepines	--	1.5	--
Opioids	nr	3.4	1.1
Central Nervous System Stimulants	nr	3.5	1.6
Illicit Drugs Other Than Marijuana²	nr	8.5	3.4
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.4A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 to 25; Numbers in Thousands, 2021
Drug	Lifetime (2021)	Past Year (2021)	Past Month (2021)
ILLICIT DRUGS¹	17,919	12,710	8,472
Marijuana	16,687	11,833	8,073
Cocaine	2,819	1,173	373
Crack	303	74	30
Heroin	327	66	24
Hallucinogens	5,154	2,361	525
LSD	3,173	1,012	172
PCP	230	55	21
Ecstasy	2,658	688	167
Inhalants	2,770	497	121
Methamphetamine	597	166	90
Misuse of Prescription Psychotherapeutics	nr	2,486	584
Pain Relievers	nr	1,018	213
Stimulants	nr	1,244	300
Tranquilizers or Sedatives	nr	874	164
Tranquilizers	nr	810	143
Sedatives	nr	141	31
Benzodiazepines	--	787	--
Opioids	nr	1,035	221
Central Nervous System Stimulants	nr	2,111	669
Illicit Drugs Other Than Marijuana²	nr	4,614	1,361
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.4B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 to 25; Percentages, 2021
Drug	Lifetime (2021)	Past Year (2021)	Past Month (2021)
ILLICIT DRUGS¹	53.6	38.0	25.3
Marijuana	49.9	35.4	24.1
Cocaine	8.4	3.5	1.1
Crack	0.9	0.2	0.1
Heroin	1.0	0.2	0.1
Hallucinogens	15.4	7.1	1.6
LSD	9.5	3.0	0.5
PCP	0.7	0.2	0.1
Ecstasy	7.9	2.1	0.5
Inhalants	8.3	1.5	0.4
Methamphetamine	1.8	0.5	0.3
Misuse of Prescription Psychotherapeutics	nr	7.4	1.7
Pain Relievers	nr	3.0	0.6
Stimulants	nr	3.7	0.9
Tranquilizers or Sedatives	nr	2.6	0.5
Tranquilizers	nr	2.4	0.4
Sedatives	nr	0.4	0.1
Benzodiazepines	--	2.4	--
Opioids	nr	3.1	0.7
Central Nervous System Stimulants	nr	6.3	2.0
Illicit Drugs Other Than Marijuana²	nr	13.8	4.1
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.5A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 26 or Older; Numbers in Thousands, 2021
Drug	Lifetime (2021)	Past Year (2021)	Past Month (2021)
ILLICIT DRUGS¹	115,321	44,831	29,680
Marijuana	107,906	37,897	26,791
Cocaine	37,980	3,551	1,455
Crack	10,320	919	496
Heroin	6,302	1,033	565
Hallucinogens	40,081	4,697	1,631
LSD	25,909	1,216	311
PCP	6,204	108	71
Ecstasy	18,318	1,420	419
Inhalants	20,532	1,055	504
Methamphetamine	16,182	2,346	1,513
Misuse of Prescription Psychotherapeutics	nr	10,947	3,478
Pain Relievers	nr	7,195	2,073
Stimulants	nr	2,184	730
Tranquilizers or Sedatives	nr	3,788	1,166
Tranquilizers	nr	3,309	1,012
Sedatives	nr	740	177
Benzodiazepines	--	2,973	--
Opioids	nr	7,703	2,456
Central Nervous System Stimulants	nr	6,727	3,365
Illicit Drugs Other Than Marijuana²	nr	17,073	7,193
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.5B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 26 or Older; Percentages, 2021
Drug	Lifetime (2021)	Past Year (2021)	Past Month (2021)
ILLICIT DRUGS¹	52.3	20.3	13.5
Marijuana	49.0	17.2	12.2
Cocaine	17.2	1.6	0.7
Crack	4.7	0.4	0.2
Heroin	2.9	0.5	0.3
Hallucinogens	18.2	2.1	0.7
LSD	11.8	0.6	0.1
PCP	2.8	0.0	0.0
Ecstasy	8.3	0.6	0.2
Inhalants	9.3	0.5	0.2
Methamphetamine	7.3	1.1	0.7
Misuse of Prescription Psychotherapeutics	nr	5.0	1.6
Pain Relievers	nr	3.3	0.9
Stimulants	nr	1.0	0.3
Tranquilizers or Sedatives	nr	1.7	0.5
Tranquilizers	nr	1.5	0.5
Sedatives	nr	0.3	0.1
Benzodiazepines	--	1.3	--
Opioids	nr	3.5	1.1
Central Nervous System Stimulants	nr	3.1	1.5
Illicit Drugs Other Than Marijuana²	nr	7.7	3.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.6A – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021
Age Category	Lifetime (2021)	Past Year (2021)	Past Month (2021)
TOTAL	138,790	61,203	39,995
12-20	11,254	7,998	4,553
21 or Older	127,536	53,205	35,442
12-17	5,549	3,662	1,844
12-13	1,020	544	206
14-15	1,687	1,038	485
16-17	2,842	2,080	1,153
18 or Older	133,241	57,542	38,152
18-25	17,919	12,710	8,472
18-20	5,705	4,337	2,709
21-25	12,214	8,373	5,763
26 or Older	115,321	44,831	29,680
26-49	59,739	28,947	19,377
26-29	10,688	6,448	4,537
30-34	13,599	7,240	5,006
35-39	13,440	6,064	3,972
40-44	11,838	5,177	3,279
45-49	10,173	4,018	2,584
50 or Older	55,583	15,884	10,302
50-54	10,697	3,691	2,349
55-59	11,293	3,700	2,421
60-64	12,747	3,522	2,492
65 or Older	20,845	4,971	3,040
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.6B – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021
Age Category	Lifetime (2021)	Past Year (2021)	Past Month (2021)
TOTAL	49.6	21.9	14.3
12-20	28.8	20.5	11.6
21 or Older	53.0	22.1	14.7
12-17	21.3	14.1	7.1
12-13	11.3	6.0	2.3
14-15	20.0	12.3	5.7
16-17	33.3	24.3	13.5
18 or Older	52.5	22.7	15.0
18-25	53.6	38.0	25.3
18-20	43.6	33.2	20.7
21-25	59.9	41.1	28.3
26 or Older	52.3	20.3	13.5
26-49	58.4	28.3	18.9
26-29	61.3	37.0	26.0
30-34	59.8	31.8	22.0
35-39	60.1	27.1	17.8
40-44	58.0	25.4	16.1
45-49	52.5	20.7	13.3
50 or Older	47.1	13.5	8.7
50-54	55.2	19.0	12.1
55-59	53.0	17.4	11.4
60-64	56.5	15.6	11.0
65 or Older	38.0	9.1	5.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.7A – Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021
Age Category	Lifetime (2021)	Past Year (2021)	Past Month (2021)
TOTAL	128,016	52,454	36,363
12-20	8,557	6,772	4,118
21 or Older	119,459	45,682	32,244
12-17	3,423	2,724	1,499
12-13	256	197	71
14-15	962	778	393
16-17	2,204	1,748	1,035
18 or Older	124,593	49,730	34,864
18-25	16,687	11,833	8,073
18-20	5,134	4,049	2,619
21-25	11,553	7,785	5,454
26 or Older	107,906	37,897	26,791
26-49	55,948	25,147	17,860
26-29	10,141	5,838	4,263
30-34	12,945	6,508	4,645
35-39	12,570	5,200	3,674
40-44	10,958	4,369	2,946
45-49	9,334	3,232	2,332
50 or Older	51,958	12,750	8,931
50-54	9,723	2,948	2,062
55-59	10,698	3,014	2,077
60-64	12,173	2,922	2,212
65 or Older	19,364	3,867	2,580
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.7B – Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021
Age Category	Lifetime (2021)	Past Year (2021)	Past Month (2021)
TOTAL	45.7	18.7	13.0
12-20	21.9	17.3	10.5
21 or Older	49.6	19.0	13.4
12-17	13.2	10.5	5.8
12-13	2.8	2.2	0.8
14-15	11.4	9.2	4.6
16-17	25.8	20.5	12.1
18 or Older	49.1	19.6	13.7
18-25	49.9	35.4	24.1
18-20	39.3	31.0	20.0
21-25	56.7	38.2	26.8
26 or Older	49.0	17.2	12.2
26-49	54.7	24.6	17.5
26-29	58.2	33.5	24.5
30-34	56.9	28.6	20.4
35-39	56.2	23.3	16.4
40-44	53.7	21.4	14.4
45-49	48.2	16.7	12.0
50 or Older	44.0	10.8	7.6
50-54	50.1	15.2	10.6
55-59	50.2	14.2	9.8
60-64	54.0	13.0	9.8
65 or Older	35.3	7.1	4.7
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.8A – Cocaine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021
Age Category	Lifetime (2021)	Past Year (2021)	Past Month (2021)
TOTAL	40,901	4,765	1,833
12-20	514	262	67
21 or Older	40,387	4,503	1,766
12-17	102	40	5
12-13	9	*	*
14-15	28	5	4
16-17	65	35	1
18 or Older	40,798	4,725	1,828
18-25	2,819	1,173	373
18-20	412	222	62
21-25	2,407	951	311
26 or Older	37,980	3,551	1,455
26-49	17,823	2,542	1,002
26-29	3,009	742	363
30-34	3,869	641	214
35-39	4,236	428	101
40-44	3,706	447	200
45-49	3,004	285	125
50 or Older	20,156	1,009	453
50-54	3,346	401	146
55-59	4,896	233	161
60-64	5,713	130	42
65 or Older	6,202	245	105
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.8B – Cocaine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021
Age Category	Lifetime (2021)	Past Year (2021)	Past Month (2021)
TOTAL	14.6	1.7	0.7
12-20	1.3	0.7	0.2
21 or Older	16.8	1.9	0.7
12-17	0.4	0.2	0.0
12-13	0.1	*	*
14-15	0.3	0.1	0.0
16-17	0.8	0.4	0.0
18 or Older	16.1	1.9	0.7
18-25	8.4	3.5	1.1
18-20	3.1	1.7	0.5
21-25	11.8	4.7	1.5
26 or Older	17.2	1.6	0.7
26-49	17.4	2.5	1.0
26-29	17.3	4.3	2.1
30-34	17.0	2.8	0.9
35-39	18.9	1.9	0.4
40-44	18.2	2.2	1.0
45-49	15.5	1.5	0.6
50 or Older	17.1	0.9	0.4
50-54	17.2	2.1	0.8
55-59	23.0	1.1	0.8
60-64	25.3	0.6	0.2
65 or Older	11.3	0.4	0.2
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.9A – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021
Age Category	Lifetime (2021)	Past Year (2021)	Past Month (2021)
TOTAL	10,640	996	527
12-20	70	10	4
21 or Older	10,570	986	523
12-17	16	3	*
12-13	*	*	*
14-15	11	1	1
16-17	5	2	*
18 or Older	10,623	993	526
18-25	303	74	30
18-20	53	7	3
21-25	250	68	27
26 or Older	10,320	919	496
26-49	4,400	415	197
26-29	469	52	1
30-34	734	50	24
35-39	1,137	71	29
40-44	1,138	167	101
45-49	921	75	41
50 or Older	5,921	504	299
50-54	1,308	201	79
55-59	1,601	139	129
60-64	1,794	77	34
65 or Older	1,218	87	56
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.9B – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021
Age Category	Lifetime (2021)	Past Year (2021)	Past Month (2021)
TOTAL	3.8	0.4	0.2
12-20	0.2	0.0	0.0
21 or Older	4.4	0.4	0.2
12-17	0.1	0.0	*
12-13	*	*	*
14-15	0.1	0.0	0.0
16-17	0.1	0.0	*
18 or Older	4.2	0.4	0.2
18-25	0.9	0.2	0.1
18-20	0.4	0.1	0.0
21-25	1.2	0.3	0.1
26 or Older	4.7	0.4	0.2
26-49	4.3	0.4	0.2
26-29	2.7	0.3	0.0
30-34	3.2	0.2	0.1
35-39	5.1	0.3	0.1
40-44	5.6	0.8	0.5
45-49	4.8	0.4	0.2
50 or Older	5.0	0.4	0.3
50-54	6.7	1.0	0.4
55-59	7.5	0.7	0.6
60-64	8.0	0.3	0.2
65 or Older	2.2	0.2	0.1
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.10A – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021
Age Category	Lifetime (2021)	Past Year (2021)	Past Month (2021)
TOTAL	45,826	7,406	2,234
12-20	1,920	1,138	215
21 or Older	43,906	6,268	2,018
12-17	591	347	78
12-13	53	34	5
14-15	138	76	24
16-17	401	237	48
18 or Older	45,235	7,058	2,156
18-25	5,154	2,361	525
18-20	1,329	790	137
21-25	3,825	1,571	388
26 or Older	40,081	4,697	1,631
26-49	22,625	4,128	1,382
26-29	4,135	1,424	567
30-34	5,280	1,040	350
35-39	4,941	744	182
40-44	4,570	550	176
45-49	3,700	369	107
50 or Older	17,456	570	249
50-54	3,058	224	109
55-59	3,703	130	73
60-64	5,017	129	62
65 or Older	5,678	87	5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.10B – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021
Age Category	Lifetime (2021)	Past Year (2021)	Past Month (2021)
TOTAL	16.4	2.6	0.8
12-20	4.9	2.9	0.6
21 or Older	18.2	2.6	0.8
12-17	2.3	1.3	0.3
12-13	0.6	0.4	0.1
14-15	1.6	0.9	0.3
16-17	4.7	2.8	0.6
18 or Older	17.8	2.8	0.8
18-25	15.4	7.1	1.6
18-20	10.2	6.0	1.0
21-25	18.8	7.7	1.9
26 or Older	18.2	2.1	0.7
26-49	22.1	4.0	1.4
26-29	23.7	8.2	3.3
30-34	23.2	4.6	1.5
35-39	22.1	3.3	0.8
40-44	22.4	2.7	0.9
45-49	19.1	1.9	0.6
50 or Older	14.8	0.5	0.2
50-54	15.8	1.2	0.6
55-59	17.4	0.6	0.3
60-64	22.2	0.6	0.3
65 or Older	10.4	0.2	0.0
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.11A – Inhalant Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021
Age Category	Lifetime (2021)	Past Year (2021)	Past Month (2021)
TOTAL	25,596	2,178	830
12-20	3,183	789	245
21 or Older	22,413	1,389	585
12-17	2,294	626	205
12-13	651	233	104
14-15	780	167	46
16-17	863	226	56
18 or Older	23,302	1,552	625
18-25	2,770	497	121
18-20	889	163	40
21-25	1,881	334	81
26 or Older	20,532	1,055	504
26-49	11,544	862	376
26-29	2,038	277	89
30-34	2,340	221	87
35-39	2,417	146	63
40-44	2,538	102	49
45-49	2,212	115	89
50 or Older	8,988	193	128
50-54	1,965	88	79
55-59	2,445	73	26
60-64	2,241	12	8
65 or Older	2,337	21	15
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.11B – Inhalant Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021
Age Category	Lifetime (2021)	Past Year (2021)	Past Month (2021)
TOTAL	9.1	0.8	0.3
12-20	8.1	2.0	0.6
21 or Older	9.3	0.6	0.2
12-17	8.8	2.4	0.8
12-13	7.2	2.6	1.1
14-15	9.2	2.0	0.5
16-17	10.1	2.6	0.7
18 or Older	9.2	0.6	0.2
18-25	8.3	1.5	0.4
18-20	6.8	1.2	0.3
21-25	9.2	1.6	0.4
26 or Older	9.3	0.5	0.2
26-49	11.3	0.8	0.4
26-29	11.7	1.6	0.5
30-34	10.3	1.0	0.4
35-39	10.8	0.7	0.3
40-44	12.4	0.5	0.2
45-49	11.4	0.6	0.5
50 or Older	7.6	0.2	0.1
50-54	10.1	0.5	0.4
55-59	11.5	0.3	0.1
60-64	9.9	0.1	0.0
65 or Older	4.3	0.0	0.0
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.12A – Methamphetamine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021
Age Category	Lifetime (2021)	Past Year (2021)	Past Month (2021)
TOTAL	16,830	2,549	1,617
12-20	178	86	21
21 or Older	16,652	2,463	1,596
12-17	50	37	14
12-13	3	3	3
14-15	10	10	3
16-17	37	24	8
18 or Older	16,780	2,512	1,603
18-25	597	166	90
18-20	127	49	7
21-25	470	117	83
26 or Older	16,182	2,346	1,513
26-49	8,139	1,453	816
26-29	1,062	279	179
30-34	1,468	293	152
35-39	2,052	377	169
40-44	2,066	279	173
45-49	1,491	224	143
50 or Older	8,043	893	697
50-54	1,623	254	181
55-59	2,138	278	175
60-64	2,120	172	152
65 or Older	2,163	189	189
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.12B – Methamphetamine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021
Age Category	Lifetime (2021)	Past Year (2021)	Past Month (2021)
TOTAL	6.0	0.9	0.6
12-20	0.5	0.2	0.1
21 or Older	6.9	1.0	0.7
12-17	0.2	0.1	0.1
12-13	0.0	0.0	0.0
14-15	0.1	0.1	0.0
16-17	0.4	0.3	0.1
18 or Older	6.6	1.0	0.6
18-25	1.8	0.5	0.3
18-20	1.0	0.4	0.1
21-25	2.3	0.6	0.4
26 or Older	7.3	1.1	0.7
26-49	8.0	1.4	0.8
26-29	6.1	1.6	1.0
30-34	6.5	1.3	0.7
35-39	9.2	1.7	0.8
40-44	10.1	1.4	0.8
45-49	7.7	1.2	0.7
50 or Older	6.8	0.8	0.6
50-54	8.4	1.3	0.9
55-59	10.0	1.3	0.8
60-64	9.4	0.8	0.7
65 or Older	3.9	0.3	0.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.13A – Any Use of Prescription Pain Relievers in Past Year and Misuse of Prescription Pain Relievers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021
Age Category	Any Use in Past Year (2021)	Misuse in Past Year (2021)	Misuse in Past Month (2021)
TOTAL	71,688	8,711	2,401
12-20	5,380	820	171
21 or Older	66,309	7,891	2,230
12-17	3,342	497	115
12-13	924	158	29
14-15	1,025	138	35
16-17	1,393	201	51
18 or Older	68,346	8,213	2,286
18-25	6,119	1,018	213
18-20	2,038	322	56
21-25	4,081	696	158
26 or Older	62,227	7,195	2,073
26-49	25,899	4,120	1,004
26-29	3,567	749	268
30-34	5,672	983	206
35-39	5,830	863	168
40-44	5,441	932	219
45-49	5,388	593	143
50 or Older	36,329	3,075	1,069
50-54	6,361	770	213
55-59	6,617	575	175
60-64	7,112	816	358
65 or Older	16,238	914	323
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.13B – Any Use of Prescription Pain Relievers in Past Year and Misuse of Prescription Pain Relievers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021
Age Category	Any Use in Past Year (2021)	Misuse in Past Year (2021)	Misuse in Past Month (2021)
TOTAL	25.6	3.1	0.9
12-20	13.8	2.1	0.4
21 or Older	27.5	3.3	0.9
12-17	12.8	1.9	0.4
12-13	10.2	1.8	0.3
14-15	12.1	1.6	0.4
16-17	16.3	2.4	0.6
18 or Older	26.9	3.2	0.9
18-25	18.3	3.0	0.6
18-20	15.6	2.5	0.4
21-25	20.0	3.4	0.8
26 or Older	28.2	3.3	0.9
26-49	25.3	4.0	1.0
26-29	20.5	4.3	1.5
30-34	24.9	4.3	0.9
35-39	26.1	3.9	0.8
40-44	26.7	4.6	1.1
45-49	27.8	3.1	0.7
50 or Older	30.8	2.6	0.9
50-54	32.8	4.0	1.1
55-59	31.1	2.7	0.8
60-64	31.5	3.6	1.6
65 or Older	29.6	1.7	0.6
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.14A – Any Use of Prescription Stimulants in Past Year and Misuse of Prescription Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021
Age Category	Any Use in Past Year (2021)	Misuse in Past Year (2021)	Misuse in Past Month (2021)
TOTAL	16,630	3,733	1,104
12-20	2,932	655	155
21 or Older	13,697	3,077	949
12-17	1,821	304	74
12-13	436	26	5
14-15	598	91	23
16-17	787	187	47
18 or Older	14,808	3,429	1,029
18-25	3,354	1,244	300
18-20	1,111	351	81
21-25	2,243	893	219
26 or Older	11,454	2,184	730
26-49	7,531	1,906	627
26-29	1,628	531	107
30-34	1,819	477	202
35-39	1,707	494	161
40-44	1,292	224	75
45-49	1,084	179	82
50 or Older	3,923	278	102
50-54	1,251	86	53
55-59	1,000	82	32
60-64	634	81	14
65 or Older	1,039	29	3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.14B – Any Use of Prescription Stimulants in Past Year and Misuse of Prescription Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021
Age Category	Any Use in Past Year (2021)	Misuse in Past Year (2021)	Misuse in Past Month (2021)
TOTAL	5.9	1.3	0.4
12-20	7.5	1.7	0.4
21 or Older	5.7	1.3	0.4
12-17	7.0	1.2	0.3
12-13	4.8	0.3	0.1
14-15	7.1	1.1	0.3
16-17	9.2	2.2	0.5
18 or Older	5.8	1.4	0.4
18-25	10.0	3.7	0.9
18-20	8.5	2.7	0.6
21-25	11.0	4.4	1.1
26 or Older	5.2	1.0	0.3
26-49	7.4	1.9	0.6
26-29	9.3	3.0	0.6
30-34	8.0	2.1	0.9
35-39	7.6	2.2	0.7
40-44	6.3	1.1	0.4
45-49	5.6	0.9	0.4
50 or Older	3.3	0.2	0.1
50-54	6.4	0.4	0.3
55-59	4.7	0.4	0.2
60-64	2.8	0.4	0.1
65 or Older	1.9	0.1	0.0
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.15A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year and Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021
Age Category	Any Use in Past Year (2021)	Misuse in Past Year (2021)	Misuse in Past Month (2021)
TOTAL	40,899	4,887	1,373
12-20	1,908	495	83
21 or Older	38,991	4,393	1,290
12-17	1,002	225	44
12-13	224	12	3
14-15	298	66	25
16-17	480	147	15
18 or Older	39,897	4,662	1,330
18-25	2,950	874	164
18-20	906	269	40
21-25	2,044	605	124
26 or Older	36,947	3,788	1,166
26-49	14,732	2,421	656
26-29	2,125	494	156
30-34	2,979	684	150
35-39	3,295	483	127
40-44	3,198	393	117
45-49	3,136	368	105
50 or Older	22,215	1,366	510
50-54	3,666	266	91
55-59	4,068	452	178
60-64	4,324	285	86
65 or Older	10,157	363	155
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.15B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year and Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021
Age Category	Any Use in Past Year (2021)	Misuse in Past Year (2021)	Misuse in Past Month (2021)
TOTAL	14.6	1.7	0.5
12-20	4.9	1.3	0.2
21 or Older	16.2	1.8	0.5
12-17	3.9	0.9	0.2
12-13	2.5	0.1	0.0
14-15	3.5	0.8	0.3
16-17	5.6	1.7	0.2
18 or Older	15.7	1.8	0.5
18-25	8.8	2.6	0.5
18-20	6.9	2.1	0.3
21-25	10.0	3.0	0.6
26 or Older	16.8	1.7	0.5
26-49	14.4	2.4	0.6
26-29	12.2	2.8	0.9
30-34	13.1	3.0	0.7
35-39	14.7	2.2	0.6
40-44	15.7	1.9	0.6
45-49	16.2	1.9	0.5
50 or Older	18.8	1.2	0.4
50-54	18.9	1.4	0.5
55-59	19.1	2.1	0.8
60-64	19.2	1.3	0.4
65 or Older	18.5	0.7	0.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.16A – Any Use of Prescription Tranquilizers in Past Year and Misuse of Prescription Tranquilizers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021
Age Category	Any Use in Past Year (2021)	Misuse in Past Year (2021)	Misuse in Past Month (2021)
TOTAL	32,735	4,317	1,184
12-20	1,440	441	59
21 or Older	31,295	3,876	1,125
12-17	737	198	28
12-13	141	7	*
14-15	212	50	17
16-17	384	141	11
18 or Older	31,998	4,119	1,155
18-25	2,449	810	143
18-20	703	243	31
21-25	1,746	567	113
26 or Older	29,549	3,309	1,012
26-49	12,520	2,247	579
26-29	1,945	462	134
30-34	2,623	659	128
35-39	2,779	424	122
40-44	2,677	355	99
45-49	2,497	347	95
50 or Older	17,029	1,062	434
50-54	2,794	197	90
55-59	3,158	363	165
60-64	3,328	233	59
65 or Older	7,749	269	120
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.16B – Any Use of Prescription Tranquilizers in Past Year and Misuse of Prescription Tranquilizers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021
Age Category	Any Use in Past Year (2021)	Misuse in Past Year (2021)	Misuse in Past Month (2021)
TOTAL	11.7	1.5	0.4
12-20	3.7	1.1	0.2
21 or Older	13.0	1.6	0.5
12-17	2.8	0.8	0.1
12-13	1.6	0.1	*
14-15	2.5	0.6	0.2
16-17	4.5	1.7	0.1
18 or Older	12.6	1.6	0.5
18-25	7.3	2.4	0.4
18-20	5.4	1.9	0.2
21-25	8.6	2.8	0.6
26 or Older	13.4	1.5	0.5
26-49	12.2	2.2	0.6
26-29	11.2	2.7	0.8
30-34	11.5	2.9	0.6
35-39	12.4	1.9	0.5
40-44	13.1	1.7	0.5
45-49	12.9	1.8	0.5
50 or Older	14.4	0.9	0.4
50-54	14.4	1.0	0.5
55-59	14.8	1.7	0.8
60-64	14.8	1.0	0.3
65 or Older	14.1	0.5	0.2
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.17A – Any Use of Prescription Sedatives in Past Year and Misuse of Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021
Age Category	Any Use in Past Year (2021)	Misuse in Past Year (2021)	Misuse in Past Month (2021)
TOTAL	14,548	923	227
12-20	685	74	30
21 or Older	13,863	849	198
12-17	408	41	19
12-13	107	7	3
14-15	139	21	12
16-17	162	14	4
18 or Older	14,140	881	208
18-25	846	141	31
18-20	277	32	11
21-25	568	109	20
26 or Older	13,295	740	177
26-49	4,437	415	100
26-29	480	93	29
30-34	740	93	22
35-39	960	80	7
40-44	1,134	106	21
45-49	1,122	43	20
50 or Older	8,858	325	78
50-54	1,455	70	2
55-59	1,540	91	14
60-64	1,911	57	27
65 or Older	3,951	107	34
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.17B – Any Use of Prescription Sedatives in Past Year and Misuse of Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021
Age Category	Any Use in Past Year (2021)	Misuse in Past Year (2021)	Misuse in Past Month (2021)
TOTAL	5.2	0.3	0.1
12-20	1.8	0.2	0.1
21 or Older	5.8	0.4	0.1
12-17	1.6	0.2	0.1
12-13	1.2	0.1	0.0
14-15	1.6	0.2	0.1
16-17	1.9	0.2	0.0
18 or Older	5.6	0.3	0.1
18-25	2.5	0.4	0.1
18-20	2.1	0.2	0.1
21-25	2.8	0.5	0.1
26 or Older	6.0	0.3	0.1
26-49	4.3	0.4	0.1
26-29	2.8	0.5	0.2
30-34	3.3	0.4	0.1
35-39	4.3	0.4	0.0
40-44	5.6	0.5	0.1
45-49	5.8	0.2	0.1
50 or Older	7.5	0.3	0.1
50-54	7.5	0.4	0.0
55-59	7.2	0.4	0.1
60-64	8.5	0.3	0.1
65 or Older	7.2	0.2	0.1
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.18A – Any Use and Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021
Age Category	Any Use in Past Year (2021)	Misuse in Past Year (2021)
TOTAL	25,630	3,941
12-20	1,106	419
21 or Older	24,524	3,522
12-17	462	181
12-13	64	9
14-15	127	41
16-17	270	131
18 or Older	25,168	3,760
18-25	2,147	787
18-20	644	238
21-25	1,503	549
26 or Older	23,021	2,973
26-49	10,134	2,078
26-29	1,569	434
30-34	2,229	634
35-39	2,216	377
40-44	2,234	316
45-49	1,886	316
50 or Older	12,887	895
50-54	2,091	164
55-59	2,348	293
60-64	2,752	218
65 or Older	5,696	221
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.18B – Any Use and Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021
Age Category	Any Use in Past Year (2021)	Misuse in Past Year (2021)
TOTAL	9.2	1.4
12-20	2.8	1.1
21 or Older	10.2	1.5
12-17	1.8	0.7
12-13	0.7	0.1
14-15	1.5	0.5
16-17	3.2	1.5
18 or Older	9.9	1.5
18-25	6.4	2.4
18-20	4.9	1.8
21-25	7.4	2.7
26 or Older	10.4	1.3
26-49	9.9	2.0
26-29	9.0	2.5
30-34	9.8	2.8
35-39	9.9	1.7
40-44	10.9	1.5
45-49	9.7	1.6
50 or Older	10.9	0.8
50-54	10.8	0.8
55-59	11.0	1.4
60-64	12.2	1.0
65 or Older	10.4	0.4
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.19A – Any Use of Opioids in Past Year and Misuse of Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021
Age Category	Any Use in Past Year¹ (2021)	Misuse in Past Year (2021)	Misuse in Past Month (2021)
TOTAL	71,901	9,236	2,791
12-20	5,380	824	174
21 or Older	66,520	8,411	2,617
12-17	3,342	497	115
12-13	924	158	29
14-15	1,025	138	35
16-17	1,393	201	51
18 or Older	68,558	8,738	2,676
18-25	6,128	1,035	221
18-20	2,038	327	59
21-25	4,090	708	161
26 or Older	62,430	7,703	2,456
26-49	26,031	4,402	1,278
26-29	3,585	790	302
30-34	5,689	1,035	266
35-39	5,860	949	231
40-44	5,481	1,005	317
45-49	5,416	623	162
50 or Older	36,399	3,301	1,178
50-54	6,363	772	219
55-59	6,617	582	195
60-64	7,112	897	372
65 or Older	16,307	1,051	391
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Any use of opioids includes the use of heroin or any use of prescription pain relievers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.19B – Any Use of Opioids in Past Year and Misuse of Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021
Age Category	Any Use in Past Year¹ (2021)	Misuse in Past Year (2021)	Misuse in Past Month (2021)
TOTAL	25.7	3.3	1.0
12-20	13.8	2.1	0.4
21 or Older	27.6	3.5	1.1
12-17	12.8	1.9	0.4
12-13	10.2	1.8	0.3
14-15	12.1	1.6	0.4
16-17	16.3	2.4	0.6
18 or Older	27.0	3.4	1.1
18-25	18.3	3.1	0.7
18-20	15.6	2.5	0.5
21-25	20.1	3.5	0.8
26 or Older	28.3	3.5	1.1
26-49	25.4	4.3	1.2
26-29	20.6	4.5	1.7
30-34	25.0	4.6	1.2
35-39	26.2	4.2	1.0
40-44	26.8	4.9	1.6
45-49	27.9	3.2	0.8
50 or Older	30.8	2.8	1.0
50-54	32.8	4.0	1.1
55-59	31.1	2.7	0.9
60-64	31.5	4.0	1.7
65 or Older	29.8	1.9	0.7
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Any use of opioids includes the use of heroin or any use of prescription pain relievers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.20A – Any Use of Central Nervous System Stimulants in Past Year and Misuse of Central Nervous System Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021
Age Category	Any Use in Past Year¹ (2021)	Misuse in Past Year (2021)	Misuse in Past Month (2021)
TOTAL	21,329	9,177	4,126
12-20	3,077	862	232
21 or Older	18,252	8,315	3,894
12-17	1,841	339	92
12-13	436	29	8
14-15	601	97	27
16-17	804	213	56
18 or Older	19,488	8,838	4,034
18-25	4,064	2,111	669
18-20	1,236	523	141
21-25	2,828	1,588	529
26 or Older	15,424	6,727	3,365
26-49	9,988	4,808	2,187
26-29	2,214	1,245	598
30-34	2,299	1,093	504
35-39	2,251	1,126	401
40-44	1,761	747	360
45-49	1,463	596	323
50 or Older	5,435	1,919	1,178
50-54	1,795	660	344
55-59	1,394	485	334
60-64	841	322	208
65 or Older	1,405	451	292
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.20B – Any Use of Central Nervous System Stimulants in Past Year and Misuse of Central Nervous System Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021
Age Category	Any Use in Past Year¹ (2021)	Misuse in Past Year (2021)	Misuse in Past Month (2021)
TOTAL	7.6	3.3	1.5
12-20	7.9	2.2	0.6
21 or Older	7.6	3.5	1.6
12-17	7.1	1.3	0.4
12-13	4.8	0.3	0.1
14-15	7.1	1.1	0.3
16-17	9.4	2.5	0.7
18 or Older	7.7	3.5	1.6
18-25	12.1	6.3	2.0
18-20	9.5	4.0	1.1
21-25	13.9	7.8	2.6
26 or Older	7.0	3.1	1.5
26-49	9.8	4.7	2.1
26-29	12.7	7.1	3.4
30-34	10.1	4.8	2.2
35-39	10.1	5.0	1.8
40-44	8.6	3.7	1.8
45-49	7.5	3.1	1.7
50 or Older	4.6	1.6	1.0
50-54	9.3	3.4	1.8
55-59	6.5	2.3	1.6
60-64	3.7	1.4	0.9
65 or Older	2.6	0.8	0.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.21A – Use of Illicit Drugs Other Than Marijuana in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021
Age Category	Past Year (2021)	Past Month (2021)
TOTAL	23,249	9,030
12-20	2,996	838
21 or Older	20,252	8,193
12-17	1,562	476
12-13	395	137
14-15	408	124
16-17	759	216
18 or Older	21,687	8,554
18-25	4,614	1,361
18-20	1,434	361
21-25	3,179	1,000
26 or Older	17,073	7,193
26-49	11,359	4,577
26-29	2,718	1,297
30-34	2,661	1,077
35-39	2,461	844
40-44	1,992	811
45-49	1,527	548
50 or Older	5,714	2,615
50-54	1,420	623
55-59	1,316	658
60-64	1,331	581
65 or Older	1,647	753
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.21B – Use of Illicit Drugs Other Than Marijuana in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021
Age Category	Past Year (2021)	Past Month (2021)
TOTAL	8.3	3.2
12-20	7.7	2.1
21 or Older	8.4	3.4
12-17	6.0	1.8
12-13	4.4	1.5
14-15	4.8	1.5
16-17	8.9	2.5
18 or Older	8.5	3.4
18-25	13.8	4.1
18-20	11.0	2.8
21-25	15.6	4.9
26 or Older	7.7	3.3
26-49	11.1	4.5
26-29	15.6	7.4
30-34	11.7	4.7
35-39	11.0	3.8
40-44	9.8	4.0
45-49	7.9	2.8
50 or Older	4.8	2.2
50-54	7.3	3.2
55-59	6.2	3.1
60-64	5.9	2.6
65 or Older	3.0	1.4
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.22A – Any Use and Misuse of Prescription Psychotherapeutics in Past Year: Among People Aged 12 or Older; Misuse of Prescription Psychotherapeutics in Past Year: Among Past Year Any Users Aged 12 or Older; by Age Group, Numbers in Thousands, 2021
Prescription Drug/Age Group	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Past Year Any Users (2021)
PSYCHOTHERAPEUTICS	97,719	14,284	14,284
12-17	4,986	851	851
18 or Older	92,733	13,433	13,433
18-25	9,552	2,486	2,486
26 or Older	83,181	10,947	10,947
PAIN RELIEVERS	71,688	8,711	8,711
12-17	3,342	497	497
18 or Older	68,346	8,213	8,213
18-25	6,119	1,018	1,018
26 or Older	62,227	7,195	7,195
STIMULANTS	16,630	3,733	3,733
12-17	1,821	304	304
18 or Older	14,808	3,429	3,429
18-25	3,354	1,244	1,244
26 or Older	11,454	2,184	2,184
TRANQUILIZERS OR SEDATIVES	40,899	4,887	4,887
12-17	1,002	225	225
18 or Older	39,897	4,662	4,662
18-25	2,950	874	874
26 or Older	36,947	3,788	3,788
TRANQUILIZERS	32,735	4,317	4,317
12-17	737	198	198
18 or Older	31,998	4,119	4,119
18-25	2,449	810	810
26 or Older	29,549	3,309	3,309
SEDATIVES	14,548	923	923
12-17	408	41	41
18 or Older	14,140	881	881
18-25	846	141	141
26 or Older	13,295	740	740
BENZODIAZEPINES	25,630	3,941	3,941
12-17	462	181	*
18 or Older	25,168	3,760	3,760
18-25	2,147	787	787
26 or Older	23,021	2,973	2,973
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.22B – Any Use and Misuse of Prescription Psychotherapeutics in Past Year: Among People Aged 12 or Older; Misuse of Prescription Psychotherapeutics in Past Year: Among Past Year Any Users Aged 12 or Older; by Age Group, Percentages, 2021
Prescription Drug/Age Group	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Misuse in Past Year among Past Year Any Users (2021)
PSYCHOTHERAPEUTICS	34.9	5.1	14.6
12-17	19.2	3.3	17.1
18 or Older	36.5	5.3	14.5
18-25	28.5	7.4	26.0
26 or Older	37.7	5.0	13.2
PAIN RELIEVERS	25.6	3.1	12.2
12-17	12.8	1.9	14.9
18 or Older	26.9	3.2	12.0
18-25	18.3	3.0	16.6
26 or Older	28.2	3.3	11.6
STIMULANTS	5.9	1.3	22.4
12-17	7.0	1.2	16.7
18 or Older	5.8	1.4	23.2
18-25	10.0	3.7	37.1
26 or Older	5.2	1.0	19.1
TRANQUILIZERS OR SEDATIVES	14.6	1.7	12.0
12-17	3.9	0.9	22.5
18 or Older	15.7	1.8	11.7
18-25	8.8	2.6	29.6
26 or Older	16.8	1.7	10.3
TRANQUILIZERS	11.7	1.5	13.2
12-17	2.8	0.8	26.9
18 or Older	12.6	1.6	12.9
18-25	7.3	2.4	33.1
26 or Older	13.4	1.5	11.2
SEDATIVES	5.2	0.3	6.3
12-17	1.6	0.2	10.2
18 or Older	5.6	0.3	6.2
18-25	2.5	0.4	16.7
26 or Older	6.0	0.3	5.6
BENZODIAZEPINES	9.2	1.4	15.4
12-17	1.8	0.7	*
18 or Older	9.9	1.5	14.9
18-25	6.4	2.4	36.6
26 or Older	10.4	1.3	12.9
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.23A – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	138,790	5,549	133,241	17,919	115,321
GENDER
Male	71,693	2,590	69,103	8,980	60,123
Female	67,097	2,959	64,137	8,939	55,198
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	119,405	4,114	115,292	14,117	101,175
White	93,800	2,839	90,961	10,317	80,644
Black or African American	16,433	690	15,743	2,241	13,502
AIAN	1,173	*	1,098	*	846
NHOPI	*	*	*	*	*
Asian	4,107	202	3,904	668	3,237
Two or More Races	3,320	235	3,085	555	2,530
Hispanic or Latino	19,384	1,435	17,949	3,802	14,147
EDUCATION LEVEL
< High School	da	da	11,336	1,760	9,576
High School Graduate	da	da	33,841	5,285	28,556
Some College/Associate’s Degree	da	da	45,509	7,813	37,696
College Graduate	da	da	42,554	3,060	39,494
EMPLOYMENT STATUS
Full-Time	da	da	65,708	7,594	58,114
Part-Time	da	da	17,068	4,323	12,745
Unemployed	da	da	7,924	1,785	6,139
Other¹	da	da	42,541	4,218	38,323
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.23B – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	49.6	21.3	52.5	53.6	52.3
GENDER
Male	52.4	19.5	56.0	53.7	56.3
Female	46.9	23.2	49.2	53.4	48.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	51.9	21.2	54.7	55.1	54.7
White	54.8	21.6	57.6	58.2	57.5
Black or African American	48.0	19.5	51.2	49.1	51.6
AIAN	65.4	*	67.7	*	65.3
NHOPI	*	*	*	*	*
Asian	24.9	13.8	26.0	34.2	24.8
Two or More Races	61.5	25.6	68.9	61.0	70.9
Hispanic or Latino	38.9	21.6	41.6	48.6	40.1
EDUCATION LEVEL
< High School	da	da	39.4	47.1	38.3
High School Graduate	da	da	48.5	49.7	48.2
Some College/Associate’s Degree	da	da	59.1	55.5	59.9
College Graduate	da	da	54.4	60.9	53.9
EMPLOYMENT STATUS
Full-Time	da	da	57.5	60.2	57.2
Part-Time	da	da	55.9	52.8	57.0
Unemployed	da	da	59.9	56.8	60.9
Other¹	da	da	44.4	44.3	44.4
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.24A – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	61,203	3,662	57,542	12,710	44,831
GENDER
Male	32,561	1,603	30,959	6,526	24,433
Female	28,642	2,059	26,583	6,185	20,398
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	51,539	2,754	48,785	10,140	38,645
White	38,526	1,924	36,603	7,248	29,355
Black or African American	8,318	455	7,863	1,757	6,106
AIAN	648	*	605	*	410
NHOPI	*	*	*	*	*
Asian	1,832	99	1,733	482	1,251
Two or More Races	1,868	182	1,686	414	1,273
Hispanic or Latino	9,664	908	8,757	2,570	6,187
EDUCATION LEVEL
< High School	da	da	5,803	1,295	4,508
High School Graduate	da	da	15,247	3,820	11,427
Some College/Associate’s Degree	da	da	20,873	5,586	15,288
College Graduate	da	da	15,619	2,009	13,609
EMPLOYMENT STATUS
Full-Time	da	da	27,286	5,100	22,187
Part-Time	da	da	8,471	3,274	5,197
Unemployed	da	da	4,755	1,377	3,378
Other¹	da	da	17,030	2,959	14,070
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.24B – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	21.9	14.1	22.7	38.0	20.3
GENDER
Male	23.8	12.1	25.1	39.0	22.9
Female	20.0	16.2	20.4	37.0	18.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	22.4	14.2	23.2	39.6	20.9
White	22.5	14.6	23.2	40.9	20.9
Black or African American	24.3	12.9	25.6	38.5	23.3
AIAN	36.1	*	37.3	*	31.6
NHOPI	*	*	*	*	*
Asian	11.1	6.8	11.5	24.7	9.6
Two or More Races	34.6	19.8	37.7	45.5	35.7
Hispanic or Latino	19.4	13.7	20.3	32.9	17.5
EDUCATION LEVEL
< High School	da	da	20.2	34.6	18.0
High School Graduate	da	da	21.8	36.0	19.3
Some College/Associate’s Degree	da	da	27.1	39.7	24.3
College Graduate	da	da	20.0	40.0	18.6
EMPLOYMENT STATUS
Full-Time	da	da	23.9	40.5	21.8
Part-Time	da	da	27.7	40.0	23.2
Unemployed	da	da	35.9	43.8	33.5
Other¹	da	da	17.8	31.1	16.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.25A – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	39,995	1,844	38,152	8,472	29,680
GENDER
Male	22,291	835	21,456	4,504	16,952
Female	17,704	1,009	16,696	3,968	12,727
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	34,030	1,422	32,608	6,775	25,833
White	25,464	982	24,482	4,752	19,730
Black or African American	5,641	264	5,377	1,247	4,129
AIAN	500	*	475	*	346
NHOPI	188	*	*	*	*
Asian	980	31	950	301	649
Two or More Races	1,256	88	1,168	312	856
Hispanic or Latino	5,965	421	5,544	1,697	3,847
EDUCATION LEVEL
< High School	da	da	3,926	940	2,986
High School Graduate	da	da	10,730	2,613	8,117
Some College/Associate’s Degree	da	da	14,124	3,614	10,510
College Graduate	da	da	9,372	1,305	8,066
EMPLOYMENT STATUS
Full-Time	da	da	17,585	3,493	14,091
Part-Time	da	da	5,469	2,055	3,414
Unemployed	da	da	3,440	1,011	2,429
Other¹	da	da	11,658	1,913	9,745
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.25B – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	14.3	7.1	15.0	25.3	13.5
GENDER
Male	16.3	6.3	17.4	26.9	15.9
Female	12.4	7.9	12.8	23.7	11.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	14.8	7.3	15.5	26.4	14.0
White	14.9	7.5	15.5	26.8	14.1
Black or African American	16.5	7.5	17.5	27.3	15.8
AIAN	27.9	*	29.3	*	26.7
NHOPI	18.4	*	*	*	*
Asian	5.9	2.1	6.3	15.4	5.0
Two or More Races	23.3	9.6	26.1	34.3	24.0
Hispanic or Latino	12.0	6.3	12.9	21.7	10.9
EDUCATION LEVEL
< High School	da	da	13.7	25.1	11.9
High School Graduate	da	da	15.4	24.6	13.7
Some College/Associate’s Degree	da	da	18.3	25.7	16.7
College Graduate	da	da	12.0	26.0	11.0
EMPLOYMENT STATUS
Full-Time	da	da	15.4	27.7	13.9
Part-Time	da	da	17.9	25.1	15.3
Unemployed	da	da	26.0	32.2	24.1
Other¹	da	da	12.2	20.1	11.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.26A – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	128,016	3,423	124,593	16,687	107,906
GENDER
Male	66,431	1,566	64,865	8,397	56,468
Female	61,585	1,857	59,728	8,290	51,438
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	111,064	2,562	108,502	13,178	95,324
White	87,745	1,831	85,914	9,635	76,279
Black or African American	15,158	392	14,765	2,148	12,617
AIAN	1,090	*	1,040	*	803
NHOPI	*	*	*	*	*
Asian	3,501	71	3,430	572	2,858
Two or More Races	3,095	157	2,938	502	2,436
Hispanic or Latino	16,951	860	16,091	3,509	12,582
EDUCATION LEVEL
< High School	da	da	10,102	1,598	8,504
High School Graduate	da	da	31,666	4,883	26,782
Some College/Associate’s Degree	da	da	43,029	7,287	35,742
College Graduate	da	da	39,796	2,919	36,878
EMPLOYMENT STATUS
Full-Time	da	da	61,933	7,237	54,697
Part-Time	da	da	15,865	4,000	11,865
Unemployed	da	da	7,452	1,602	5,850
Other¹	da	da	39,342	3,849	35,493
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.26B – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	45.7	13.2	49.1	49.9	49.0
GENDER
Male	48.6	11.8	52.5	50.2	52.9
Female	43.0	14.6	45.8	49.5	45.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	48.3	13.2	51.5	51.4	51.5
White	51.3	13.9	54.4	54.4	54.4
Black or African American	44.2	11.1	48.0	47.1	48.2
AIAN	60.7	*	64.1	*	61.9
NHOPI	*	*	*	*	*
Asian	21.2	4.8	22.8	29.3	21.9
Two or More Races	57.4	17.1	65.6	55.2	68.3
Hispanic or Latino	34.1	12.9	37.3	44.9	35.6
EDUCATION LEVEL
< High School	da	da	35.1	42.7	34.0
High School Graduate	da	da	45.4	46.0	45.2
Some College/Associate’s Degree	da	da	55.9	51.8	56.8
College Graduate	da	da	50.8	58.1	50.4
EMPLOYMENT STATUS
Full-Time	da	da	54.2	57.4	53.8
Part-Time	da	da	51.9	48.9	53.0
Unemployed	da	da	56.3	50.9	58.0
Other¹	da	da	41.1	40.4	41.1
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.27A – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	52,454	2,724	49,730	11,833	37,897
GENDER
Male	28,489	1,230	27,258	6,113	21,145
Female	23,965	1,494	22,472	5,720	16,752
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	44,603	2,106	42,497	9,431	33,067
White	33,317	1,488	31,829	6,713	25,116
Black or African American	7,294	338	6,956	1,691	5,265
AIAN	628	*	593	*	404
NHOPI	*	*	*	*	*
Asian	1,425	59	1,366	422	944
Two or More Races	1,655	137	1,519	378	1,141
Hispanic or Latino	7,851	618	7,233	2,403	4,830
EDUCATION LEVEL
< High School	da	da	4,695	1,196	3,499
High School Graduate	da	da	13,059	3,496	9,563
Some College/Associate’s Degree	da	da	18,483	5,266	13,218
College Graduate	da	da	13,493	1,876	11,617
EMPLOYMENT STATUS
Full-Time	da	da	23,830	4,763	19,066
Part-Time	da	da	7,614	3,063	4,551
Unemployed	da	da	4,258	1,281	2,976
Other¹	da	da	14,028	2,726	11,303
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.27B – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	18.7	10.5	19.6	35.4	17.2
GENDER
Male	20.8	9.3	22.1	36.6	19.8
Female	16.7	11.7	17.2	34.2	14.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	19.4	10.9	20.2	36.8	17.9
White	19.5	11.3	20.2	37.9	17.9
Black or African American	21.3	9.6	22.6	37.0	20.1
AIAN	35.0	*	36.6	*	31.2
NHOPI	*	*	*	*	*
Asian	8.6	4.1	9.1	21.6	7.2
Two or More Races	30.7	14.9	33.9	41.6	32.0
Hispanic or Latino	15.8	9.3	16.8	30.7	13.7
EDUCATION LEVEL
< High School	da	da	16.3	32.0	14.0
High School Graduate	da	da	18.7	32.9	16.2
Some College/Associate’s Degree	da	da	24.0	37.4	21.0
College Graduate	da	da	17.2	37.3	15.9
EMPLOYMENT STATUS
Full-Time	da	da	20.9	37.8	18.8
Part-Time	da	da	24.9	37.4	20.3
Unemployed	da	da	32.2	40.7	29.5
Other¹	da	da	14.6	28.6	13.1
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.28A – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	36,363	1,499	34,864	8,073	26,791
GENDER
Male	20,682	692	19,991	4,358	15,633
Female	15,680	807	14,873	3,715	11,158
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	31,128	1,173	29,956	6,477	23,478
White	23,153	844	22,308	4,516	17,793
Black or African American	5,278	200	5,078	1,214	3,864
AIAN	485	*	466	*	338
NHOPI	179	*	*	*	*
Asian	893	18	876	283	593
Two or More Races	1,141	63	1,077	309	768
Hispanic or Latino	5,234	326	4,908	1,596	3,312
EDUCATION LEVEL
< High School	da	da	3,483	905	2,578
High School Graduate	da	da	9,699	2,455	7,244
Some College/Associate’s Degree	da	da	13,199	3,487	9,712
College Graduate	da	da	8,483	1,227	7,256
EMPLOYMENT STATUS
Full-Time	da	da	16,409	3,347	13,062
Part-Time	da	da	5,091	1,955	3,137
Unemployed	da	da	3,196	962	2,234
Other¹	da	da	10,168	1,810	8,358
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.28B – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	13.0	5.8	13.7	24.1	12.2
GENDER
Male	15.1	5.2	16.2	26.1	14.6
Female	11.0	6.3	11.4	22.2	9.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	13.5	6.1	14.2	25.3	12.7
White	13.5	6.4	14.1	25.5	12.7
Black or African American	15.4	5.6	16.5	26.6	14.8
AIAN	27.0	*	28.8	*	26.1
NHOPI	17.4	*	*	*	*
Asian	5.4	1.2	5.8	14.5	4.5
Two or More Races	21.1	6.9	24.1	34.0	21.5
Hispanic or Latino	10.5	4.9	11.4	20.4	9.4
EDUCATION LEVEL
< High School	da	da	12.1	24.2	10.3
High School Graduate	da	da	13.9	23.1	12.2
Some College/Associate’s Degree	da	da	17.1	24.8	15.4
College Graduate	da	da	10.8	24.4	9.9
EMPLOYMENT STATUS
Full-Time	da	da	14.4	26.6	12.9
Part-Time	da	da	16.7	23.9	14.0
Unemployed	da	da	24.2	30.6	22.2
Other¹	da	da	10.6	19.0	9.7
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.29A – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	40,901	102	40,798	2,819	37,980
GENDER
Male	23,395	70	23,325	1,599	21,726
Female	17,506	33	17,473	1,220	16,253
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	35,709	66	35,643	2,229	33,414
White	29,714	61	29,653	1,878	27,775
Black or African American	3,526	4	3,522	69	3,453
AIAN	408	0	407	*	351
NHOPI	*	*	*	*	*
Asian	845	*	845	119	726
Two or More Races	1,114	2	1,113	100	1,013
Hispanic or Latino	5,192	36	5,156	590	4,566
EDUCATION LEVEL
< High School	da	da	3,818	255	3,563
High School Graduate	da	da	10,930	746	10,184
Some College/Associate’s Degree	da	da	14,657	1,169	13,488
College Graduate	da	da	11,394	649	10,745
EMPLOYMENT STATUS
Full-Time	da	da	19,288	1,277	18,012
Part-Time	da	da	4,920	595	4,325
Unemployed	da	da	2,860	336	2,525
Other¹	da	da	13,730	612	13,119
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.29B – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	14.6	0.4	16.1	8.4	17.2
GENDER
Male	17.1	0.5	18.9	9.6	20.4
Female	12.2	0.3	13.4	7.3	14.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	15.5	0.3	16.9	8.7	18.1
White	17.4	0.5	18.8	10.6	19.8
Black or African American	10.3	0.1	11.5	1.5	13.2
AIAN	22.7	0.3	25.1	*	27.1
NHOPI	*	*	*	*	*
Asian	5.1	*	5.6	6.1	5.6
Two or More Races	20.7	0.2	24.9	10.9	28.4
Hispanic or Latino	10.4	0.5	12.0	7.5	12.9
EDUCATION LEVEL
< High School	da	da	13.3	6.8	14.2
High School Graduate	da	da	15.7	7.0	17.2
Some College/Associate’s Degree	da	da	19.0	8.3	21.4
College Graduate	da	da	14.6	12.9	14.7
EMPLOYMENT STATUS
Full-Time	da	da	16.9	10.1	17.7
Part-Time	da	da	16.1	7.3	19.3
Unemployed	da	da	21.6	10.7	25.0
Other¹	da	da	14.3	6.4	15.2
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.30A – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	4,765	40	4,725	1,173	3,551
GENDER
Male	2,946	25	2,920	650	2,270
Female	1,819	14	1,804	523	1,281
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,907	34	3,873	958	2,914
White	2,927	32	2,895	759	2,136
Black or African American	594	*	594	45	548
AIAN	51	0	51	*	13
NHOPI	*	*	*	*	*
Asian	157	*	157	87	70
Two or More Races	172	1	171	29	141
Hispanic or Latino	858	6	852	215	637
EDUCATION LEVEL
< High School	da	da	657	89	568
High School Graduate	da	da	1,279	273	1,006
Some College/Associate’s Degree	da	da	1,785	563	1,222
College Graduate	da	da	1,004	249	756
EMPLOYMENT STATUS
Full-Time	da	da	2,068	511	1,557
Part-Time	da	da	689	286	403
Unemployed	da	da	591	155	436
Other¹	da	da	1,377	221	1,155
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.30B – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1.7	0.2	1.9	3.5	1.6
GENDER
Male	2.2	0.2	2.4	3.9	2.1
Female	1.3	0.1	1.4	3.1	1.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.7	0.2	1.8	3.7	1.6
White	1.7	0.2	1.8	4.3	1.5
Black or African American	1.7	*	1.9	1.0	2.1
AIAN	2.8	0.0	3.1	*	1.0
NHOPI	*	*	*	*	*
Asian	1.0	*	1.0	4.4	0.5
Two or More Races	3.2	0.1	3.8	3.2	4.0
Hispanic or Latino	1.7	0.1	2.0	2.7	1.8
EDUCATION LEVEL
< High School	da	da	2.3	2.4	2.3
High School Graduate	da	da	1.8	2.6	1.7
Some College/Associate’s Degree	da	da	2.3	4.0	1.9
College Graduate	da	da	1.3	4.9	1.0
EMPLOYMENT STATUS
Full-Time	da	da	1.8	4.1	1.5
Part-Time	da	da	2.3	3.5	1.8
Unemployed	da	da	4.5	4.9	4.3
Other¹	da	da	1.4	2.3	1.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.31A – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1,833	5	1,828	373	1,455
GENDER
Male	1,099	5	1,094	201	893
Female	734	*	734	172	562
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,477	4	1,473	294	1,179
White	1,097	4	1,093	234	859
Black or African American	276	*	276	12	263
AIAN	14	*	14	7	7
NHOPI	*	*	*	*	*
Asian	51	*	51	39	12
Two or More Races	39	*	39	2	37
Hispanic or Latino	356	1	355	79	276
EDUCATION LEVEL
< High School	da	da	333	32	301
High School Graduate	da	da	505	101	404
Some College/Associate’s Degree	da	da	664	168	496
College Graduate	da	da	325	71	254
EMPLOYMENT STATUS
Full-Time	da	da	742	164	578
Part-Time	da	da	283	114	169
Unemployed	da	da	213	36	176
Other¹	da	da	591	59	532
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.31B – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.7	0.0	0.7	1.1	0.7
GENDER
Male	0.8	0.0	0.9	1.2	0.8
Female	0.5	*	0.6	1.0	0.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.6	0.0	0.7	1.1	0.6
White	0.6	0.0	0.7	1.3	0.6
Black or African American	0.8	*	0.9	0.3	1.0
AIAN	0.8	*	0.8	2.0	0.5
NHOPI	*	*	*	*	*
Asian	0.3	*	0.3	2.0	0.1
Two or More Races	0.7	*	0.9	0.2	1.0
Hispanic or Latino	0.7	0.0	0.8	1.0	0.8
EDUCATION LEVEL
< High School	da	da	1.2	0.9	1.2
High School Graduate	da	da	0.7	0.9	0.7
Some College/Associate’s Degree	da	da	0.9	1.2	0.8
College Graduate	da	da	0.4	1.4	0.3
EMPLOYMENT STATUS
Full-Time	da	da	0.6	1.3	0.6
Part-Time	da	da	0.9	1.4	0.8
Unemployed	da	da	1.6	1.2	1.7
Other¹	da	da	0.6	0.6	0.6
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.32A – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	10,640	16	10,623	303	10,320
GENDER
Male	6,458	14	6,444	179	6,264
Female	4,182	2	4,179	124	4,056
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	9,447	16	9,431	242	9,188
White	7,203	16	7,186	185	7,001
Black or African American	1,748	*	1,748	1	1,746
AIAN	113	0	113	*	90
NHOPI	*	*	*	*	*
Asian	74	*	74	18	56
Two or More Races	247	*	247	9	237
Hispanic or Latino	1,192	*	1,192	61	1,132
EDUCATION LEVEL
< High School	da	da	1,860	79	1,781
High School Graduate	da	da	4,168	130	4,038
Some College/Associate’s Degree	da	da	3,523	73	3,449
College Graduate	da	da	1,072	21	1,052
EMPLOYMENT STATUS
Full-Time	da	da	4,103	120	3,984
Part-Time	da	da	1,056	38	1,018
Unemployed	da	da	1,129	61	1,068
Other¹	da	da	4,334	84	4,251
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.32B – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	3.8	0.1	4.2	0.9	4.7
GENDER
Male	4.7	0.1	5.2	1.1	5.9
Female	2.9	0.0	3.2	0.7	3.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	4.1	0.1	4.5	0.9	5.0
White	4.2	0.1	4.5	1.0	5.0
Black or African American	5.1	*	5.7	0.0	6.7
AIAN	6.3	0.2	6.9	*	6.9
NHOPI	*	*	*	*	*
Asian	0.4	*	0.5	0.9	0.4
Two or More Races	4.6	*	5.5	1.0	6.7
Hispanic or Latino	2.4	*	2.8	0.8	3.2
EDUCATION LEVEL
< High School	da	da	6.5	2.1	7.1
High School Graduate	da	da	6.0	1.2	6.8
Some College/Associate’s Degree	da	da	4.6	0.5	5.5
College Graduate	da	da	1.4	0.4	1.4
EMPLOYMENT STATUS
Full-Time	da	da	3.6	0.9	3.9
Part-Time	da	da	3.5	0.5	4.6
Unemployed	da	da	8.5	1.9	10.6
Other¹	da	da	4.5	0.9	4.9
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.33A – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	996	3	993	74	919
GENDER
Male	644	1	643	31	613
Female	352	2	350	44	306
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	926	3	923	55	868
White	538	3	535	22	513
Black or African American	300	*	300	*	300
AIAN	*	*	*	*	5
NHOPI	*	*	*	*	*
Asian	13	*	13	*	*
Two or More Races	53	*	53	3	50
Hispanic or Latino	70	*	70	19	51
EDUCATION LEVEL
< High School	da	da	236	20	216
High School Graduate	da	da	396	31	365
Some College/Associate’s Degree	da	da	299	8	291
College Graduate	da	da	62	15	47
EMPLOYMENT STATUS
Full-Time	da	da	264	38	226
Part-Time	da	da	60	3	58
Unemployed	da	da	247	33	214
Other¹	da	da	422	1	421
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.33B – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.4	0.0	0.4	0.2	0.4
GENDER
Male	0.5	0.0	0.5	0.2	0.6
Female	0.2	0.0	0.3	0.3	0.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.4	0.0	0.4	0.2	0.5
White	0.3	0.0	0.3	0.1	0.4
Black or African American	0.9	*	1.0	*	1.1
AIAN	*	*	*	*	0.4
NHOPI	*	*	*	*	*
Asian	0.1	*	0.1	*	*
Two or More Races	1.0	*	1.2	0.3	1.4
Hispanic or Latino	0.1	*	0.2	0.2	0.1
EDUCATION LEVEL
< High School	da	da	0.8	0.5	0.9
High School Graduate	da	da	0.6	0.3	0.6
Some College/Associate’s Degree	da	da	0.4	0.1	0.5
College Graduate	da	da	0.1	0.3	0.1
EMPLOYMENT STATUS
Full-Time	da	da	0.2	0.3	0.2
Part-Time	da	da	0.2	0.0	0.3
Unemployed	da	da	1.9	1.0	2.1
Other¹	da	da	0.4	0.0	0.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.34A – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	527	*	526	30	496
GENDER
Male	317	1	316	11	306
Female	210	*	210	19	190
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	503	1	502	11	491
White	338	1	337	11	327
Black or African American	152	*	152	*	152
AIAN	0	*	0	*	0
NHOPI	*	*	*	*	*
Asian	*	*	*	*	*
Two or More Races	12	*	12	*	12
Hispanic or Latino	24	*	24	19	5
EDUCATION LEVEL
< High School	da	da	156	14	142
High School Graduate	da	da	160	9	151
Some College/Associate’s Degree	da	da	174	7	168
College Graduate	da	da	36	*	36
EMPLOYMENT STATUS
Full-Time	da	da	115	23	92
Part-Time	da	da	45	*	45
Unemployed	da	da	114	7	107
Other¹	da	da	252	*	252
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.34B – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.2	*	0.2	0.1	0.2
GENDER
Male	0.2	0.0	0.3	0.1	0.3
Female	0.1	*	0.2	0.1	0.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.2	0.0	0.2	0.0	0.3
White	0.2	0.0	0.2	0.1	0.2
Black or African American	0.4	*	0.5	*	0.6
AIAN	0.0	*	0.0	*	0.0
NHOPI	*	*	*	*	*
Asian	*	*	*	*	*
Two or More Races	0.2	*	0.3	*	0.3
Hispanic or Latino	0.0	*	0.1	0.2	0.0
EDUCATION LEVEL
< High School	da	da	0.5	0.4	0.6
High School Graduate	da	da	0.2	0.1	0.3
Some College/Associate’s Degree	da	da	0.2	0.0	0.3
College Graduate	da	da	0.0	*	0.0
EMPLOYMENT STATUS
Full-Time	da	da	0.1	0.2	0.1
Part-Time	da	da	0.1	*	0.2
Unemployed	da	da	0.9	0.2	1.1
Other¹	da	da	0.3	*	0.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.35A – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	45,826	591	45,235	5,154	40,081
GENDER
Male	26,679	367	26,312	2,914	23,398
Female	19,147	224	18,923	2,240	16,683
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	40,311	386	39,925	4,248	35,677
White	34,139	308	33,832	3,309	30,523
Black or African American	3,062	28	3,035	369	2,666
AIAN	451	*	446	*	352
NHOPI	159	*	*	*	*
Asian	1,133	2	1,131	267	864
Two or More Races	1,367	15	1,353	194	1,158
Hispanic or Latino	5,515	205	5,310	907	4,403
EDUCATION LEVEL
< High School	da	da	3,207	451	2,756
High School Graduate	da	da	11,269	1,567	9,702
Some College/Associate’s Degree	da	da	16,287	2,207	14,081
College Graduate	da	da	14,471	930	13,542
EMPLOYMENT STATUS
Full-Time	da	da	22,438	2,184	20,253
Part-Time	da	da	6,068	1,174	4,893
Unemployed	da	da	3,172	605	2,567
Other¹	da	da	13,557	1,190	12,367
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.35B – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	16.4	2.3	17.8	15.4	18.2
GENDER
Male	19.5	2.8	21.3	17.4	21.9
Female	13.4	1.8	14.5	13.4	14.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	17.5	2.0	18.9	16.6	19.3
White	20.0	2.3	21.4	18.7	21.8
Black or African American	8.9	0.8	9.9	8.1	10.2
AIAN	25.1	*	27.5	*	27.2
NHOPI	15.5	*	*	*	*
Asian	6.9	0.1	7.5	13.7	6.6
Two or More Races	25.3	1.6	30.2	21.3	32.5
Hispanic or Latino	11.1	3.1	12.3	11.6	12.5
EDUCATION LEVEL
< High School	da	da	11.2	12.1	11.0
High School Graduate	da	da	16.1	14.7	16.4
Some College/Associate’s Degree	da	da	21.2	15.7	22.4
College Graduate	da	da	18.5	18.5	18.5
EMPLOYMENT STATUS
Full-Time	da	da	19.6	17.3	19.9
Part-Time	da	da	19.9	14.3	21.9
Unemployed	da	da	24.0	19.2	25.5
Other¹	da	da	14.1	12.5	14.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.36A – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	7,406	347	7,058	2,361	4,697
GENDER
Male	4,399	195	4,204	1,277	2,927
Female	3,007	152	2,854	1,084	1,770
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	6,233	226	6,007	1,925	4,082
White	4,988	177	4,812	1,487	3,325
Black or African American	591	15	576	181	395
AIAN	73	*	69	*	27
NHOPI	49	*	*	*	*
Asian	234	0	234	112	122
Two or More Races	298	9	289	92	198
Hispanic or Latino	1,173	122	1,051	436	615
EDUCATION LEVEL
< High School	da	da	396	180	217
High School Graduate	da	da	1,696	738	959
Some College/Associate’s Degree	da	da	2,717	1,057	1,660
College Graduate	da	da	2,249	387	1,862
EMPLOYMENT STATUS
Full-Time	da	da	3,496	956	2,540
Part-Time	da	da	1,280	600	680
Unemployed	da	da	769	248	521
Other¹	da	da	1,514	558	956
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.36B – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	2.6	1.3	2.8	7.1	2.1
GENDER
Male	3.2	1.5	3.4	7.6	2.7
Female	2.1	1.2	2.2	6.5	1.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2.7	1.2	2.9	7.5	2.2
White	2.9	1.3	3.0	8.4	2.4
Black or African American	1.7	0.4	1.9	4.0	1.5
AIAN	4.1	*	4.2	*	2.1
NHOPI	4.8	*	*	*	*
Asian	1.4	0.0	1.6	5.7	0.9
Two or More Races	5.5	0.9	6.5	10.1	5.5
Hispanic or Latino	2.4	1.8	2.4	5.6	1.7
EDUCATION LEVEL
< High School	da	da	1.4	4.8	0.9
High School Graduate	da	da	2.4	6.9	1.6
Some College/Associate’s Degree	da	da	3.5	7.5	2.6
College Graduate	da	da	2.9	7.7	2.5
EMPLOYMENT STATUS
Full-Time	da	da	3.1	7.6	2.5
Part-Time	da	da	4.2	7.3	3.0
Unemployed	da	da	5.8	7.9	5.2
Other¹	da	da	1.6	5.9	1.1
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.37A – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	2,234	78	2,156	525	1,631
GENDER
Male	1,294	55	1,239	301	938
Female	940	23	917	224	693
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,824	68	1,756	402	1,354
White	1,484	54	1,429	301	1,128
Black or African American	172	8	164	48	116
AIAN	17	*	13	*	*
NHOPI	27	*	*	*	*
Asian	49	*	49	23	26
Two or More Races	76	2	74	15	59
Hispanic or Latino	410	10	400	123	276
EDUCATION LEVEL
< High School	da	da	100	25	75
High School Graduate	da	da	577	186	391
Some College/Associate’s Degree	da	da	831	215	617
College Graduate	da	da	648	99	548
EMPLOYMENT STATUS
Full-Time	da	da	993	247	747
Part-Time	da	da	341	126	214
Unemployed	da	da	271	53	218
Other¹	da	da	550	99	451
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.37B – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.8	0.3	0.8	1.6	0.7
GENDER
Male	0.9	0.4	1.0	1.8	0.9
Female	0.7	0.2	0.7	1.3	0.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.8	0.4	0.8	1.6	0.7
White	0.9	0.4	0.9	1.7	0.8
Black or African American	0.5	0.2	0.5	1.0	0.4
AIAN	1.0	*	0.8	*	*
NHOPI	2.6	*	*	*	*
Asian	0.3	*	0.3	1.2	0.2
Two or More Races	1.4	0.2	1.6	1.6	1.6
Hispanic or Latino	0.8	0.1	0.9	1.6	0.8
EDUCATION LEVEL
< High School	da	da	0.3	0.7	0.3
High School Graduate	da	da	0.8	1.8	0.7
Some College/Associate’s Degree	da	da	1.1	1.5	1.0
College Graduate	da	da	0.8	2.0	0.7
EMPLOYMENT STATUS
Full-Time	da	da	0.9	2.0	0.7
Part-Time	da	da	1.1	1.5	1.0
Unemployed	da	da	2.1	1.7	2.2
Other¹	da	da	0.6	1.0	0.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.38A – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	25,596	2,294	23,302	2,770	20,532
GENDER
Male	15,130	1,085	14,045	1,506	12,539
Female	10,466	1,209	9,257	1,264	7,994
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	22,463	1,742	20,721	2,185	18,535
White	19,401	1,256	18,145	1,745	16,400
Black or African American	1,340	277	1,063	156	907
AIAN	148	*	124	*	84
NHOPI	*	*	*	*	*
Asian	719	102	617	128	489
Two or More Races	730	69	661	108	553
Hispanic or Latino	3,133	552	2,581	585	1,997
EDUCATION LEVEL
< High School	da	da	1,708	319	1,389
High School Graduate	da	da	5,079	808	4,271
Some College/Associate’s Degree	da	da	8,360	1,176	7,184
College Graduate	da	da	8,155	466	7,689
EMPLOYMENT STATUS
Full-Time	da	da	12,101	1,077	11,024
Part-Time	da	da	3,257	689	2,569
Unemployed	da	da	1,539	292	1,247
Other¹	da	da	6,404	712	5,692
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.38B – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	9.1	8.8	9.2	8.3	9.3
GENDER
Male	11.1	8.2	11.4	9.0	11.7
Female	7.3	9.5	7.1	7.6	7.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	9.8	9.0	9.8	8.5	10.0
White	11.3	9.6	11.5	9.8	11.7
Black or African American	3.9	7.8	3.5	3.4	3.5
AIAN	8.2	*	7.7	*	6.5
NHOPI	*	*	*	*	*
Asian	4.4	7.0	4.1	6.6	3.7
Two or More Races	13.5	7.5	14.8	11.8	15.5
Hispanic or Latino	6.3	8.3	6.0	7.5	5.7
EDUCATION LEVEL
< High School	da	da	5.9	8.5	5.6
High School Graduate	da	da	7.3	7.6	7.2
Some College/Associate’s Degree	da	da	10.9	8.4	11.4
College Graduate	da	da	10.4	9.3	10.5
EMPLOYMENT STATUS
Full-Time	da	da	10.6	8.5	10.8
Part-Time	da	da	10.7	8.4	11.5
Unemployed	da	da	11.6	9.3	12.4
Other¹	da	da	6.7	7.5	6.6
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.39A – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	2,178	626	1,552	497	1,055
GENDER
Male	1,436	305	1,132	308	823
Female	741	321	420	189	231
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,816	482	1,334	409	925
White	1,410	346	1,064	314	750
Black or African American	182	81	101	22	79
AIAN	15	*	7	1	6
NHOPI	3	*	2	*	2
Asian	145	30	115	53	62
Two or More Races	61	16	45	20	25
Hispanic or Latino	362	144	218	88	130
EDUCATION LEVEL
< High School	da	da	71	29	42
High School Graduate	da	da	394	154	240
Some College/Associate’s Degree	da	da	475	215	260
College Graduate	da	da	612	98	514
EMPLOYMENT STATUS
Full-Time	da	da	744	172	572
Part-Time	da	da	222	114	108
Unemployed	da	da	143	74	69
Other¹	da	da	443	137	306
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.39B – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.8	2.4	0.6	1.5	0.5
GENDER
Male	1.1	2.3	0.9	1.8	0.8
Female	0.5	2.5	0.3	1.1	0.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.8	2.5	0.6	1.6	0.5
White	0.8	2.6	0.7	1.8	0.5
Black or African American	0.5	2.3	0.3	0.5	0.3
AIAN	0.8	*	0.5	0.4	0.5
NHOPI	0.3	*	0.2	*	0.2
Asian	0.9	2.0	0.8	2.7	0.5
Two or More Races	1.1	1.8	1.0	2.2	0.7
Hispanic or Latino	0.7	2.2	0.5	1.1	0.4
EDUCATION LEVEL
< High School	da	da	0.2	0.8	0.2
High School Graduate	da	da	0.6	1.5	0.4
Some College/Associate’s Degree	da	da	0.6	1.5	0.4
College Graduate	da	da	0.8	2.0	0.7
EMPLOYMENT STATUS
Full-Time	da	da	0.7	1.4	0.6
Part-Time	da	da	0.7	1.4	0.5
Unemployed	da	da	1.1	2.4	0.7
Other¹	da	da	0.5	1.4	0.4
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.40A – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	830	205	625	121	504
GENDER
Male	613	112	501	73	427
Female	218	93	124	47	77
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	674	153	521	93	428
White	534	82	452	79	373
Black or African American	83	43	40	9	31
AIAN	13	*	*	0	*
NHOPI	1	*	*	*	*
Asian	26	12	14	4	10
Two or More Races	17	8	9	1	8
Hispanic or Latino	156	52	104	28	76
EDUCATION LEVEL
< High School	da	da	23	1	21
High School Graduate	da	da	180	38	142
Some College/Associate’s Degree	da	da	142	55	87
College Graduate	da	da	280	26	253
EMPLOYMENT STATUS
Full-Time	da	da	298	33	265
Part-Time	da	da	77	35	42
Unemployed	da	da	64	21	43
Other¹	da	da	186	32	154
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.40B – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.3	0.8	0.2	0.4	0.2
GENDER
Male	0.4	0.8	0.4	0.4	0.4
Female	0.2	0.7	0.1	0.3	0.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.3	0.8	0.2	0.4	0.2
White	0.3	0.6	0.3	0.4	0.3
Black or African American	0.2	1.2	0.1	0.2	0.1
AIAN	0.7	*	*	0.0	*
NHOPI	0.1	*	*	*	*
Asian	0.2	0.8	0.1	0.2	0.1
Two or More Races	0.3	0.9	0.2	0.1	0.2
Hispanic or Latino	0.3	0.8	0.2	0.4	0.2
EDUCATION LEVEL
< High School	da	da	0.1	0.0	0.1
High School Graduate	da	da	0.3	0.4	0.2
Some College/Associate’s Degree	da	da	0.2	0.4	0.1
College Graduate	da	da	0.4	0.5	0.3
EMPLOYMENT STATUS
Full-Time	da	da	0.3	0.3	0.3
Part-Time	da	da	0.3	0.4	0.2
Unemployed	da	da	0.5	0.7	0.4
Other¹	da	da	0.2	0.3	0.2
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.41A – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	16,830	50	16,780	597	16,182
GENDER
Male	9,543	27	9,516	337	9,179
Female	7,287	23	7,264	260	7,004
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	14,712	37	14,675	500	14,176
White	13,183	25	13,158	402	12,757
Black or African American	511	10	502	20	481
AIAN	201	1	200	*	166
NHOPI	28	*	28	*	28
Asian	222	*	222	16	206
Two or More Races	566	1	565	28	537
Hispanic or Latino	2,118	14	2,104	98	2,006
EDUCATION LEVEL
< High School	da	da	1,876	171	1,705
High School Graduate	da	da	5,701	255	5,446
Some College/Associate’s Degree	da	da	6,296	142	6,154
College Graduate	da	da	2,906	29	2,877
EMPLOYMENT STATUS
Full-Time	da	da	6,872	264	6,609
Part-Time	da	da	2,036	79	1,957
Unemployed	da	da	1,450	100	1,351
Other¹	da	da	6,421	155	6,266
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.41B – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	6.0	0.2	6.6	1.8	7.3
GENDER
Male	7.0	0.2	7.7	2.0	8.6
Female	5.1	0.2	5.6	1.6	6.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	6.4	0.2	7.0	1.9	7.7
White	7.7	0.2	8.3	2.3	9.1
Black or African American	1.5	0.3	1.6	0.4	1.8
AIAN	11.2	0.6	12.3	*	12.8
NHOPI	2.8	*	3.2	*	4.0
Asian	1.3	*	1.5	0.8	1.6
Two or More Races	10.5	0.1	12.6	3.0	15.1
Hispanic or Latino	4.3	0.2	4.9	1.2	5.7
EDUCATION LEVEL
< High School	da	da	6.5	4.6	6.8
High School Graduate	da	da	8.2	2.4	9.2
Some College/Associate’s Degree	da	da	8.2	1.0	9.8
College Graduate	da	da	3.7	0.6	3.9
EMPLOYMENT STATUS
Full-Time	da	da	6.0	2.1	6.5
Part-Time	da	da	6.7	1.0	8.7
Unemployed	da	da	11.0	3.2	13.4
Other¹	da	da	6.7	1.6	7.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.42A – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	2,549	37	2,512	166	2,346
GENDER
Male	1,617	22	1,595	78	1,517
Female	932	15	917	88	829
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2,197	24	2,172	123	2,050
White	1,869	14	1,855	99	1,756
Black or African American	152	10	142	2	140
AIAN	34	*	34	3	30
NHOPI	*	*	*	*	*
Asian	48	*	48	*	37
Two or More Races	88	*	88	8	80
Hispanic or Latino	352	13	339	43	296
EDUCATION LEVEL
< High School	da	da	347	53	294
High School Graduate	da	da	1,058	76	982
Some College/Associate’s Degree	da	da	897	31	866
College Graduate	da	da	210	7	203
EMPLOYMENT STATUS
Full-Time	da	da	600	44	556
Part-Time	da	da	376	30	346
Unemployed	da	da	450	34	415
Other¹	da	da	1,086	58	1,028
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.42B – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.9	0.1	1.0	0.5	1.1
GENDER
Male	1.2	0.2	1.3	0.5	1.4
Female	0.7	0.1	0.7	0.5	0.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.0	0.1	1.0	0.5	1.1
White	1.1	0.1	1.2	0.6	1.3
Black or African American	0.4	0.3	0.5	0.0	0.5
AIAN	1.9	*	2.1	1.0	2.3
NHOPI	*	*	*	*	*
Asian	0.3	*	0.3	*	0.3
Two or More Races	1.6	*	2.0	0.9	2.3
Hispanic or Latino	0.7	0.2	0.8	0.6	0.8
EDUCATION LEVEL
< High School	da	da	1.2	1.4	1.2
High School Graduate	da	da	1.5	0.7	1.7
Some College/Associate’s Degree	da	da	1.2	0.2	1.4
College Graduate	da	da	0.3	0.1	0.3
EMPLOYMENT STATUS
Full-Time	da	da	0.5	0.3	0.5
Part-Time	da	da	1.2	0.4	1.5
Unemployed	da	da	3.4	1.1	4.1
Other¹	da	da	1.1	0.6	1.2
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.43A – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1,617	14	1,603	90	1,513
GENDER
Male	987	4	983	47	936
Female	630	10	620	43	577
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,344	14	1,330	69	1,261
White	1,153	4	1,149	59	1,091
Black or African American	59	10	49	2	47
AIAN	19	*	19	1	18
NHOPI	*	*	*	*	*
Asian	34	*	34	*	34
Two or More Races	73	*	73	7	66
Hispanic or Latino	274	0	273	22	252
EDUCATION LEVEL
< High School	da	da	227	21	206
High School Graduate	da	da	698	53	645
Some College/Associate’s Degree	da	da	566	13	552
College Graduate	da	da	113	4	109
EMPLOYMENT STATUS
Full-Time	da	da	416	17	399
Part-Time	da	da	172	8	164
Unemployed	da	da	268	18	250
Other¹	da	da	747	47	700
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.43B – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.6	0.1	0.6	0.3	0.7
GENDER
Male	0.7	0.0	0.8	0.3	0.9
Female	0.4	0.1	0.5	0.3	0.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.6	0.1	0.6	0.3	0.7
White	0.7	0.0	0.7	0.3	0.8
Black or African American	0.2	0.3	0.2	0.0	0.2
AIAN	1.1	*	1.2	0.3	1.4
NHOPI	*	*	*	*	*
Asian	0.2	*	0.2	*	0.3
Two or More Races	1.4	*	1.6	0.7	1.9
Hispanic or Latino	0.5	0.0	0.6	0.3	0.7
EDUCATION LEVEL
< High School	da	da	0.8	0.6	0.8
High School Graduate	da	da	1.0	0.5	1.1
Some College/Associate’s Degree	da	da	0.7	0.1	0.9
College Graduate	da	da	0.1	0.1	0.1
EMPLOYMENT STATUS
Full-Time	da	da	0.4	0.1	0.4
Part-Time	da	da	0.6	0.1	0.7
Unemployed	da	da	2.0	0.6	2.5
Other¹	da	da	0.8	0.5	0.8
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.44A – Any Use of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	71,688	3,342	68,346	6,119	62,227
GENDER
Male	32,314	1,477	30,837	2,720	28,117
Female	39,374	1,865	37,509	3,399	34,110
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	61,290	2,431	58,860	4,768	54,091
White	46,671	1,611	45,060	3,248	41,812
Black or African American	9,923	483	9,441	981	8,459
AIAN	579	*	537	*	449
NHOPI	*	*	*	*	*
Asian	2,348	163	2,186	243	1,943
Two or More Races	1,505	125	1,379	188	1,191
Hispanic or Latino	10,398	911	9,487	1,350	8,136
EDUCATION LEVEL
< High School	da	da	8,187	704	7,482
High School Graduate	da	da	19,673	1,961	17,712
Some College/Associate’s Degree	da	da	23,178	2,672	20,505
College Graduate	da	da	17,309	781	16,528
EMPLOYMENT STATUS
Full-Time	da	da	27,124	2,418	24,706
Part-Time	da	da	7,762	1,353	6,409
Unemployed	da	da	3,795	702	3,092
Other¹	da	da	29,665	1,645	28,021
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.44B – Any Use of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	25.6	12.8	26.9	18.3	28.2
GENDER
Male	23.6	11.1	25.0	16.3	26.3
Female	27.5	14.6	28.8	20.3	30.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	26.6	12.5	27.9	18.6	29.2
White	27.3	12.3	28.5	18.3	29.8
Black or African American	29.0	13.7	30.7	21.5	32.3
AIAN	32.3	*	33.1	*	34.6
NHOPI	*	*	*	*	*
Asian	14.3	11.1	14.6	12.4	14.9
Two or More Races	27.9	13.7	30.8	20.7	33.4
Hispanic or Latino	20.9	13.7	22.0	17.3	23.0
EDUCATION LEVEL
< High School	da	da	28.5	18.8	29.9
High School Graduate	da	da	28.2	18.5	29.9
Some College/Associate’s Degree	da	da	30.1	19.0	32.6
College Graduate	da	da	22.1	15.5	22.6
EMPLOYMENT STATUS
Full-Time	da	da	23.7	19.2	24.3
Part-Time	da	da	25.4	16.5	28.7
Unemployed	da	da	28.7	22.3	30.7
Other¹	da	da	31.0	17.3	32.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.45A – Misuse of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	8,711	497	8,213	1,018	7,195
GENDER
Male	4,345	199	4,146	487	3,659
Female	4,366	298	4,067	531	3,537
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	7,172	350	6,821	786	6,036
White	5,136	244	4,892	503	4,389
Black or African American	1,207	49	1,158	136	1,022
AIAN	79	*	70	*	43
NHOPI	*	*	*	*	*
Asian	355	18	337	55	282
Two or More Races	337	30	307	54	254
Hispanic or Latino	1,539	147	1,392	232	1,160
EDUCATION LEVEL
< High School	da	da	1,275	169	1,106
High School Graduate	da	da	2,632	372	2,261
Some College/Associate’s Degree	da	da	2,656	356	2,300
College Graduate	da	da	1,650	121	1,529
EMPLOYMENT STATUS
Full-Time	da	da	3,188	393	2,795
Part-Time	da	da	1,000	196	804
Unemployed	da	da	882	152	730
Other¹	da	da	3,143	277	2,867
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.45B – Misuse of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	3.1	1.9	3.2	3.0	3.3
GENDER
Male	3.2	1.5	3.4	2.9	3.4
Female	3.1	2.3	3.1	3.2	3.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.1	1.8	3.2	3.1	3.3
White	3.0	1.9	3.1	2.8	3.1
Black or African American	3.5	1.4	3.8	3.0	3.9
AIAN	4.4	*	4.3	*	3.3
NHOPI	*	*	*	*	*
Asian	2.2	1.2	2.2	2.8	2.2
Two or More Races	6.3	3.3	6.9	5.9	7.1
Hispanic or Latino	3.1	2.2	3.2	3.0	3.3
EDUCATION LEVEL
< High School	da	da	4.4	4.5	4.4
High School Graduate	da	da	3.8	3.5	3.8
Some College/Associate’s Degree	da	da	3.4	2.5	3.7
College Graduate	da	da	2.1	2.4	2.1
EMPLOYMENT STATUS
Full-Time	da	da	2.8	3.1	2.8
Part-Time	da	da	3.3	2.4	3.6
Unemployed	da	da	6.7	4.8	7.2
Other¹	da	da	3.3	2.9	3.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.46A – Misuse of Prescription Pain Relievers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	2,401	115	2,286	213	2,073
GENDER
Male	1,247	37	1,211	101	1,110
Female	1,153	78	1,075	112	963
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,971	75	1,895	154	1,741
White	1,441	40	1,400	90	1,310
Black or African American	344	15	329	27	303
AIAN	22	1	21	*	17
NHOPI	*	*	*	*	*
Asian	58	1	57	*	46
Two or More Races	98	18	80	14	66
Hispanic or Latino	430	40	391	59	332
EDUCATION LEVEL
< High School	da	da	385	44	341
High School Graduate	da	da	853	90	763
Some College/Associate’s Degree	da	da	625	55	570
College Graduate	da	da	423	24	399
EMPLOYMENT STATUS
Full-Time	da	da	787	83	704
Part-Time	da	da	245	42	203
Unemployed	da	da	188	26	161
Other¹	da	da	1,066	62	1,005
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.46B – Misuse of Prescription Pain Relievers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.9	0.4	0.9	0.6	0.9
GENDER
Male	0.9	0.3	1.0	0.6	1.0
Female	0.8	0.6	0.8	0.7	0.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.9	0.4	0.9	0.6	0.9
White	0.8	0.3	0.9	0.5	0.9
Black or African American	1.0	0.4	1.1	0.6	1.2
AIAN	1.2	0.5	1.3	*	1.3
NHOPI	*	*	*	*	*
Asian	0.4	0.1	0.4	*	0.3
Two or More Races	1.8	2.0	1.8	1.5	1.8
Hispanic or Latino	0.9	0.6	0.9	0.8	0.9
EDUCATION LEVEL
< High School	da	da	1.3	1.2	1.4
High School Graduate	da	da	1.2	0.8	1.3
Some College/Associate’s Degree	da	da	0.8	0.4	0.9
College Graduate	da	da	0.5	0.5	0.5
EMPLOYMENT STATUS
Full-Time	da	da	0.7	0.7	0.7
Part-Time	da	da	0.8	0.5	0.9
Unemployed	da	da	1.4	0.8	1.6
Other¹	da	da	1.1	0.6	1.2
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.47A – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	16,630	1,821	14,808	3,354	11,454
GENDER
Male	7,733	1,010	6,723	1,737	4,985
Female	8,897	811	8,086	1,617	6,469
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	14,409	1,518	12,891	2,855	10,036
White	11,800	1,212	10,588	2,264	8,323
Black or African American	1,307	146	1,161	248	913
AIAN	117	*	106	*	25
NHOPI	31	*	25	*	16
Asian	593	61	532	153	379
Two or More Races	561	81	480	101	380
Hispanic or Latino	2,220	303	1,917	499	1,419
EDUCATION LEVEL
< High School	da	da	1,273	328	945
High School Graduate	da	da	3,050	768	2,282
Some College/Associate’s Degree	da	da	5,737	1,633	4,104
College Graduate	da	da	4,748	625	4,123
EMPLOYMENT STATUS
Full-Time	da	da	7,537	1,359	6,178
Part-Time	da	da	1,947	893	1,054
Unemployed	da	da	1,046	330	716
Other¹	da	da	4,278	772	3,506
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.47B – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	5.9	7.0	5.8	10.0	5.2
GENDER
Male	5.7	7.6	5.4	10.4	4.7
Female	6.2	6.4	6.2	9.7	5.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	6.3	7.8	6.1	11.1	5.4
White	6.9	9.2	6.7	12.8	5.9
Black or African American	3.8	4.1	3.8	5.4	3.5
AIAN	6.5	*	6.5	*	2.0
NHOPI	3.1	*	2.8	*	2.2
Asian	3.6	4.2	3.5	7.8	2.9
Two or More Races	10.4	8.8	10.7	11.1	10.6
Hispanic or Latino	4.5	4.6	4.4	6.4	4.0
EDUCATION LEVEL
< High School	da	da	4.4	8.8	3.8
High School Graduate	da	da	4.4	7.2	3.9
Some College/Associate’s Degree	da	da	7.5	11.6	6.5
College Graduate	da	da	6.1	12.4	5.6
EMPLOYMENT STATUS
Full-Time	da	da	6.6	10.8	6.1
Part-Time	da	da	6.4	10.9	4.7
Unemployed	da	da	7.9	10.5	7.1
Other¹	da	da	4.5	8.1	4.1
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.48A – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	3,733	304	3,429	1,244	2,184
GENDER
Male	1,945	148	1,796	652	1,144
Female	1,788	156	1,632	592	1,041
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,241	222	3,019	1,092	1,928
White	2,712	177	2,536	877	1,659
Black or African American	215	18	197	78	119
AIAN	33	1	32	*	10
NHOPI	13	*	13	*	*
Asian	100	4	96	55	41
Two or More Races	169	22	147	52	95
Hispanic or Latino	492	82	409	152	257
EDUCATION LEVEL
< High School	da	da	177	76	101
High School Graduate	da	da	758	253	506
Some College/Associate’s Degree	da	da	1,402	606	796
College Graduate	da	da	1,091	309	782
EMPLOYMENT STATUS
Full-Time	da	da	1,784	538	1,246
Part-Time	da	da	621	358	263
Unemployed	da	da	299	109	191
Other¹	da	da	724	239	485
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.48B – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1.3	1.2	1.4	3.7	1.0
GENDER
Male	1.4	1.1	1.5	3.9	1.1
Female	1.2	1.2	1.3	3.5	0.9
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.4	1.1	1.4	4.3	1.0
White	1.6	1.3	1.6	4.9	1.2
Black or African American	0.6	0.5	0.6	1.7	0.5
AIAN	1.8	0.5	2.0	*	0.8
NHOPI	1.2	*	1.4	*	*
Asian	0.6	0.3	0.6	2.8	0.3
Two or More Races	3.1	2.4	3.3	5.7	2.7
Hispanic or Latino	1.0	1.2	0.9	1.9	0.7
EDUCATION LEVEL
< High School	da	da	0.6	2.0	0.4
High School Graduate	da	da	1.1	2.4	0.9
Some College/Associate’s Degree	da	da	1.8	4.3	1.3
College Graduate	da	da	1.4	6.2	1.1
EMPLOYMENT STATUS
Full-Time	da	da	1.6	4.3	1.2
Part-Time	da	da	2.0	4.4	1.2
Unemployed	da	da	2.3	3.5	1.9
Other¹	da	da	0.8	2.5	0.6
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.49A – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1,104	74	1,029	300	730
GENDER
Male	628	26	602	159	442
Female	476	48	428	140	287
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	984	43	941	284	657
White	817	40	778	216	562
Black or African American	52	1	50	17	34
AIAN	1	*	1	0	1
NHOPI	*	*	*	*	*
Asian	39	*	39	31	8
Two or More Races	66	1	65	12	53
Hispanic or Latino	120	31	88	15	73
EDUCATION LEVEL
< High School	da	da	54	16	38
High School Graduate	da	da	193	38	156
Some College/Associate’s Degree	da	da	425	169	256
College Graduate	da	da	357	77	280
EMPLOYMENT STATUS
Full-Time	da	da	579	106	474
Part-Time	da	da	175	76	99
Unemployed	da	da	109	44	65
Other¹	da	da	166	74	92
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.49B – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.4	0.3	0.4	0.9	0.3
GENDER
Male	0.5	0.2	0.5	1.0	0.4
Female	0.3	0.4	0.3	0.8	0.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.4	0.2	0.4	1.1	0.4
White	0.5	0.3	0.5	1.2	0.4
Black or African American	0.2	0.0	0.2	0.4	0.1
AIAN	0.1	*	0.0	0.0	0.0
NHOPI	*	*	*	*	*
Asian	0.2	*	0.3	1.6	0.1
Two or More Races	1.2	0.1	1.5	1.4	1.5
Hispanic or Latino	0.2	0.5	0.2	0.2	0.2
EDUCATION LEVEL
< High School	da	da	0.2	0.4	0.2
High School Graduate	da	da	0.3	0.4	0.3
Some College/Associate’s Degree	da	da	0.6	1.2	0.4
College Graduate	da	da	0.5	1.5	0.4
EMPLOYMENT STATUS
Full-Time	da	da	0.5	0.8	0.5
Part-Time	da	da	0.6	0.9	0.4
Unemployed	da	da	0.8	1.4	0.6
Other¹	da	da	0.2	0.8	0.1
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.50A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	40,899	1,002	39,897	2,950	36,947
GENDER
Male	16,021	455	15,566	1,184	14,382
Female	24,877	546	24,331	1,766	22,565
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	36,012	702	35,310	2,522	32,788
White	30,437	547	29,891	2,025	27,865
Black or African American	3,438	85	3,353	289	3,064
AIAN	167	1	166	26	140
NHOPI	*	*	*	*	*
Asian	988	28	959	86	874
Two or More Races	843	30	813	82	731
Hispanic or Latino	4,887	300	4,587	428	4,159
EDUCATION LEVEL
< High School	da	da	3,410	274	3,136
High School Graduate	da	da	11,192	914	10,278
Some College/Associate’s Degree	da	da	12,501	1,237	11,263
College Graduate	da	da	12,795	525	12,270
EMPLOYMENT STATUS
Full-Time	da	da	14,879	1,196	13,683
Part-Time	da	da	4,704	672	4,032
Unemployed	da	da	1,867	342	1,525
Other¹	da	da	18,447	740	17,707
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.50B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	14.6	3.9	15.7	8.8	16.8
GENDER
Male	11.7	3.4	12.6	7.1	13.5
Female	17.4	4.3	18.7	10.6	19.9
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	15.7	3.6	16.8	9.8	17.7
White	17.8	4.2	18.9	11.4	19.9
Black or African American	10.0	2.4	10.9	6.3	11.7
AIAN	9.3	0.5	10.3	8.0	10.8
NHOPI	*	*	*	*	*
Asian	6.0	1.9	6.4	4.4	6.7
Two or More Races	15.6	3.3	18.2	9.0	20.5
Hispanic or Latino	9.8	4.5	10.6	5.5	11.8
EDUCATION LEVEL
< High School	da	da	11.9	7.3	12.5
High School Graduate	da	da	16.0	8.6	17.4
Some College/Associate’s Degree	da	da	16.2	8.8	17.9
College Graduate	da	da	16.3	10.5	16.8
EMPLOYMENT STATUS
Full-Time	da	da	13.0	9.5	13.5
Part-Time	da	da	15.4	8.2	18.0
Unemployed	da	da	14.1	10.9	15.1
Other¹	da	da	19.3	7.8	20.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.51A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	4,887	225	4,662	874	3,788
GENDER
Male	2,308	111	2,197	440	1,757
Female	2,579	114	2,465	435	2,030
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	4,219	119	4,100	750	3,351
White	3,517	96	3,421	618	2,803
Black or African American	433	13	420	70	350
AIAN	46	*	46	5	41
NHOPI	*	*	*	*	*
Asian	81	*	81	18	63
Two or More Races	134	9	125	32	93
Hispanic or Latino	668	106	562	125	437
EDUCATION LEVEL
< High School	da	da	306	105	201
High School Graduate	da	da	1,404	306	1,097
Some College/Associate’s Degree	da	da	1,483	337	1,146
College Graduate	da	da	1,470	126	1,344
EMPLOYMENT STATUS
Full-Time	da	da	2,152	365	1,787
Part-Time	da	da	596	209	387
Unemployed	da	da	384	104	280
Other¹	da	da	1,531	197	1,334
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.51B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1.7	0.9	1.8	2.6	1.7
GENDER
Male	1.7	0.8	1.8	2.6	1.6
Female	1.8	0.9	1.9	2.6	1.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.8	0.6	1.9	2.9	1.8
White	2.1	0.7	2.2	3.5	2.0
Black or African American	1.3	0.4	1.4	1.5	1.3
AIAN	2.6	*	2.8	1.5	3.2
NHOPI	*	*	*	*	*
Asian	0.5	*	0.5	0.9	0.5
Two or More Races	2.5	1.0	2.8	3.5	2.6
Hispanic or Latino	1.3	1.6	1.3	1.6	1.2
EDUCATION LEVEL
< High School	da	da	1.1	2.8	0.8
High School Graduate	da	da	2.0	2.9	1.9
Some College/Associate’s Degree	da	da	1.9	2.4	1.8
College Graduate	da	da	1.9	2.5	1.8
EMPLOYMENT STATUS
Full-Time	da	da	1.9	2.9	1.8
Part-Time	da	da	1.9	2.6	1.7
Unemployed	da	da	2.9	3.3	2.8
Other¹	da	da	1.6	2.1	1.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.52A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1,373	44	1,330	164	1,166
GENDER
Male	638	7	631	86	545
Female	735	36	699	78	621
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,245	31	1,214	145	1,069
White	1,059	25	1,034	107	926
Black or African American	98	5	93	21	72
AIAN	8	*	8	*	5
NHOPI	*	*	*	*	*
Asian	46	*	46	1	45
Two or More Races	27	1	26	5	21
Hispanic or Latino	128	12	116	19	97
EDUCATION LEVEL
< High School	da	da	96	31	65
High School Graduate	da	da	417	57	360
Some College/Associate’s Degree	da	da	329	42	287
College Graduate	da	da	488	34	454
EMPLOYMENT STATUS
Full-Time	da	da	428	60	369
Part-Time	da	da	169	42	127
Unemployed	da	da	114	27	87
Other¹	da	da	619	35	584
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.52B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.5	0.2	0.5	0.5	0.5
GENDER
Male	0.5	0.1	0.5	0.5	0.5
Female	0.5	0.3	0.5	0.5	0.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.5	0.2	0.6	0.6	0.6
White	0.6	0.2	0.7	0.6	0.7
Black or African American	0.3	0.1	0.3	0.5	0.3
AIAN	0.4	*	0.5	*	0.4
NHOPI	*	*	*	*	*
Asian	0.3	*	0.3	0.1	0.3
Two or More Races	0.5	0.1	0.6	0.6	0.6
Hispanic or Latino	0.3	0.2	0.3	0.2	0.3
EDUCATION LEVEL
< High School	da	da	0.3	0.8	0.3
High School Graduate	da	da	0.6	0.5	0.6
Some College/Associate’s Degree	da	da	0.4	0.3	0.5
College Graduate	da	da	0.6	0.7	0.6
EMPLOYMENT STATUS
Full-Time	da	da	0.4	0.5	0.4
Part-Time	da	da	0.6	0.5	0.6
Unemployed	da	da	0.9	0.9	0.9
Other¹	da	da	0.6	0.4	0.7
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.53A – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	32,735	737	31,998	2,449	29,549
GENDER
Male	12,501	317	12,183	947	11,236
Female	20,234	420	19,815	1,502	18,313
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	28,760	499	28,260	2,099	26,161
White	24,654	397	24,257	1,705	22,552
Black or African American	2,564	54	2,510	226	2,284
AIAN	152	0	152	25	127
NHOPI	60	*	49	*	36
Asian	600	11	590	61	529
Two or More Races	729	27	702	68	634
Hispanic or Latino	3,976	238	3,738	350	3,388
EDUCATION LEVEL
< High School	da	da	2,795	231	2,564
High School Graduate	da	da	9,102	765	8,337
Some College/Associate’s Degree	da	da	10,295	1,018	9,277
College Graduate	da	da	9,806	434	9,372
EMPLOYMENT STATUS
Full-Time	da	da	11,726	1,034	10,692
Part-Time	da	da	3,987	577	3,410
Unemployed	da	da	1,472	260	1,212
Other¹	da	da	14,814	579	14,235
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.53B – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	11.7	2.8	12.6	7.3	13.4
GENDER
Male	9.1	2.4	9.9	5.7	10.5
Female	14.1	3.3	15.2	9.0	16.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	12.5	2.6	13.4	8.2	14.1
White	14.4	3.0	15.4	9.6	16.1
Black or African American	7.5	1.5	8.2	5.0	8.7
AIAN	8.5	0.0	9.4	7.8	9.8
NHOPI	5.8	*	5.6	*	5.0
Asian	3.6	0.7	3.9	3.1	4.0
Two or More Races	13.5	3.0	15.7	7.5	17.8
Hispanic or Latino	8.0	3.6	8.7	4.5	9.6
EDUCATION LEVEL
< High School	da	da	9.7	6.2	10.3
High School Graduate	da	da	13.0	7.2	14.1
Some College/Associate’s Degree	da	da	13.4	7.2	14.7
College Graduate	da	da	12.5	8.6	12.8
EMPLOYMENT STATUS
Full-Time	da	da	10.3	8.2	10.5
Part-Time	da	da	13.0	7.0	15.2
Unemployed	da	da	11.1	8.3	12.0
Other¹	da	da	15.5	6.1	16.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.54A – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	4,317	198	4,119	810	3,309
GENDER
Male	2,053	100	1,953	411	1,542
Female	2,264	98	2,166	398	1,767
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,717	97	3,620	699	2,921
White	3,106	81	3,025	571	2,453
Black or African American	368	7	361	70	292
AIAN	46	*	46	5	41
NHOPI	*	*	*	*	*
Asian	64	*	64	17	47
Two or More Races	125	9	117	29	88
Hispanic or Latino	600	101	499	111	388
EDUCATION LEVEL
< High School	da	da	271	105	167
High School Graduate	da	da	1,304	281	1,024
Some College/Associate’s Degree	da	da	1,338	306	1,032
College Graduate	da	da	1,205	119	1,086
EMPLOYMENT STATUS
Full-Time	da	da	1,925	342	1,583
Part-Time	da	da	558	191	367
Unemployed	da	da	354	91	264
Other¹	da	da	1,282	186	1,095
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.54B – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1.5	0.8	1.6	2.4	1.5
GENDER
Male	1.5	0.8	1.6	2.5	1.4
Female	1.6	0.8	1.7	2.4	1.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.6	0.5	1.7	2.7	1.6
White	1.8	0.6	1.9	3.2	1.7
Black or African American	1.1	0.2	1.2	1.5	1.1
AIAN	2.6	*	2.8	1.5	3.2
NHOPI	*	*	*	*	*
Asian	0.4	*	0.4	0.9	0.4
Two or More Races	2.3	0.9	2.6	3.2	2.5
Hispanic or Latino	1.2	1.5	1.2	1.4	1.1
EDUCATION LEVEL
< High School	da	da	0.9	2.8	0.7
High School Graduate	da	da	1.9	2.6	1.7
Some College/Associate’s Degree	da	da	1.7	2.2	1.6
College Graduate	da	da	1.5	2.4	1.5
EMPLOYMENT STATUS
Full-Time	da	da	1.7	2.7	1.6
Part-Time	da	da	1.8	2.3	1.6
Unemployed	da	da	2.7	2.9	2.6
Other¹	da	da	1.3	2.0	1.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.55A – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1,184	28	1,155	143	1,012
GENDER
Male	606	4	602	82	519
Female	578	24	554	61	493
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,099	19	1,080	126	955
White	931	15	916	94	822
Black or African American	87	3	84	20	64
AIAN	8	*	8	*	5
NHOPI	*	*	*	*	*
Asian	43	*	43	*	43
Two or More Races	22	1	22	1	20
Hispanic or Latino	84	9	75	18	57
EDUCATION LEVEL
< High School	da	da	89	28	61
High School Graduate	da	da	361	55	307
Some College/Associate’s Degree	da	da	299	27	271
College Graduate	da	da	406	33	373
EMPLOYMENT STATUS
Full-Time	da	da	373	58	316
Part-Time	da	da	155	31	124
Unemployed	da	da	97	26	71
Other¹	da	da	531	29	501
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.55B – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.4	0.1	0.5	0.4	0.5
GENDER
Male	0.4	0.0	0.5	0.5	0.5
Female	0.4	0.2	0.4	0.4	0.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.5	0.1	0.5	0.5	0.5
White	0.5	0.1	0.6	0.5	0.6
Black or African American	0.3	0.1	0.3	0.4	0.2
AIAN	0.4	*	0.5	*	0.4
NHOPI	*	*	*	*	*
Asian	0.3	*	0.3	*	0.3
Two or More Races	0.4	0.1	0.5	0.2	0.6
Hispanic or Latino	0.2	0.1	0.2	0.2	0.2
EDUCATION LEVEL
< High School	da	da	0.3	0.7	0.2
High School Graduate	da	da	0.5	0.5	0.5
Some College/Associate’s Degree	da	da	0.4	0.2	0.4
College Graduate	da	da	0.5	0.7	0.5
EMPLOYMENT STATUS
Full-Time	da	da	0.3	0.5	0.3
Part-Time	da	da	0.5	0.4	0.6
Unemployed	da	da	0.7	0.8	0.7
Other¹	da	da	0.6	0.3	0.6
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.56A – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	14,548	408	14,140	846	13,295
GENDER
Male	5,827	181	5,646	350	5,296
Female	8,721	227	8,494	496	7,998
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	12,928	305	12,623	739	11,884
White	10,651	230	10,420	544	9,877
Black or African American	1,353	48	1,305	115	1,190
AIAN	55	1	55	*	47
NHOPI	*	*	*	*	*
Asian	521	18	503	38	466
Two or More Races	251	8	243	28	215
Hispanic or Latino	1,620	103	1,517	107	1,410
EDUCATION LEVEL
< High School	da	da	1,191	75	1,116
High School Graduate	da	da	3,732	234	3,497
Some College/Associate’s Degree	da	da	4,328	404	3,924
College Graduate	da	da	4,889	132	4,757
EMPLOYMENT STATUS
Full-Time	da	da	5,167	294	4,873
Part-Time	da	da	1,482	202	1,280
Unemployed	da	da	688	111	576
Other¹	da	da	6,803	238	6,565
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.56B – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	5.2	1.6	5.6	2.5	6.0
GENDER
Male	4.3	1.4	4.6	2.1	5.0
Female	6.1	1.8	6.5	3.0	7.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	5.6	1.6	6.0	2.9	6.4
White	6.2	1.8	6.6	3.1	7.0
Black or African American	3.9	1.4	4.2	2.5	4.5
AIAN	3.1	0.4	3.4	*	3.7
NHOPI	*	*	*	*	*
Asian	3.2	1.2	3.4	1.9	3.6
Two or More Races	4.7	0.9	5.4	3.1	6.0
Hispanic or Latino	3.3	1.6	3.5	1.4	4.0
EDUCATION LEVEL
< High School	da	da	4.1	2.0	4.5
High School Graduate	da	da	5.3	2.2	5.9
Some College/Associate’s Degree	da	da	5.6	2.9	6.2
College Graduate	da	da	6.2	2.6	6.5
EMPLOYMENT STATUS
Full-Time	da	da	4.5	2.3	4.8
Part-Time	da	da	4.8	2.5	5.7
Unemployed	da	da	5.2	3.5	5.7
Other¹	da	da	7.1	2.5	7.6
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.57A – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	923	41	881	141	740
GENDER
Male	441	21	420	58	362
Female	482	20	461	83	378
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	810	27	783	124	659
White	652	21	631	100	531
Black or African American	96	6	90	4	86
AIAN	1	*	1	0	1
NHOPI	*	*	*	*	*
Asian	25	*	25	1	24
Two or More Races	29	1	29	12	17
Hispanic or Latino	112	14	98	17	81
EDUCATION LEVEL
< High School	da	da	90	22	68
High School Graduate	da	da	216	42	175
Some College/Associate’s Degree	da	da	238	62	176
College Graduate	da	da	337	16	321
EMPLOYMENT STATUS
Full-Time	da	da	374	48	326
Part-Time	da	da	79	44	35
Unemployed	da	da	81	19	62
Other¹	da	da	347	31	317
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.57B – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.3	0.2	0.3	0.4	0.3
GENDER
Male	0.3	0.2	0.3	0.3	0.3
Female	0.3	0.2	0.4	0.5	0.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.4	0.1	0.4	0.5	0.4
White	0.4	0.2	0.4	0.6	0.4
Black or African American	0.3	0.2	0.3	0.1	0.3
AIAN	0.1	*	0.1	0.0	0.1
NHOPI	*	*	*	*	*
Asian	0.2	*	0.2	0.1	0.2
Two or More Races	0.5	0.1	0.6	1.3	0.5
Hispanic or Latino	0.2	0.2	0.2	0.2	0.2
EDUCATION LEVEL
< High School	da	da	0.3	0.6	0.3
High School Graduate	da	da	0.3	0.4	0.3
Some College/Associate’s Degree	da	da	0.3	0.4	0.3
College Graduate	da	da	0.4	0.3	0.4
EMPLOYMENT STATUS
Full-Time	da	da	0.3	0.4	0.3
Part-Time	da	da	0.3	0.5	0.2
Unemployed	da	da	0.6	0.6	0.6
Other¹	da	da	0.4	0.3	0.4
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.58A – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	227	19	208	31	177
GENDER
Male	48	5	43	5	38
Female	179	14	165	26	139
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	183	16	167	29	138
White	156	14	142	15	126
Black or African American	11	2	9	1	8
AIAN	0	*	0	*	0
NHOPI	*	*	*	*	*
Asian	2	*	2	1	1
Two or More Races	6	*	6	4	2
Hispanic or Latino	44	3	41	2	39
EDUCATION LEVEL
< High School	da	da	15	11	4
High School Graduate	da	da	71	3	68
Some College/Associate’s Degree	da	da	36	16	20
College Graduate	da	da	86	1	85
EMPLOYMENT STATUS
Full-Time	da	da	65	4	61
Part-Time	da	da	22	19	4
Unemployed	da	da	28	2	26
Other¹	da	da	93	7	86
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.58B – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.1	0.1	0.1	0.1	0.1
GENDER
Male	0.0	0.0	0.0	0.0	0.0
Female	0.1	0.1	0.1	0.2	0.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.1	0.1	0.1	0.1	0.1
White	0.1	0.1	0.1	0.1	0.1
Black or African American	0.0	0.1	0.0	0.0	0.0
AIAN	0.0	*	0.0	*	0.0
NHOPI	*	*	*	*	*
Asian	0.0	*	0.0	0.1	0.0
Two or More Races	0.1	*	0.1	0.4	0.1
Hispanic or Latino	0.1	0.0	0.1	0.0	0.1
EDUCATION LEVEL
< High School	da	da	0.1	0.3	0.0
High School Graduate	da	da	0.1	0.0	0.1
Some College/Associate’s Degree	da	da	0.0	0.1	0.0
College Graduate	da	da	0.1	0.0	0.1
EMPLOYMENT STATUS
Full-Time	da	da	0.1	0.0	0.1
Part-Time	da	da	0.1	0.2	0.0
Unemployed	da	da	0.2	0.1	0.3
Other¹	da	da	0.1	0.1	0.1
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.59A – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	25,630	462	25,168	2,147	23,021
GENDER
Male	10,001	208	9,793	846	8,947
Female	15,628	254	15,374	1,301	14,074
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	22,364	302	22,062	1,846	20,216
White	19,289	228	19,061	1,485	17,577
Black or African American	1,890	41	1,850	211	1,639
AIAN	99	0	99	20	80
NHOPI	*	*	*	*	*
Asian	423	11	412	59	353
Two or More Races	547	21	526	59	467
Hispanic or Latino	3,266	160	3,106	301	2,805
EDUCATION LEVEL
< High School	da	da	2,278	210	2,069
High School Graduate	da	da	7,238	648	6,590
Some College/Associate’s Degree	da	da	7,808	928	6,880
College Graduate	da	da	7,843	362	7,482
EMPLOYMENT STATUS
Full-Time	da	da	9,562	903	8,659
Part-Time	da	da	3,004	506	2,497
Unemployed	da	da	1,278	224	1,053
Other¹	da	da	11,325	514	10,811
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.59B – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	9.2	1.8	9.9	6.4	10.4
GENDER
Male	7.3	1.6	7.9	5.1	8.4
Female	10.9	2.0	11.8	7.8	12.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	9.7	1.6	10.5	7.2	10.9
White	11.3	1.7	12.1	8.4	12.5
Black or African American	5.5	1.2	6.0	4.6	6.3
AIAN	5.5	0.1	6.1	6.0	6.1
NHOPI	*	*	*	*	*
Asian	2.6	0.7	2.7	3.0	2.7
Two or More Races	10.1	2.3	11.7	6.5	13.1
Hispanic or Latino	6.6	2.4	7.2	3.8	7.9
EDUCATION LEVEL
< High School	da	da	7.9	5.6	8.3
High School Graduate	da	da	10.4	6.1	11.1
Some College/Associate’s Degree	da	da	10.1	6.6	10.9
College Graduate	da	da	10.0	7.2	10.2
EMPLOYMENT STATUS
Full-Time	da	da	8.4	7.2	8.5
Part-Time	da	da	9.8	6.2	11.2
Unemployed	da	da	9.7	7.1	10.4
Other¹	da	da	11.8	5.4	12.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.60A – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	3,941	181	3,760	787	2,973
GENDER
Male	1,895	94	1,801	391	1,410
Female	2,046	87	1,959	395	1,564
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,436	96	3,339	668	2,672
White	2,874	78	2,796	546	2,250
Black or African American	323	9	313	63	250
AIAN	42	*	42	5	37
NHOPI	*	*	*	*	*
Asian	64	*	64	17	47
Two or More Races	125	9	117	29	88
Hispanic or Latino	506	85	421	119	302
EDUCATION LEVEL
< High School	da	da	263	105	158
High School Graduate	da	da	1,216	262	954
Some College/Associate’s Degree	da	da	1,258	304	955
College Graduate	da	da	1,023	116	907
EMPLOYMENT STATUS
Full-Time	da	da	1,789	347	1,442
Part-Time	da	da	477	182	296
Unemployed	da	da	336	87	249
Other¹	da	da	1,158	171	987
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.60B – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1.4	0.7	1.5	2.4	1.3
GENDER
Male	1.4	0.7	1.5	2.3	1.3
Female	1.4	0.7	1.5	2.4	1.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.5	0.5	1.6	2.6	1.4
White	1.7	0.6	1.8	3.1	1.6
Black or African American	0.9	0.3	1.0	1.4	1.0
AIAN	2.3	*	2.6	1.5	2.8
NHOPI	*	*	*	*	*
Asian	0.4	*	0.4	0.9	0.4
Two or More Races	2.3	0.9	2.6	3.2	2.5
Hispanic or Latino	1.0	1.3	1.0	1.5	0.9
EDUCATION LEVEL
< High School	da	da	0.9	2.8	0.6
High School Graduate	da	da	1.7	2.5	1.6
Some College/Associate’s Degree	da	da	1.6	2.2	1.5
College Graduate	da	da	1.3	2.3	1.2
EMPLOYMENT STATUS
Full-Time	da	da	1.6	2.8	1.4
Part-Time	da	da	1.6	2.2	1.3
Unemployed	da	da	2.5	2.8	2.5
Other¹	da	da	1.2	1.8	1.1
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.61A – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	71,901	3,342	68,558	6,128	62,430
GENDER
Male	32,469	1,477	30,992	2,723	28,268
Female	39,431	1,865	37,567	3,405	34,162
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	61,494	2,431	59,063	4,778	54,286
White	46,844	1,611	45,233	3,257	41,976
Black or African American	9,949	483	9,466	981	8,484
AIAN	581	*	540	*	451
NHOPI	*	*	*	*	*
Asian	2,348	163	2,186	243	1,943
Two or More Races	1,508	125	1,383	188	1,194
Hispanic or Latino	10,407	911	9,495	1,351	8,144
EDUCATION LEVEL
< High School	da	da	8,272	706	7,566
High School Graduate	da	da	19,732	1,969	17,763
Some College/Associate’s Degree	da	da	23,243	2,672	20,571
College Graduate	da	da	17,311	781	16,530
EMPLOYMENT STATUS
Full-Time	da	da	27,138	2,419	24,719
Part-Time	da	da	7,833	1,359	6,474
Unemployed	da	da	3,828	702	3,125
Other¹	da	da	29,760	1,648	28,112
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Any use of opioids includes the use of heroin or any use of prescription pain relievers. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.61B – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	25.7	12.8	27.0	18.3	28.3
GENDER
Male	23.7	11.1	25.1	16.3	26.5
Female	27.6	14.6	28.8	20.3	30.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	26.7	12.5	28.0	18.6	29.3
White	27.4	12.3	28.6	18.4	29.9
Black or African American	29.0	13.7	30.8	21.5	32.4
AIAN	32.4	*	33.3	*	34.8
NHOPI	*	*	*	*	*
Asian	14.3	11.1	14.6	12.4	14.9
Two or More Races	28.0	13.7	30.9	20.7	33.5
Hispanic or Latino	20.9	13.7	22.0	17.3	23.1
EDUCATION LEVEL
< High School	da	da	28.8	18.9	30.2
High School Graduate	da	da	28.3	18.5	30.0
Some College/Associate’s Degree	da	da	30.2	19.0	32.7
College Graduate	da	da	22.1	15.6	22.6
EMPLOYMENT STATUS
Full-Time	da	da	23.8	19.2	24.3
Part-Time	da	da	25.6	16.6	28.9
Unemployed	da	da	28.9	22.3	31.0
Other¹	da	da	31.1	17.3	32.6
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Any use of opioids includes the use of heroin or any use of prescription pain relievers. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.62A – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	9,236	497	8,738	1,035	7,703
GENDER
Male	4,697	199	4,498	491	4,007
Female	4,538	298	4,240	544	3,696
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	7,620	350	7,270	797	6,473
White	5,522	244	5,278	515	4,763
Black or African American	1,247	49	1,198	136	1,062
AIAN	82	*	73	*	46
NHOPI	*	*	*	*	*
Asian	372	18	353	55	299
Two or More Races	342	30	312	54	258
Hispanic or Latino	1,615	147	1,468	238	1,230
EDUCATION LEVEL
< High School	da	da	1,492	175	1,317
High School Graduate	da	da	2,802	381	2,420
Some College/Associate’s Degree	da	da	2,784	356	2,428
College Graduate	da	da	1,660	123	1,537
EMPLOYMENT STATUS
Full-Time	da	da	3,281	399	2,881
Part-Time	da	da	1,135	201	934
Unemployed	da	da	955	152	802
Other¹	da	da	3,368	282	3,085
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.62B – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	3.3	1.9	3.4	3.1	3.5
GENDER
Male	3.4	1.5	3.6	2.9	3.8
Female	3.2	2.3	3.3	3.3	3.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.3	1.8	3.5	3.1	3.5
White	3.2	1.9	3.3	2.9	3.4
Black or African American	3.6	1.4	3.9	3.0	4.1
AIAN	4.6	*	4.5	*	3.5
NHOPI	*	*	*	*	*
Asian	2.3	1.2	2.4	2.8	2.3
Two or More Races	6.3	3.3	7.0	6.0	7.2
Hispanic or Latino	3.2	2.2	3.4	3.0	3.5
EDUCATION LEVEL
< High School	da	da	5.2	4.7	5.3
High School Graduate	da	da	4.0	3.6	4.1
Some College/Associate’s Degree	da	da	3.6	2.5	3.9
College Graduate	da	da	2.1	2.5	2.1
EMPLOYMENT STATUS
Full-Time	da	da	2.9	3.2	2.8
Part-Time	da	da	3.7	2.5	4.2
Unemployed	da	da	7.2	4.8	8.0
Other¹	da	da	3.5	3.0	3.6
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.63A – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	2,791	115	2,676	221	2,456
GENDER
Male	1,449	37	1,412	105	1,307
Female	1,342	78	1,264	116	1,148
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2,282	75	2,207	159	2,048
White	1,718	40	1,678	94	1,584
Black or African American	352	15	337	27	311
AIAN	31	1	30	*	25
NHOPI	*	*	*	*	*
Asian	74	1	73	*	62
Two or More Races	99	18	81	14	67
Hispanic or Latino	509	40	469	62	407
EDUCATION LEVEL
< High School	da	da	479	48	431
High School Graduate	da	da	1,010	94	916
Some College/Associate’s Degree	da	da	752	55	697
College Graduate	da	da	436	24	412
EMPLOYMENT STATUS
Full-Time	da	da	846	86	759
Part-Time	da	da	306	43	263
Unemployed	da	da	279	26	252
Other¹	da	da	1,246	65	1,181
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.63B – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1.0	0.4	1.1	0.7	1.1
GENDER
Male	1.1	0.3	1.1	0.6	1.2
Female	0.9	0.6	1.0	0.7	1.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.0	0.4	1.0	0.6	1.1
White	1.0	0.3	1.1	0.5	1.1
Black or African American	1.0	0.4	1.1	0.6	1.2
AIAN	1.7	0.5	1.8	*	1.9
NHOPI	*	*	*	*	*
Asian	0.5	0.1	0.5	*	0.5
Two or More Races	1.8	2.0	1.8	1.6	1.9
Hispanic or Latino	1.0	0.6	1.1	0.8	1.2
EDUCATION LEVEL
< High School	da	da	1.7	1.3	1.7
High School Graduate	da	da	1.4	0.9	1.5
Some College/Associate’s Degree	da	da	1.0	0.4	1.1
College Graduate	da	da	0.6	0.5	0.6
EMPLOYMENT STATUS
Full-Time	da	da	0.7	0.7	0.7
Part-Time	da	da	1.0	0.5	1.2
Unemployed	da	da	2.1	0.8	2.5
Other¹	da	da	1.3	0.7	1.4
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.64A – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	21,329	1,841	19,488	4,064	15,424
GENDER
Male	10,809	1,023	9,786	2,154	7,632
Female	10,520	818	9,702	1,911	7,791
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	18,186	1,533	16,653	3,387	13,266
White	14,660	1,227	13,433	2,690	10,743
Black or African American	1,912	146	1,766	274	1,493
AIAN	186	*	174	*	56
NHOPI	42	*	36	*	27
Asian	701	61	640	187	453
Two or More Races	685	81	604	109	495
Hispanic or Latino	3,143	308	2,835	677	2,157
EDUCATION LEVEL
< High School	da	da	2,047	437	1,609
High School Graduate	da	da	4,723	1,004	3,719
Some College/Associate’s Degree	da	da	7,327	1,908	5,419
College Graduate	da	da	5,391	715	4,676
EMPLOYMENT STATUS
Full-Time	da	da	9,261	1,637	7,623
Part-Time	da	da	2,548	1,044	1,503
Unemployed	da	da	1,727	448	1,279
Other¹	da	da	5,953	935	5,018
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.64B – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	7.6	7.1	7.7	12.1	7.0
GENDER
Male	7.9	7.7	7.9	12.9	7.1
Female	7.4	6.4	7.4	11.4	6.9
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	7.9	7.9	7.9	13.2	7.2
White	8.6	9.3	8.5	15.2	7.7
Black or African American	5.6	4.1	5.7	6.0	5.7
AIAN	10.4	*	10.7	*	4.3
NHOPI	4.1	*	4.1	*	3.7
Asian	4.3	4.2	4.3	9.6	3.5
Two or More Races	12.7	8.8	13.5	12.0	13.9
Hispanic or Latino	6.3	4.6	6.6	8.7	6.1
EDUCATION LEVEL
< High School	da	da	7.1	11.7	6.4
High School Graduate	da	da	6.8	9.5	6.3
Some College/Associate’s Degree	da	da	9.5	13.6	8.6
College Graduate	da	da	6.9	14.2	6.4
EMPLOYMENT STATUS
Full-Time	da	da	8.1	13.0	7.5
Part-Time	da	da	8.3	12.8	6.7
Unemployed	da	da	13.1	14.2	12.7
Other¹	da	da	6.2	9.8	5.8
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.65A – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	9,177	339	8,838	2,111	6,727
GENDER
Male	5,426	169	5,258	1,162	4,096
Female	3,750	170	3,580	949	2,631
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	7,630	250	7,380	1,758	5,622
White	6,047	202	5,845	1,387	4,458
Black or African American	871	21	850	115	735
AIAN	103	1	103	*	43
NHOPI	24	*	24	*	16
Asian	240	4	236	121	115
Two or More Races	345	22	323	68	256
Hispanic or Latino	1,546	88	1,458	353	1,105
EDUCATION LEVEL
< High School	da	da	1,036	194	842
High School Graduate	da	da	2,609	526	2,083
Some College/Associate’s Degree	da	da	3,259	964	2,295
College Graduate	da	da	1,933	426	1,508
EMPLOYMENT STATUS
Full-Time	da	da	3,770	888	2,882
Part-Time	da	da	1,345	549	795
Unemployed	da	da	1,083	239	844
Other¹	da	da	2,640	434	2,206
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.65B – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	3.3	1.3	3.5	6.3	3.1
GENDER
Male	4.0	1.3	4.3	6.9	3.8
Female	2.6	1.3	2.7	5.7	2.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.3	1.3	3.5	6.9	3.0
White	3.5	1.5	3.7	7.8	3.2
Black or African American	2.5	0.6	2.8	2.5	2.8
AIAN	5.8	0.5	6.3	*	3.3
NHOPI	2.3	*	2.7	*	2.2
Asian	1.5	0.3	1.6	6.2	0.9
Two or More Races	6.4	2.4	7.2	7.4	7.2
Hispanic or Latino	3.1	1.3	3.4	4.5	3.1
EDUCATION LEVEL
< High School	da	da	3.6	5.2	3.4
High School Graduate	da	da	3.7	5.0	3.5
Some College/Associate’s Degree	da	da	4.2	6.9	3.6
College Graduate	da	da	2.5	8.5	2.1
EMPLOYMENT STATUS
Full-Time	da	da	3.3	7.0	2.8
Part-Time	da	da	4.4	6.7	3.6
Unemployed	da	da	8.2	7.6	8.4
Other¹	da	da	2.8	4.6	2.6
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.66A – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	4,126	92	4,034	669	3,365
GENDER
Male	2,406	33	2,373	353	2,019
Female	1,720	58	1,662	316	1,345
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,426	59	3,367	570	2,796
White	2,740	46	2,694	437	2,257
Black or African American	372	11	360	31	329
AIAN	30	*	30	8	22
NHOPI	14	*	14	*	*
Asian	123	*	123	68	54
Two or More Races	147	1	146	18	129
Hispanic or Latino	700	33	667	99	568
EDUCATION LEVEL
< High School	da	da	544	66	478
High School Graduate	da	da	1,276	165	1,111
Some College/Associate’s Degree	da	da	1,479	308	1,171
College Graduate	da	da	734	131	604
EMPLOYMENT STATUS
Full-Time	da	da	1,532	240	1,292
Part-Time	da	da	574	181	393
Unemployed	da	da	538	88	450
Other¹	da	da	1,390	160	1,230
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.66B – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1.5	0.4	1.6	2.0	1.5
GENDER
Male	1.8	0.3	1.9	2.1	1.9
Female	1.2	0.5	1.3	1.9	1.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.5	0.3	1.6	2.2	1.5
White	1.6	0.3	1.7	2.5	1.6
Black or African American	1.1	0.3	1.2	0.7	1.3
AIAN	1.7	*	1.8	2.3	1.7
NHOPI	1.3	*	1.6	*	*
Asian	0.7	*	0.8	3.5	0.4
Two or More Races	2.7	0.1	3.3	2.0	3.6
Hispanic or Latino	1.4	0.5	1.5	1.3	1.6
EDUCATION LEVEL
< High School	da	da	1.9	1.8	1.9
High School Graduate	da	da	1.8	1.6	1.9
Some College/Associate’s Degree	da	da	1.9	2.2	1.9
College Graduate	da	da	0.9	2.6	0.8
EMPLOYMENT STATUS
Full-Time	da	da	1.3	1.9	1.3
Part-Time	da	da	1.9	2.2	1.8
Unemployed	da	da	4.1	2.8	4.5
Other¹	da	da	1.5	1.7	1.4
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.67A – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	23,249	1,562	21,687	4,614	17,073
GENDER
Male	12,676	713	11,963	2,490	9,473
Female	10,573	849	9,724	2,124	7,600
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	19,252	1,104	18,148	3,738	14,410
White	14,864	793	14,071	2,910	11,161
Black or African American	2,534	152	2,382	368	2,014
AIAN	188	*	175	*	105
NHOPI	117	*	*	*	*
Asian	773	44	729	204	525
Two or More Races	776	79	697	171	526
Hispanic or Latino	3,997	458	3,539	875	2,663
EDUCATION LEVEL
< High School	da	da	2,514	465	2,049
High School Graduate	da	da	6,040	1,472	4,568
Some College/Associate’s Degree	da	da	7,480	1,951	5,529
College Graduate	da	da	5,653	725	4,928
EMPLOYMENT STATUS
Full-Time	da	da	9,726	1,881	7,845
Part-Time	da	da	3,178	1,128	2,050
Unemployed	da	da	2,141	510	1,631
Other¹	da	da	6,642	1,094	5,548
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.67B – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	8.3	6.0	8.5	13.8	7.7
GENDER
Male	9.3	5.4	9.7	14.9	8.9
Female	7.4	6.7	7.5	12.7	6.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	8.4	5.7	8.6	14.6	7.8
White	8.7	6.0	8.9	16.4	8.0
Black or African American	7.4	4.3	7.8	8.1	7.7
AIAN	10.5	*	10.8	*	8.1
NHOPI	11.4	*	*	*	*
Asian	4.7	3.0	4.9	10.4	4.0
Two or More Races	14.4	8.6	15.6	18.8	14.7
Hispanic or Latino	8.0	6.9	8.2	11.2	7.5
EDUCATION LEVEL
< High School	da	da	8.7	12.4	8.2
High School Graduate	da	da	8.7	13.9	7.7
Some College/Associate’s Degree	da	da	9.7	13.9	8.8
College Graduate	da	da	7.2	14.4	6.7
EMPLOYMENT STATUS
Full-Time	da	da	8.5	14.9	7.7
Part-Time	da	da	10.4	13.8	9.2
Unemployed	da	da	16.2	16.2	16.2
Other¹	da	da	6.9	11.5	6.4
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.68A – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	9,030	476	8,554	1,361	7,193
GENDER
Male	5,037	227	4,810	727	4,083
Female	3,993	249	3,744	634	3,110
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	7,429	355	7,074	1,081	5,993
White	5,888	222	5,667	810	4,857
Black or African American	870	78	792	104	688
AIAN	88	*	76	15	61
NHOPI	33	*	32	*	*
Asian	276	13	263	100	163
Two or More Races	273	29	244	41	204
Hispanic or Latino	1,602	122	1,480	280	1,199
EDUCATION LEVEL
< High School	da	da	1,064	127	937
High School Graduate	da	da	2,567	442	2,125
Some College/Associate’s Degree	da	da	2,768	541	2,227
College Graduate	da	da	2,155	252	1,903
EMPLOYMENT STATUS
Full-Time	da	da	3,407	563	2,843
Part-Time	da	da	1,122	316	806
Unemployed	da	da	940	167	773
Other¹	da	da	3,086	316	2,770
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.68B – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021
Demographic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	3.2	1.8	3.4	4.1	3.3
GENDER
Male	3.7	1.7	3.9	4.3	3.8
Female	2.8	2.0	2.9	3.8	2.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.2	1.8	3.4	4.2	3.2
White	3.4	1.7	3.6	4.6	3.5
Black or African American	2.5	2.2	2.6	2.3	2.6
AIAN	4.9	*	4.7	4.5	4.7
NHOPI	3.3	*	3.6	*	*
Asian	1.7	0.9	1.8	5.1	1.2
Two or More Races	5.1	3.1	5.5	4.5	5.7
Hispanic or Latino	3.2	1.8	3.4	3.6	3.4
EDUCATION LEVEL
< High School	da	da	3.7	3.4	3.7
High School Graduate	da	da	3.7	4.2	3.6
Some College/Associate’s Degree	da	da	3.6	3.8	3.5
College Graduate	da	da	2.8	5.0	2.6
EMPLOYMENT STATUS
Full-Time	da	da	3.0	4.5	2.8
Part-Time	da	da	3.7	3.9	3.6
Unemployed	da	da	7.1	5.3	7.7
Other¹	da	da	3.2	3.3	3.2
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.69A – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	61,203	3,662	57,542	12,710	44,831
GEOGRAPHIC REGION
Northeast	11,190	582	10,608	2,170	8,439
Midwest	12,927	796	12,131	2,929	9,202
South	19,787	1,264	18,523	4,232	14,291
West	17,299	1,020	16,279	3,379	12,900
COUNTY TYPE
Large Metro	34,374	1,993	32,381	6,904	25,477
Small Metro	19,192	1,183	18,009	4,222	13,787
Nonmetro	7,637	486	7,152	1,585	5,567
Urbanized	3,166	237	2,928	759	2,169
Less Urbanized	3,768	211	3,557	692	2,865
Completely Rural	703	37	666	133	533
POVERTY LEVEL¹
Less Than 100%	11,396	708	10,688	3,153	7,536
100-199%	13,075	812	12,263	3,156	9,107
200% or More	36,719	2,142	34,576	6,388	28,188
HEALTH INSURANCE²
Private	33,071	1,922	31,149	7,336	23,813
Medicaid/CHIP	16,087	1,611	14,476	3,060	11,416
Other³	11,272	162	11,110	938	10,172
No Coverage	7,526	197	7,329	1,898	5,431
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.69B – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	21.9	14.1	22.7	38.0	20.3
GEOGRAPHIC REGION
Northeast	22.9	14.0	23.7	37.9	21.6
Midwest	22.3	14.5	23.1	41.2	20.3
South	18.6	12.4	19.2	33.3	17.1
West	26.1	16.4	27.1	42.6	24.7
COUNTY TYPE
Large Metro	22.5	13.9	23.4	38.4	21.1
Small Metro	22.4	15.0	23.2	38.5	20.7
Nonmetro	18.4	12.9	19.0	35.1	16.8
Urbanized	20.1	16.6	20.4	39.1	17.5
Less Urbanized	17.7	10.9	18.4	32.6	16.7
Completely Rural	15.8	9.7	16.4	29.4	14.8
POVERTY LEVEL¹
Less Than 100%	26.5	13.2	28.4	37.0	25.9
100-199%	23.4	14.6	24.4	39.8	21.5
200% or More	20.3	14.2	20.8	37.7	18.9
HEALTH INSURANCE²
Private	19.6	13.6	20.2	38.6	17.6
Medicaid/CHIP	28.2	15.3	31.1	36.2	30.0
Other³	14.7	11.2	14.8	37.1	14.0
No Coverage	28.1	14.3	28.8	38.1	26.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.70A – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	39,995	1,844	38,152	8,472	29,680
GEOGRAPHIC REGION
Northeast	7,722	324	7,398	1,490	5,907
Midwest	8,683	426	8,257	1,950	6,307
South	12,014	593	11,421	2,615	8,806
West	11,576	500	11,076	2,416	8,660
COUNTY TYPE
Large Metro	22,356	940	21,416	4,649	16,767
Small Metro	12,616	625	11,991	2,748	9,242
Nonmetro	5,024	279	4,745	1,074	3,671
Urbanized	2,159	113	2,046	551	1,496
Less Urbanized	2,423	141	2,282	447	1,835
Completely Rural	442	25	416	76	340
POVERTY LEVEL¹
Less Than 100%	7,650	347	7,303	2,158	5,145
100-199%	9,051	430	8,621	2,124	6,498
200% or More	23,284	1,067	22,217	4,181	18,037
HEALTH INSURANCE²
Private	20,211	927	19,284	4,689	14,595
Medicaid/CHIP	11,204	886	10,318	2,196	8,122
Other³	7,424	45	7,379	602	6,777
No Coverage	5,513	98	5,415	1,366	4,049
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.70B – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	14.3	7.1	15.0	25.3	13.5
GEOGRAPHIC REGION
Northeast	15.8	7.8	16.5	26.0	15.1
Midwest	15.0	7.8	15.7	27.5	13.9
South	11.3	5.8	11.8	20.6	10.5
West	17.5	8.0	18.4	30.5	16.6
COUNTY TYPE
Large Metro	14.6	6.5	15.5	25.9	13.9
Small Metro	14.8	7.9	15.5	25.1	13.9
Nonmetro	12.1	7.4	12.6	23.8	11.1
Urbanized	13.7	7.9	14.3	28.4	12.1
Less Urbanized	11.4	7.3	11.8	21.1	10.7
Completely Rural	9.9	6.6	10.3	16.8	9.4
POVERTY LEVEL¹
Less Than 100%	17.8	6.5	19.4	25.4	17.7
100-199%	16.2	7.7	17.1	26.8	15.3
200% or More	12.9	7.1	13.4	24.7	12.1
HEALTH INSURANCE²
Private	12.0	6.6	12.5	24.7	10.8
Medicaid/CHIP	19.6	8.4	22.2	26.0	21.4
Other³	9.7	3.1	9.8	23.8	9.3
No Coverage	20.6	7.1	21.3	27.4	19.8
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.71A – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	52,454	2,724	49,730	11,833	37,897
GEOGRAPHIC REGION
Northeast	9,808	474	9,334	2,014	7,320
Midwest	11,391	614	10,777	2,766	8,010
South	16,258	875	15,382	3,844	11,538
West	14,997	760	14,237	3,209	11,029
COUNTY TYPE
Large Metro	29,354	1,438	27,916	6,462	21,454
Small Metro	16,587	912	15,675	3,914	11,761
Nonmetro	6,513	374	6,139	1,457	4,682
Urbanized	2,752	181	2,571	709	1,862
Less Urbanized	3,137	162	2,975	622	2,353
Completely Rural	624	31	593	126	467
POVERTY LEVEL¹
Less Than 100%	9,647	513	9,133	2,925	6,209
100-199%	11,335	597	10,738	2,929	7,810
200% or More	31,459	1,614	29,845	5,967	23,878
HEALTH INSURANCE²
Private	28,466	1,432	27,034	6,855	20,178
Medicaid/CHIP	13,411	1,220	12,190	2,810	9,380
Other³	9,212	99	9,113	855	8,258
No Coverage	6,797	142	6,655	1,781	4,874
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.71B – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	18.7	10.5	19.6	35.4	17.2
GEOGRAPHIC REGION
Northeast	20.0	11.4	20.8	35.2	18.7
Midwest	19.6	11.2	20.5	38.9	17.6
South	15.3	8.6	16.0	30.3	13.8
West	22.6	12.2	23.7	40.4	21.2
COUNTY TYPE
Large Metro	19.2	10.0	20.2	35.9	17.8
Small Metro	19.4	11.5	20.2	35.7	17.7
Nonmetro	15.7	10.0	16.3	32.2	14.1
Urbanized	17.4	12.6	17.9	36.5	15.0
Less Urbanized	14.8	8.4	15.4	29.3	13.7
Completely Rural	14.0	8.1	14.6	27.8	12.9
POVERTY LEVEL¹
Less Than 100%	22.5	9.6	24.3	34.4	21.4
100-199%	20.3	10.7	21.4	36.9	18.4
200% or More	17.4	10.7	18.0	35.3	16.0
HEALTH INSURANCE²
Private	16.9	10.2	17.5	36.1	14.9
Medicaid/CHIP	23.5	11.6	26.2	33.2	24.7
Other³	12.0	6.8	12.1	33.8	11.4
No Coverage	25.3	10.3	26.2	35.7	23.8
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.72A – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	36,363	1,499	34,864	8,073	26,791
GEOGRAPHIC REGION
Northeast	7,006	260	6,746	1,423	5,323
Midwest	8,039	375	7,664	1,889	5,775
South	10,753	455	10,298	2,518	7,780
West	10,564	408	10,156	2,244	7,912
COUNTY TYPE
Large Metro	20,384	749	19,636	4,448	15,188
Small Metro	11,404	522	10,882	2,593	8,290
Nonmetro	4,574	229	4,346	1,032	3,313
Urbanized	1,965	92	1,873	522	1,351
Less Urbanized	2,195	115	2,080	436	1,644
Completely Rural	415	22	393	75	319
POVERTY LEVEL¹
Less Than 100%	6,810	276	6,534	2,017	4,517
100-199%	8,292	333	7,959	2,020	5,939
200% or More	21,250	890	20,361	4,027	16,334
HEALTH INSURANCE²
Private	18,657	775	17,882	4,491	13,391
Medicaid/CHIP	9,895	710	9,185	2,061	7,124
Other³	6,488	28	6,460	572	5,888
No Coverage	5,113	81	5,032	1,311	3,721
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.72B – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	13.0	5.8	13.7	24.1	12.2
GEOGRAPHIC REGION
Northeast	14.3	6.3	15.1	24.9	13.6
Midwest	13.9	6.8	14.6	26.6	12.7
South	10.1	4.5	10.7	19.8	9.3
West	15.9	6.5	16.9	28.3	15.2
COUNTY TYPE
Large Metro	13.3	5.2	14.2	24.7	12.6
Small Metro	13.3	6.6	14.0	23.7	12.4
Nonmetro	11.0	6.1	11.5	22.9	10.0
Urbanized	12.4	6.4	13.0	26.9	10.9
Less Urbanized	10.3	5.9	10.8	20.5	9.6
Completely Rural	9.3	5.7	9.7	16.5	8.8
POVERTY LEVEL¹
Less Than 100%	15.9	5.1	17.4	23.7	15.5
100-199%	14.9	6.0	15.8	25.5	14.0
200% or More	11.7	5.9	12.3	23.8	11.0
HEALTH INSURANCE²
Private	11.1	5.5	11.6	23.6	9.9
Medicaid/CHIP	17.4	6.7	19.8	24.4	18.7
Other³	8.5	2.0	8.6	22.6	8.1
No Coverage	19.1	5.9	19.8	26.3	18.2
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.73A – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	4,765	40	4,725	1,173	3,551
GEOGRAPHIC REGION
Northeast	1,029	4	1,026	203	823
Midwest	922	11	912	193	719
South	1,528	12	1,516	330	1,186
West	1,285	13	1,272	448	824
COUNTY TYPE
Large Metro	2,847	21	2,826	662	2,164
Small Metro	1,411	7	1,405	397	1,008
Nonmetro	506	12	494	114	380
Urbanized	219	*	213	54	160
Less Urbanized	213	6	207	53	154
Completely Rural	74	*	74	8	66
POVERTY LEVEL¹
Less Than 100%	1,195	2	1,193	306	887
100-199%	1,009	7	1,002	248	754
200% or More	2,561	31	2,530	620	1,910
HEALTH INSURANCE²
Private	2,065	7	2,058	689	1,369
Medicaid/CHIP	1,598	16	1,583	191	1,392
Other³	788	5	783	94	688
No Coverage	821	12	809	223	586
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.73B – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1.7	0.2	1.9	3.5	1.6
GEOGRAPHIC REGION
Northeast	2.1	0.1	2.3	3.5	2.1
Midwest	1.6	0.2	1.7	2.7	1.6
South	1.4	0.1	1.6	2.6	1.4
West	1.9	0.2	2.1	5.6	1.6
COUNTY TYPE
Large Metro	1.9	0.1	2.0	3.7	1.8
Small Metro	1.7	0.1	1.8	3.6	1.5
Nonmetro	1.2	0.3	1.3	2.5	1.1
Urbanized	1.4	*	1.5	2.8	1.3
Less Urbanized	1.0	0.3	1.1	2.5	0.9
Completely Rural	1.7	*	1.8	1.7	1.8
POVERTY LEVEL¹
Less Than 100%	2.8	0.0	3.2	3.6	3.1
100-199%	1.8	0.1	2.0	3.1	1.8
200% or More	1.4	0.2	1.5	3.7	1.3
HEALTH INSURANCE²
Private	1.2	0.0	1.3	3.6	1.0
Medicaid/CHIP	2.8	0.1	3.4	2.3	3.7
Other³	1.0	0.4	1.0	3.7	0.9
No Coverage	3.1	0.9	3.2	4.5	2.9
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.74A – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1,833	5	1,828	373	1,455
GEOGRAPHIC REGION
Northeast	536	3	533	92	441
Midwest	271	0	271	59	212
South	597	*	597	71	526
West	429	2	427	151	276
COUNTY TYPE
Large Metro	1,112	4	1,109	231	878
Small Metro	575	2	574	104	469
Nonmetro	145	*	145	37	108
Urbanized	75	*	75	12	63
Less Urbanized	45	*	45	22	23
Completely Rural	26	*	26	3	22
POVERTY LEVEL¹
Less Than 100%	439	*	439	91	347
100-199%	398	4	395	101	294
200% or More	996	2	994	181	813
HEALTH INSURANCE²
Private	633	1	632	206	426
Medicaid/CHIP	704	4	700	67	633
Other³	375	*	375	27	348
No Coverage	350	*	350	79	270
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.74B – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.7	0.0	0.7	1.1	0.7
GEOGRAPHIC REGION
Northeast	1.1	0.1	1.2	1.6	1.1
Midwest	0.5	0.0	0.5	0.8	0.5
South	0.6	*	0.6	0.6	0.6
West	0.6	0.0	0.7	1.9	0.5
COUNTY TYPE
Large Metro	0.7	0.0	0.8	1.3	0.7
Small Metro	0.7	0.0	0.7	1.0	0.7
Nonmetro	0.4	*	0.4	0.8	0.3
Urbanized	0.5	*	0.5	0.6	0.5
Less Urbanized	0.2	*	0.2	1.0	0.1
Completely Rural	0.6	*	0.6	0.8	0.6
POVERTY LEVEL¹
Less Than 100%	1.0	*	1.2	1.1	1.2
100-199%	0.7	0.1	0.8	1.3	0.7
200% or More	0.6	0.0	0.6	1.1	0.5
HEALTH INSURANCE²
Private	0.4	0.0	0.4	1.1	0.3
Medicaid/CHIP	1.2	0.0	1.5	0.8	1.7
Other³	0.5	*	0.5	1.1	0.5
No Coverage	1.3	*	1.4	1.6	1.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.75A – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Lifetime (2021)	Past Year (2021)	Past Month (2021)
TOTAL	10,640	996	527
GEOGRAPHIC REGION
Northeast	1,795	285	189
Midwest	2,516	169	63
South	3,515	447	246
West	2,814	95	29
COUNTY TYPE
Large Metro	5,474	550	312
Small Metro	3,634	343	179
Nonmetro	1,532	103	36
Urbanized	582	37	26
Less Urbanized	751	25	6
Completely Rural	199	*	4
POVERTY LEVEL¹
Less Than 100%	2,939	393	208
100-199%	2,934	329	192
200% or More	4,767	275	127
HEALTH INSURANCE²
Private	3,959	131	37
Medicaid/CHIP	4,104	577	325
Other³	2,767	324	218
No Coverage	1,683	188	99
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.75B – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Lifetime (2021)	Past Year (2021)	Past Month (2021)
TOTAL	3.8	0.4	0.2
GEOGRAPHIC REGION
Northeast	3.7	0.6	0.4
Midwest	4.3	0.3	0.1
South	3.3	0.4	0.2
West	4.2	0.1	0.0
COUNTY TYPE
Large Metro	3.6	0.4	0.2
Small Metro	4.2	0.4	0.2
Nonmetro	3.7	0.2	0.1
Urbanized	3.7	0.2	0.2
Less Urbanized	3.5	0.1	0.0
Completely Rural	4.5	*	0.1
POVERTY LEVEL¹
Less Than 100%	6.8	0.9	0.5
100-199%	5.3	0.6	0.3
200% or More	2.6	0.2	0.1
HEALTH INSURANCE²
Private	2.3	0.1	0.0
Medicaid/CHIP	7.2	1.0	0.6
Other³	3.6	0.4	0.3
No Coverage	6.3	0.7	0.4
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.76A – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Lifetime (2021)	Past Year (2021)	Past Month (2021)
TOTAL	45,826	7,406	2,234
GEOGRAPHIC REGION
Northeast	7,993	1,086	361
Midwest	9,590	1,674	522
South	14,019	2,025	497
West	14,225	2,620	854
COUNTY TYPE
Large Metro	25,936	4,467	1,339
Small Metro	14,387	1,965	549
Nonmetro	5,503	974	346
Urbanized	2,397	533	184
Less Urbanized	2,524	389	136
Completely Rural	583	52	26
POVERTY LEVEL¹
Less Than 100%	6,531	1,378	496
100-199%	8,882	1,661	535
200% or More	30,405	4,367	1,202
HEALTH INSURANCE²
Private	26,856	3,872	1,052
Medicaid/CHIP	9,752	2,045	711
Other³	10,095	733	157
No Coverage	5,044	1,126	402
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.76B – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Lifetime (2021)	Past Year (2021)	Past Month (2021)
TOTAL	16.4	2.6	0.8
GEOGRAPHIC REGION
Northeast	16.3	2.2	0.7
Midwest	16.5	2.9	0.9
South	13.2	1.9	0.5
West	21.5	4.0	1.3
COUNTY TYPE
Large Metro	17.0	2.9	0.9
Small Metro	16.8	2.3	0.6
Nonmetro	13.3	2.3	0.8
Urbanized	15.2	3.4	1.2
Less Urbanized	11.9	1.8	0.6
Completely Rural	13.1	1.2	0.6
POVERTY LEVEL¹
Less Than 100%	15.2	3.2	1.2
100-199%	15.9	3.0	1.0
200% or More	16.8	2.4	0.7
HEALTH INSURANCE²
Private	15.9	2.3	0.6
Medicaid/CHIP	17.1	3.6	1.2
Other³	13.2	1.0	0.2
No Coverage	18.8	4.2	1.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.77A – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	2,178	626	1,552	497	1,055
GEOGRAPHIC REGION
Northeast	474	75	399	89	310
Midwest	371	109	262	83	179
South	735	219	517	172	345
West	597	223	374	153	221
COUNTY TYPE
Large Metro	1,374	398	976	260	717
Small Metro	632	166	466	193	273
Nonmetro	171	62	110	44	65
Urbanized	69	23	46	14	32
Less Urbanized	95	34	61	29	33
Completely Rural	7	5	2	2	*
POVERTY LEVEL¹
Less Than 100%	314	96	218	120	98
100-199%	415	117	298	168	130
200% or More	1,449	413	1,036	210	826
HEALTH INSURANCE²
Private	1,245	341	904	304	600
Medicaid/CHIP	610	258	352	101	251
Other³	228	40	188	34	153
No Coverage	269	18	252	82	169
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.77B – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.8	2.4	0.6	1.5	0.5
GEOGRAPHIC REGION
Northeast	1.0	1.8	0.9	1.6	0.8
Midwest	0.6	2.0	0.5	1.2	0.4
South	0.7	2.2	0.5	1.4	0.4
West	0.9	3.6	0.6	1.9	0.4
COUNTY TYPE
Large Metro	0.9	2.8	0.7	1.4	0.6
Small Metro	0.7	2.1	0.6	1.8	0.4
Nonmetro	0.4	1.6	0.3	1.0	0.2
Urbanized	0.4	1.6	0.3	0.7	0.3
Less Urbanized	0.4	1.7	0.3	1.3	0.2
Completely Rural	0.2	1.3	0.0	0.4	*
POVERTY LEVEL¹
Less Than 100%	0.7	1.8	0.6	1.4	0.3
100-199%	0.7	2.1	0.6	2.1	0.3
200% or More	0.8	2.7	0.6	1.2	0.6
HEALTH INSURANCE²
Private	0.7	2.4	0.6	1.6	0.4
Medicaid/CHIP	1.1	2.5	0.8	1.2	0.7
Other³	0.3	2.7	0.2	1.4	0.2
No Coverage	1.0	1.3	1.0	1.6	0.8
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.78A – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	830	205	625	121	504
GEOGRAPHIC REGION
Northeast	182	21	161	24	137
Midwest	135	32	102	22	80
South	306	73	232	49	184
West	208	79	129	25	103
COUNTY TYPE
Large Metro	512	129	384	49	335
Small Metro	261	55	206	56	150
Nonmetro	57	22	35	16	19
Urbanized	24	5	19	1	18
Less Urbanized	30	13	17	15	2
Completely Rural	3	3	*	*	*
POVERTY LEVEL¹
Less Than 100%	95	28	67	39	27
100-199%	190	50	140	46	94
200% or More	545	127	418	35	383
HEALTH INSURANCE²
Private	492	111	382	73	309
Medicaid/CHIP	228	96	132	28	104
Other³	91	8	83	4	80
No Coverage	130	3	127	19	108
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.78B – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.3	0.8	0.2	0.4	0.2
GEOGRAPHIC REGION
Northeast	0.4	0.5	0.4	0.4	0.4
Midwest	0.2	0.6	0.2	0.3	0.2
South	0.3	0.7	0.2	0.4	0.2
West	0.3	1.3	0.2	0.3	0.2
COUNTY TYPE
Large Metro	0.3	0.9	0.3	0.3	0.3
Small Metro	0.3	0.7	0.3	0.5	0.2
Nonmetro	0.1	0.6	0.1	0.4	0.1
Urbanized	0.2	0.4	0.1	0.1	0.1
Less Urbanized	0.1	0.7	0.1	0.7	0.0
Completely Rural	0.1	0.9	*	*	*
POVERTY LEVEL¹
Less Than 100%	0.2	0.5	0.2	0.5	0.1
100-199%	0.3	0.9	0.3	0.6	0.2
200% or More	0.3	0.8	0.3	0.2	0.3
HEALTH INSURANCE²
Private	0.3	0.8	0.2	0.4	0.2
Medicaid/CHIP	0.4	0.9	0.3	0.3	0.3
Other³	0.1	0.6	0.1	0.1	0.1
No Coverage	0.5	0.2	0.5	0.4	0.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.79A – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	2,549	37	2,512	166	2,346
GEOGRAPHIC REGION
Northeast	284	0	284	27	256
Midwest	471	13	458	13	445
South	968	12	956	65	891
West	825	12	814	60	753
COUNTY TYPE
Large Metro	1,193	20	1,173	54	1,120
Small Metro	730	3	727	73	655
Nonmetro	625	14	611	39	572
Urbanized	204	11	192	8	185
Less Urbanized	372	2	369	29	341
Completely Rural	50	*	50	*	47
POVERTY LEVEL¹
Less Than 100%	887	8	879	67	812
100-199%	852	4	848	39	810
200% or More	809	25	784	61	724
HEALTH INSURANCE²
Private	357	6	350	47	303
Medicaid/CHIP	1,359	23	1,336	82	1,254
Other³	516	2	514	10	504
No Coverage	539	*	534	33	501
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.79B – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.9	0.1	1.0	0.5	1.1
GEOGRAPHIC REGION
Northeast	0.6	0.0	0.6	0.5	0.7
Midwest	0.8	0.2	0.9	0.2	1.0
South	0.9	0.1	1.0	0.5	1.1
West	1.2	0.2	1.4	0.8	1.4
COUNTY TYPE
Large Metro	0.8	0.1	0.8	0.3	0.9
Small Metro	0.9	0.0	0.9	0.7	1.0
Nonmetro	1.5	0.4	1.6	0.9	1.7
Urbanized	1.3	0.8	1.3	0.4	1.5
Less Urbanized	1.7	0.1	1.9	1.3	2.0
Completely Rural	1.1	*	1.2	*	1.3
POVERTY LEVEL¹
Less Than 100%	2.1	0.2	2.3	0.8	2.8
100-199%	1.5	0.1	1.7	0.5	1.9
200% or More	0.4	0.2	0.5	0.4	0.5
HEALTH INSURANCE²
Private	0.2	0.0	0.2	0.2	0.2
Medicaid/CHIP	2.4	0.2	2.9	1.0	3.3
Other³	0.7	0.1	0.7	0.4	0.7
No Coverage	2.0	*	2.1	0.7	2.4
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.80A – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1,617	14	1,603	90	1,513
GEOGRAPHIC REGION
Northeast	103	*	103	15	88
Midwest	340	*	340	2	338
South	513	10	504	34	469
West	660	4	656	39	617
COUNTY TYPE
Large Metro	792	8	785	20	765
Small Metro	413	3	410	46	364
Nonmetro	412	4	409	24	385
Urbanized	145	1	144	3	141
Less Urbanized	222	2	220	21	199
Completely Rural	45	*	45	*	45
POVERTY LEVEL¹
Less Than 100%	575	8	567	40	526
100-199%	531	2	529	18	511
200% or More	512	4	508	32	475
HEALTH INSURANCE²
Private	196	4	193	9	183
Medicaid/CHIP	886	10	876	49	827
Other³	318	*	318	9	309
No Coverage	362	*	362	27	335
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.80B – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.6	0.1	0.6	0.3	0.7
GEOGRAPHIC REGION
Northeast	0.2	*	0.2	0.3	0.2
Midwest	0.6	*	0.6	0.0	0.7
South	0.5	0.1	0.5	0.3	0.6
West	1.0	0.1	1.1	0.5	1.2
COUNTY TYPE
Large Metro	0.5	0.1	0.6	0.1	0.6
Small Metro	0.5	0.0	0.5	0.4	0.5
Nonmetro	1.0	0.1	1.1	0.5	1.2
Urbanized	0.9	0.1	1.0	0.2	1.1
Less Urbanized	1.0	0.1	1.1	1.0	1.2
Completely Rural	1.0	*	1.1	*	1.2
POVERTY LEVEL¹
Less Than 100%	1.3	0.2	1.5	0.5	1.8
100-199%	1.0	0.0	1.1	0.2	1.2
200% or More	0.3	0.0	0.3	0.2	0.3
HEALTH INSURANCE²
Private	0.1	0.0	0.1	0.0	0.1
Medicaid/CHIP	1.6	0.1	1.9	0.6	2.2
Other³	0.4	*	0.4	0.4	0.4
No Coverage	1.3	*	1.4	0.5	1.6
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.81A – Any Use of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	71,688	3,342	68,346	6,119	62,227
GEOGRAPHIC REGION
Northeast	10,315	473	9,842	864	8,979
Midwest	15,205	731	14,474	1,345	13,130
South	29,313	1,268	28,045	2,474	25,571
West	16,855	871	15,984	1,436	14,548
COUNTY TYPE
Large Metro	36,810	1,708	35,102	3,084	32,018
Small Metro	22,799	1,092	21,707	2,148	19,560
Nonmetro	12,079	542	11,536	887	10,649
Urbanized	4,500	202	4,298	356	3,941
Less Urbanized	6,171	293	5,879	410	5,469
Completely Rural	1,408	48	1,360	121	1,239
POVERTY LEVEL¹
Less Than 100%	12,535	802	11,734	1,563	10,171
100-199%	15,401	811	14,590	1,543	13,047
200% or More	43,749	1,729	42,020	3,009	39,010
HEALTH INSURANCE²
Private	39,379	1,646	37,733	3,225	34,508
Medicaid/CHIP	18,094	1,510	16,584	1,797	14,787
Other³	24,815	154	24,661	516	24,145
No Coverage	5,670	190	5,479	910	4,569
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.81B – Any Use of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	25.6	12.8	26.9	18.3	28.2
GEOGRAPHIC REGION
Northeast	21.1	11.4	22.0	15.1	23.0
Midwest	26.2	13.3	27.5	18.9	28.9
South	27.5	12.5	29.1	19.5	30.5
West	25.4	14.0	26.6	18.1	27.9
COUNTY TYPE
Large Metro	24.1	11.9	25.3	17.2	26.6
Small Metro	26.7	13.8	28.0	19.6	29.4
Nonmetro	29.1	14.4	30.6	19.6	32.1
Urbanized	28.5	14.1	29.9	18.3	31.8
Less Urbanized	29.0	15.1	30.4	19.3	31.8
Completely Rural	31.7	12.4	33.5	26.8	34.3
POVERTY LEVEL¹
Less Than 100%	29.2	14.9	31.2	18.4	35.0
100-199%	27.6	14.6	29.0	19.5	30.8
200% or More	24.2	11.5	25.3	17.8	26.2
HEALTH INSURANCE²
Private	23.4	11.7	24.4	17.0	25.5
Medicaid/CHIP	31.7	14.3	35.7	21.2	38.9
Other³	32.4	10.6	32.8	20.4	33.2
No Coverage	21.1	13.8	21.5	18.3	22.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.82A – Misuse of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	8,711	497	8,213	1,018	7,195
GEOGRAPHIC REGION
Northeast	1,518	78	1,440	166	1,274
Midwest	1,680	127	1,554	189	1,364
South	3,383	189	3,194	394	2,801
West	2,129	104	2,025	269	1,756
COUNTY TYPE
Large Metro	4,579	286	4,293	532	3,761
Small Metro	2,851	153	2,698	352	2,346
Nonmetro	1,281	59	1,223	134	1,088
Urbanized	501	31	469	58	411
Less Urbanized	650	26	624	61	563
Completely Rural	131	2	129	15	114
POVERTY LEVEL¹
Less Than 100%	2,074	122	1,952	253	1,699
100-199%	1,968	111	1,858	310	1,547
200% or More	4,668	264	4,403	454	3,949
HEALTH INSURANCE²
Private	3,888	216	3,671	449	3,223
Medicaid/CHIP	3,013	240	2,773	317	2,456
Other³	1,956	37	1,919	88	1,831
No Coverage	1,135	38	1,096	200	896
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.82B – Misuse of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	3.1	1.9	3.2	3.0	3.3
GEOGRAPHIC REGION
Northeast	3.1	1.9	3.2	2.9	3.3
Midwest	2.9	2.3	3.0	2.7	3.0
South	3.2	1.9	3.3	3.1	3.3
West	3.2	1.7	3.4	3.4	3.4
COUNTY TYPE
Large Metro	3.0	2.0	3.1	3.0	3.1
Small Metro	3.3	1.9	3.5	3.2	3.5
Nonmetro	3.1	1.6	3.2	3.0	3.3
Urbanized	3.2	2.2	3.3	3.0	3.3
Less Urbanized	3.1	1.3	3.2	2.9	3.3
Completely Rural	2.9	0.5	3.2	3.2	3.2
POVERTY LEVEL¹
Less Than 100%	4.8	2.3	5.2	3.0	5.8
100-199%	3.5	2.0	3.7	3.9	3.7
200% or More	2.6	1.8	2.7	2.7	2.7
HEALTH INSURANCE²
Private	2.3	1.5	2.4	2.4	2.4
Medicaid/CHIP	5.3	2.3	6.0	3.7	6.5
Other³	2.6	2.6	2.6	3.5	2.5
No Coverage	4.2	2.8	4.3	4.0	4.4
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.83A – Misuse of Prescription Pain Relievers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	2,401	115	2,286	213	2,073
GEOGRAPHIC REGION
Northeast	521	35	486	25	461
Midwest	413	15	398	41	357
South	929	52	876	73	803
West	538	12	526	74	452
COUNTY TYPE
Large Metro	1,217	59	1,158	96	1,063
Small Metro	877	34	843	92	751
Nonmetro	307	22	285	25	259
Urbanized	113	11	102	7	95
Less Urbanized	168	10	158	17	141
Completely Rural	25	*	25	2	23
POVERTY LEVEL¹
Less Than 100%	699	39	660	48	612
100-199%	591	45	547	82	464
200% or More	1,110	31	1,079	83	996
HEALTH INSURANCE²
Private	847	33	814	77	738
Medicaid/CHIP	1,008	65	944	99	845
Other³	733	8	726	12	714
No Coverage	302	14	288	39	249
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.83B – Misuse of Prescription Pain Relievers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.9	0.4	0.9	0.6	0.9
GEOGRAPHIC REGION
Northeast	1.1	0.8	1.1	0.4	1.2
Midwest	0.7	0.3	0.8	0.6	0.8
South	0.9	0.5	0.9	0.6	1.0
West	0.8	0.2	0.9	0.9	0.9
COUNTY TYPE
Large Metro	0.8	0.4	0.8	0.5	0.9
Small Metro	1.0	0.4	1.1	0.8	1.1
Nonmetro	0.7	0.6	0.8	0.6	0.8
Urbanized	0.7	0.8	0.7	0.4	0.8
Less Urbanized	0.8	0.5	0.8	0.8	0.8
Completely Rural	0.6	*	0.6	0.4	0.6
POVERTY LEVEL¹
Less Than 100%	1.6	0.7	1.8	0.6	2.1
100-199%	1.1	0.8	1.1	1.0	1.1
200% or More	0.6	0.2	0.7	0.5	0.7
HEALTH INSURANCE²
Private	0.5	0.2	0.5	0.4	0.5
Medicaid/CHIP	1.8	0.6	2.0	1.2	2.2
Other³	1.0	0.5	1.0	0.5	1.0
No Coverage	1.1	1.0	1.1	0.8	1.2
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.84A – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	16,630	1,821	14,808	3,354	11,454
GEOGRAPHIC REGION
Northeast	2,976	263	2,713	628	2,085
Midwest	3,613	444	3,170	679	2,491
South	6,321	715	5,606	1,252	4,355
West	3,719	400	3,319	796	2,524
COUNTY TYPE
Large Metro	9,296	971	8,325	1,856	6,469
Small Metro	5,308	545	4,762	1,089	3,673
Nonmetro	2,026	305	1,722	409	1,313
Urbanized	802	148	654	172	482
Less Urbanized	1,006	133	873	193	680
Completely Rural	219	23	195	44	151
POVERTY LEVEL¹
Less Than 100%	2,902	361	2,541	799	1,742
100-199%	3,133	378	2,755	658	2,097
200% or More	10,589	1,083	9,506	1,891	7,615
HEALTH INSURANCE²
Private	10,321	1,030	9,290	2,307	6,983
Medicaid/CHIP	4,299	762	3,537	638	2,899
Other³	2,667	112	2,555	237	2,317
No Coverage	1,287	84	1,203	322	881
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.84B – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	5.9	7.0	5.8	10.0	5.2
GEOGRAPHIC REGION
Northeast	6.1	6.3	6.1	11.0	5.3
Midwest	6.2	8.1	6.0	9.6	5.5
South	5.9	7.0	5.8	9.9	5.2
West	5.6	6.4	5.5	10.0	4.8
COUNTY TYPE
Large Metro	6.1	6.8	6.0	10.3	5.4
Small Metro	6.2	6.9	6.1	9.9	5.5
Nonmetro	4.9	8.1	4.6	9.0	4.0
Urbanized	5.1	10.3	4.6	8.9	3.9
Less Urbanized	4.7	6.9	4.5	9.1	4.0
Completely Rural	4.9	6.0	4.8	9.7	4.2
POVERTY LEVEL¹
Less Than 100%	6.8	6.7	6.8	9.4	6.0
100-199%	5.6	6.8	5.5	8.3	5.0
200% or More	5.9	7.2	5.7	11.2	5.1
HEALTH INSURANCE²
Private	6.1	7.3	6.0	12.1	5.2
Medicaid/CHIP	7.5	7.2	7.6	7.5	7.6
Other³	3.5	7.8	3.4	9.4	3.2
No Coverage	4.8	6.1	4.7	6.5	4.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.85A – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	3,733	304	3,429	1,244	2,184
GEOGRAPHIC REGION
Northeast	760	48	712	226	486
Midwest	936	85	852	285	566
South	1,180	92	1,088	402	686
West	856	79	777	331	446
COUNTY TYPE
Large Metro	2,147	200	1,947	672	1,275
Small Metro	1,169	76	1,093	426	667
Nonmetro	416	28	388	146	242
Urbanized	183	19	163	70	93
Less Urbanized	212	7	206	68	138
Completely Rural	21	2	19	8	11
POVERTY LEVEL¹
Less Than 100%	741	54	687	319	368
100-199%	672	62	610	235	374
200% or More	2,320	188	2,132	690	1,442
HEALTH INSURANCE²
Private	2,267	196	2,071	898	1,172
Medicaid/CHIP	920	83	836	199	637
Other³	339	10	330	90	240
No Coverage	470	35	434	112	322
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.85B – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1.3	1.2	1.4	3.7	1.0
GEOGRAPHIC REGION
Northeast	1.6	1.2	1.6	3.9	1.2
Midwest	1.6	1.5	1.6	4.0	1.2
South	1.1	0.9	1.1	3.2	0.8
West	1.3	1.3	1.3	4.2	0.9
COUNTY TYPE
Large Metro	1.4	1.4	1.4	3.7	1.1
Small Metro	1.4	1.0	1.4	3.9	1.0
Nonmetro	1.0	0.7	1.0	3.2	0.7
Urbanized	1.2	1.4	1.1	3.6	0.8
Less Urbanized	1.0	0.3	1.1	3.2	0.8
Completely Rural	0.5	0.4	0.5	1.8	0.3
POVERTY LEVEL¹
Less Than 100%	1.7	1.0	1.8	3.7	1.3
100-199%	1.2	1.1	1.2	3.0	0.9
200% or More	1.3	1.2	1.3	4.1	1.0
HEALTH INSURANCE²
Private	1.3	1.4	1.3	4.7	0.9
Medicaid/CHIP	1.6	0.8	1.8	2.4	1.7
Other³	0.4	0.7	0.4	3.5	0.3
No Coverage	1.8	2.6	1.7	2.2	1.6
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.86A – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1,104	74	1,029	300	730
GEOGRAPHIC REGION
Northeast	257	20	237	57	180
Midwest	355	13	342	84	258
South	270	16	254	84	170
West	221	25	196	74	123
COUNTY TYPE
Large Metro	660	52	608	176	433
Small Metro	317	14	303	94	209
Nonmetro	126	9	118	30	88
Urbanized	67	5	62	22	41
Less Urbanized	56	4	52	8	43
Completely Rural	4	*	4	0	4
POVERTY LEVEL¹
Less Than 100%	223	6	218	88	130
100-199%	206	23	183	50	133
200% or More	674	45	629	162	467
HEALTH INSURANCE²
Private	623	45	577	218	359
Medicaid/CHIP	257	19	238	45	193
Other³	113	2	111	22	89
No Coverage	165	*	156	19	137
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.86B – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.4	0.3	0.4	0.9	0.3
GEOGRAPHIC REGION
Northeast	0.5	0.5	0.5	1.0	0.5
Midwest	0.6	0.2	0.7	1.2	0.6
South	0.3	0.2	0.3	0.7	0.2
West	0.3	0.4	0.3	0.9	0.2
COUNTY TYPE
Large Metro	0.4	0.4	0.4	1.0	0.4
Small Metro	0.4	0.2	0.4	0.9	0.3
Nonmetro	0.3	0.2	0.3	0.7	0.3
Urbanized	0.4	0.3	0.4	1.1	0.3
Less Urbanized	0.3	0.2	0.3	0.4	0.3
Completely Rural	0.1	*	0.1	0.0	0.1
POVERTY LEVEL¹
Less Than 100%	0.5	0.1	0.6	1.0	0.4
100-199%	0.4	0.4	0.4	0.6	0.3
200% or More	0.4	0.3	0.4	1.0	0.3
HEALTH INSURANCE²
Private	0.4	0.3	0.4	1.1	0.3
Medicaid/CHIP	0.5	0.2	0.5	0.5	0.5
Other³	0.1	0.2	0.1	0.9	0.1
No Coverage	0.6	*	0.6	0.4	0.7
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.87A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	40,899	1,002	39,897	2,950	36,947
GEOGRAPHIC REGION
Northeast	6,642	80	6,562	474	6,089
Midwest	8,802	247	8,556	701	7,854
South	16,448	391	16,058	1,128	14,930
West	9,006	285	8,721	647	8,074
COUNTY TYPE
Large Metro	21,114	518	20,597	1,542	19,054
Small Metro	13,278	358	12,921	962	11,959
Nonmetro	6,506	126	6,379	446	5,934
Urbanized	2,406	64	2,342	206	2,136
Less Urbanized	3,551	55	3,496	196	3,300
Completely Rural	549	7	542	44	498
POVERTY LEVEL¹
Less Than 100%	6,119	205	5,914	625	5,289
100-199%	8,139	245	7,894	703	7,190
200% or More	26,640	552	26,089	1,621	24,468
HEALTH INSURANCE²
Private	24,318	527	23,791	1,840	21,951
Medicaid/CHIP	9,165	471	8,695	689	8,006
Other³	15,105	40	15,065	218	14,847
No Coverage	2,582	45	2,537	330	2,208
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.87B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	14.6	3.9	15.7	8.8	16.8
GEOGRAPHIC REGION
Northeast	13.6	1.9	14.7	8.3	15.6
Midwest	15.2	4.5	16.3	9.9	17.3
South	15.4	3.8	16.7	8.9	17.8
West	13.6	4.6	14.5	8.2	15.5
COUNTY TYPE
Large Metro	13.8	3.6	14.9	8.6	15.8
Small Metro	15.5	4.5	16.7	8.8	17.9
Nonmetro	15.7	3.4	16.9	9.9	17.9
Urbanized	15.2	4.5	16.3	10.6	17.2
Less Urbanized	16.7	2.8	18.1	9.2	19.2
Completely Rural	12.4	1.9	13.3	9.6	13.8
POVERTY LEVEL¹
Less Than 100%	14.2	3.8	15.7	7.3	18.2
100-199%	14.6	4.4	15.7	8.9	17.0
200% or More	14.7	3.7	15.7	9.6	16.4
HEALTH INSURANCE²
Private	14.4	3.7	15.4	9.7	16.2
Medicaid/CHIP	16.1	4.5	18.7	8.1	21.0
Other³	19.7	2.8	20.0	8.6	20.4
No Coverage	9.6	3.3	10.0	6.6	10.8
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.88A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	4,887	225	4,662	874	3,788
GEOGRAPHIC REGION
Northeast	870	15	855	147	708
Midwest	898	35	863	202	661
South	1,887	85	1,802	342	1,460
West	1,233	90	1,143	184	959
COUNTY TYPE
Large Metro	2,793	94	2,698	474	2,225
Small Metro	1,465	107	1,358	257	1,100
Nonmetro	630	24	606	144	462
Urbanized	267	13	254	70	184
Less Urbanized	330	11	319	66	253
Completely Rural	33	*	33	8	25
POVERTY LEVEL¹
Less Than 100%	719	41	678	149	529
100-199%	1,108	79	1,029	254	775
200% or More	3,061	106	2,955	471	2,484
HEALTH INSURANCE²
Private	2,480	83	2,397	483	1,914
Medicaid/CHIP	1,511	148	1,363	249	1,114
Other³	1,013	18	995	36	959
No Coverage	481	*	472	129	342
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.88B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1.7	0.9	1.8	2.6	1.7
GEOGRAPHIC REGION
Northeast	1.8	0.4	1.9	2.6	1.8
Midwest	1.5	0.6	1.6	2.8	1.5
South	1.8	0.8	1.9	2.7	1.7
West	1.9	1.4	1.9	2.3	1.8
COUNTY TYPE
Large Metro	1.8	0.7	1.9	2.6	1.8
Small Metro	1.7	1.4	1.7	2.3	1.7
Nonmetro	1.5	0.6	1.6	3.2	1.4
Urbanized	1.7	0.9	1.8	3.6	1.5
Less Urbanized	1.6	0.5	1.7	3.1	1.5
Completely Rural	0.7	*	0.8	1.7	0.7
POVERTY LEVEL¹
Less Than 100%	1.7	0.8	1.8	1.8	1.8
100-199%	2.0	1.4	2.0	3.2	1.8
200% or More	1.7	0.7	1.8	2.8	1.7
HEALTH INSURANCE²
Private	1.5	0.6	1.6	2.5	1.4
Medicaid/CHIP	2.7	1.4	2.9	2.9	2.9
Other³	1.3	1.2	1.3	1.4	1.3
No Coverage	1.8	*	1.9	2.6	1.7
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.89A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1,373	44	1,330	164	1,166
GEOGRAPHIC REGION
Northeast	250	9	241	42	200
Midwest	317	12	305	32	273
South	425	14	411	60	351
West	382	9	373	30	343
COUNTY TYPE
Large Metro	801	18	783	65	718
Small Metro	422	20	402	79	323
Nonmetro	150	5	144	19	125
Urbanized	80	5	74	7	67
Less Urbanized	65	*	65	11	54
Completely Rural	5	*	5	1	4
POVERTY LEVEL¹
Less Than 100%	223	0	222	45	178
100-199%	272	16	256	43	213
200% or More	878	27	851	75	776
HEALTH INSURANCE²
Private	622	12	611	71	539
Medicaid/CHIP	404	22	382	69	313
Other³	398	1	398	10	388
No Coverage	199	*	190	19	171
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.89B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.5	0.2	0.5	0.5	0.5
GEOGRAPHIC REGION
Northeast	0.5	0.2	0.5	0.7	0.5
Midwest	0.5	0.2	0.6	0.5	0.6
South	0.4	0.1	0.4	0.5	0.4
West	0.6	0.1	0.6	0.4	0.7
COUNTY TYPE
Large Metro	0.5	0.1	0.6	0.4	0.6
Small Metro	0.5	0.3	0.5	0.7	0.5
Nonmetro	0.4	0.1	0.4	0.4	0.4
Urbanized	0.5	0.4	0.5	0.4	0.5
Less Urbanized	0.3	*	0.3	0.5	0.3
Completely Rural	0.1	*	0.1	0.3	0.1
POVERTY LEVEL¹
Less Than 100%	0.5	0.0	0.6	0.5	0.6
100-199%	0.5	0.3	0.5	0.5	0.5
200% or More	0.5	0.2	0.5	0.4	0.5
HEALTH INSURANCE²
Private	0.4	0.1	0.4	0.4	0.4
Medicaid/CHIP	0.7	0.2	0.8	0.8	0.8
Other³	0.5	0.0	0.5	0.4	0.5
No Coverage	0.7	*	0.7	0.4	0.8
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.90A – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	32,735	737	31,998	2,449	29,549
GEOGRAPHIC REGION
Northeast	5,370	61	5,309	420	4,889
Midwest	7,236	164	7,071	577	6,494
South	13,111	290	12,821	953	11,867
West	7,019	222	6,797	498	6,300
COUNTY TYPE
Large Metro	16,634	386	16,248	1,310	14,938
Small Metro	10,946	266	10,680	764	9,916
Nonmetro	5,155	85	5,070	375	4,695
Urbanized	1,824	45	1,779	189	1,590
Less Urbanized	2,854	37	2,817	152	2,665
Completely Rural	477	4	474	33	440
POVERTY LEVEL¹
Less Than 100%	5,034	124	4,910	475	4,435
100-199%	6,731	192	6,539	624	5,915
200% or More	20,970	421	20,549	1,349	19,200
HEALTH INSURANCE²
Private	19,180	391	18,789	1,498	17,290
Medicaid/CHIP	7,580	341	7,240	577	6,662
Other³	11,921	39	11,883	200	11,682
No Coverage	2,209	37	2,171	281	1,890
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.90B – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	11.7	2.8	12.6	7.3	13.4
GEOGRAPHIC REGION
Northeast	11.0	1.5	11.9	7.3	12.5
Midwest	12.5	3.0	13.5	8.1	14.3
South	12.3	2.9	13.3	7.5	14.2
West	10.6	3.6	11.3	6.3	12.1
COUNTY TYPE
Large Metro	10.9	2.7	11.7	7.3	12.4
Small Metro	12.8	3.4	13.8	7.0	14.9
Nonmetro	12.4	2.3	13.4	8.3	14.1
Urbanized	11.6	3.1	12.4	9.8	12.8
Less Urbanized	13.4	1.9	14.6	7.2	15.5
Completely Rural	10.7	1.0	11.7	7.4	12.2
POVERTY LEVEL¹
Less Than 100%	11.7	2.3	13.1	5.6	15.3
100-199%	12.1	3.5	13.0	7.9	14.0
200% or More	11.6	2.8	12.4	8.0	12.9
HEALTH INSURANCE²
Private	11.4	2.8	12.2	7.9	12.8
Medicaid/CHIP	13.3	3.2	15.6	6.8	17.5
Other³	15.6	2.7	15.8	7.9	16.1
No Coverage	8.2	2.7	8.5	5.6	9.2
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.91A – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	4,317	198	4,119	810	3,309
GEOGRAPHIC REGION
Northeast	784	14	769	144	625
Midwest	854	30	824	182	643
South	1,588	70	1,518	322	1,196
West	1,091	84	1,007	162	845
COUNTY TYPE
Large Metro	2,467	90	2,377	447	1,930
Small Metro	1,295	90	1,205	231	974
Nonmetro	555	18	537	132	405
Urbanized	236	9	227	62	165
Less Urbanized	286	9	277	63	214
Completely Rural	33	*	33	8	25
POVERTY LEVEL¹
Less Than 100%	664	38	626	134	492
100-199%	1,034	76	959	226	732
200% or More	2,619	85	2,534	450	2,084
HEALTH INSURANCE²
Private	2,121	72	2,049	452	1,597
Medicaid/CHIP	1,408	131	1,277	221	1,056
Other³	827	18	810	34	776
No Coverage	467	*	458	125	332
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.91B – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1.5	0.8	1.6	2.4	1.5
GEOGRAPHIC REGION
Northeast	1.6	0.3	1.7	2.5	1.6
Midwest	1.5	0.5	1.6	2.6	1.4
South	1.5	0.7	1.6	2.5	1.4
West	1.6	1.3	1.7	2.0	1.6
COUNTY TYPE
Large Metro	1.6	0.6	1.7	2.5	1.6
Small Metro	1.5	1.1	1.6	2.1	1.5
Nonmetro	1.3	0.5	1.4	2.9	1.2
Urbanized	1.5	0.7	1.6	3.2	1.3
Less Urbanized	1.3	0.4	1.4	3.0	1.2
Completely Rural	0.7	*	0.8	1.7	0.7
POVERTY LEVEL¹
Less Than 100%	1.5	0.7	1.7	1.6	1.7
100-199%	1.9	1.4	1.9	2.9	1.7
200% or More	1.4	0.6	1.5	2.7	1.4
HEALTH INSURANCE²
Private	1.3	0.5	1.3	2.4	1.2
Medicaid/CHIP	2.5	1.2	2.7	2.6	2.8
Other³	1.1	1.2	1.1	1.3	1.1
No Coverage	1.7	*	1.8	2.5	1.6
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.92A – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1,184	28	1,155	143	1,012
GEOGRAPHIC REGION
Northeast	215	9	207	35	171
Midwest	290	9	281	25	256
South	366	7	358	56	303
West	312	3	310	28	282
COUNTY TYPE
Large Metro	684	14	670	58	612
Small Metro	373	12	361	67	294
Nonmetro	127	2	125	18	107
Urbanized	60	2	59	6	53
Less Urbanized	61	*	61	11	50
Completely Rural	5	*	5	1	4
POVERTY LEVEL¹
Less Than 100%	193	0	193	31	162
100-199%	259	13	246	42	204
200% or More	732	15	717	70	647
HEALTH INSURANCE²
Private	517	9	508	69	439
Medicaid/CHIP	336	10	326	54	272
Other³	362	1	362	10	352
No Coverage	190	*	181	15	166
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.92B – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.4	0.1	0.5	0.4	0.5
GEOGRAPHIC REGION
Northeast	0.4	0.2	0.5	0.6	0.4
Midwest	0.5	0.2	0.5	0.3	0.6
South	0.3	0.1	0.4	0.4	0.4
West	0.5	0.0	0.5	0.3	0.5
COUNTY TYPE
Large Metro	0.4	0.1	0.5	0.3	0.5
Small Metro	0.4	0.2	0.5	0.6	0.4
Nonmetro	0.3	0.0	0.3	0.4	0.3
Urbanized	0.4	0.1	0.4	0.3	0.4
Less Urbanized	0.3	*	0.3	0.5	0.3
Completely Rural	0.1	*	0.1	0.3	0.1
POVERTY LEVEL¹
Less Than 100%	0.4	0.0	0.5	0.4	0.6
100-199%	0.5	0.2	0.5	0.5	0.5
200% or More	0.4	0.1	0.4	0.4	0.4
HEALTH INSURANCE²
Private	0.3	0.1	0.3	0.4	0.3
Medicaid/CHIP	0.6	0.1	0.7	0.6	0.7
Other³	0.5	0.0	0.5	0.4	0.5
No Coverage	0.7	*	0.7	0.3	0.8
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.93A – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	14,548	408	14,140	846	13,295
GEOGRAPHIC REGION
Northeast	2,411	40	2,371	107	2,264
Midwest	2,791	110	2,681	193	2,488
South	5,963	175	5,789	317	5,471
West	3,383	84	3,299	228	3,072
COUNTY TYPE
Large Metro	8,080	223	7,857	417	7,440
Small Metro	4,334	131	4,203	310	3,894
Nonmetro	2,134	54	2,080	119	1,961
Urbanized	863	26	837	56	781
Less Urbanized	1,130	25	1,105	53	1,053
Completely Rural	141	3	137	11	127
POVERTY LEVEL¹
Less Than 100%	2,250	123	2,127	219	1,908
100-199%	2,727	81	2,647	165	2,482
200% or More	9,571	204	9,366	462	8,904
HEALTH INSURANCE²
Private	8,952	209	8,743	559	8,185
Medicaid/CHIP	3,326	198	3,128	183	2,945
Other³	5,628	11	5,616	34	5,582
No Coverage	752	20	732	95	636
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.93B – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	5.2	1.6	5.6	2.5	6.0
GEOGRAPHIC REGION
Northeast	4.9	1.0	5.3	1.9	5.8
Midwest	4.8	2.0	5.1	2.7	5.5
South	5.6	1.7	6.0	2.5	6.5
West	5.1	1.3	5.5	2.9	5.9
COUNTY TYPE
Large Metro	5.3	1.6	5.7	2.3	6.2
Small Metro	5.1	1.7	5.4	2.8	5.8
Nonmetro	5.1	1.4	5.5	2.6	5.9
Urbanized	5.5	1.8	5.8	2.9	6.3
Less Urbanized	5.3	1.3	5.7	2.5	6.1
Completely Rural	3.2	0.9	3.4	2.3	3.5
POVERTY LEVEL¹
Less Than 100%	5.2	2.3	5.7	2.6	6.6
100-199%	4.9	1.5	5.3	2.1	5.9
200% or More	5.3	1.4	5.6	2.7	6.0
HEALTH INSURANCE²
Private	5.3	1.5	5.7	2.9	6.0
Medicaid/CHIP	5.8	1.9	6.7	2.2	7.7
Other³	7.3	0.8	7.5	1.4	7.7
No Coverage	2.8	1.5	2.9	1.9	3.1
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.94A – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	923	41	881	141	740
GEOGRAPHIC REGION
Northeast	155	1	154	23	131
Midwest	114	6	108	35	73
South	423	18	405	46	359
West	231	17	214	37	178
COUNTY TYPE
Large Metro	517	15	501	54	447
Small Metro	280	19	260	55	205
Nonmetro	126	7	120	32	88
Urbanized	63	5	58	28	30
Less Urbanized	58	2	56	3	52
Completely Rural	6	*	6	0	6
POVERTY LEVEL¹
Less Than 100%	136	5	131	42	89
100-199%	168	5	163	51	112
200% or More	619	32	587	48	539
HEALTH INSURANCE²
Private	514	23	491	67	424
Medicaid/CHIP	251	20	232	51	181
Other³	237	*	237	6	230
No Coverage	51	*	51	19	32
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.94B – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.3	0.2	0.3	0.4	0.3
GEOGRAPHIC REGION
Northeast	0.3	0.0	0.3	0.4	0.3
Midwest	0.2	0.1	0.2	0.5	0.2
South	0.4	0.2	0.4	0.4	0.4
West	0.3	0.3	0.4	0.5	0.3
COUNTY TYPE
Large Metro	0.3	0.1	0.4	0.3	0.4
Small Metro	0.3	0.2	0.3	0.5	0.3
Nonmetro	0.3	0.2	0.3	0.7	0.3
Urbanized	0.4	0.3	0.4	1.5	0.2
Less Urbanized	0.3	0.1	0.3	0.2	0.3
Completely Rural	0.1	*	0.1	0.0	0.2
POVERTY LEVEL¹
Less Than 100%	0.3	0.1	0.3	0.5	0.3
100-199%	0.3	0.1	0.3	0.6	0.3
200% or More	0.3	0.2	0.4	0.3	0.4
HEALTH INSURANCE²
Private	0.3	0.2	0.3	0.4	0.3
Medicaid/CHIP	0.4	0.2	0.5	0.6	0.5
Other³	0.3	*	0.3	0.3	0.3
No Coverage	0.2	*	0.2	0.4	0.2
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.95A – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	227	19	208	31	177
GEOGRAPHIC REGION
Northeast	51	*	51	15	37
Midwest	34	2	32	9	22
South	64	9	55	5	50
West	78	7	70	2	68
COUNTY TYPE
Large Metro	127	6	121	8	113
Small Metro	75	9	65	21	44
Nonmetro	25	4	22	1	20
Urbanized	19	4	16	1	15
Less Urbanized	6	*	6	0	6
Completely Rural	0	*	0	*	0
POVERTY LEVEL¹
Less Than 100%	42	*	42	21	21
100-199%	19	3	16	2	14
200% or More	165	16	150	8	142
HEALTH INSURANCE²
Private	113	7	106	4	102
Medicaid/CHIP	87	12	75	22	53
Other³	44	*	44	*	44
No Coverage	20	*	20	5	15
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.95B – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	0.1	0.1	0.1	0.1	0.1
GEOGRAPHIC REGION
Northeast	0.1	*	0.1	0.3	0.1
Midwest	0.1	0.0	0.1	0.1	0.0
South	0.1	0.1	0.1	0.0	0.1
West	0.1	0.1	0.1	0.0	0.1
COUNTY TYPE
Large Metro	0.1	0.0	0.1	0.0	0.1
Small Metro	0.1	0.1	0.1	0.2	0.1
Nonmetro	0.1	0.1	0.1	0.0	0.1
Urbanized	0.1	0.3	0.1	0.1	0.1
Less Urbanized	0.0	*	0.0	0.0	0.0
Completely Rural	0.0	*	0.0	*	0.0
POVERTY LEVEL¹
Less Than 100%	0.1	*	0.1	0.2	0.1
100-199%	0.0	0.1	0.0	0.0	0.0
200% or More	0.1	0.1	0.1	0.0	0.1
HEALTH INSURANCE²
Private	0.1	0.0	0.1	0.0	0.1
Medicaid/CHIP	0.2	0.1	0.2	0.3	0.1
Other³	0.1	*	0.1	*	0.1
No Coverage	0.1	*	0.1	0.1	0.1
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.96A – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	25,630	462	25,168	2,147	23,021
GEOGRAPHIC REGION
Northeast	4,292	50	4,242	393	3,849
Midwest	5,454	111	5,344	522	4,822
South	10,138	181	9,957	815	9,142
West	5,746	120	5,626	417	5,209
COUNTY TYPE
Large Metro	13,469	239	13,231	1,142	12,089
Small Metro	8,249	166	8,083	674	7,409
Nonmetro	3,911	57	3,854	332	3,523
Urbanized	1,414	24	1,390	169	1,222
Less Urbanized	2,187	32	2,155	144	2,011
Completely Rural	310	1	309	19	290
POVERTY LEVEL¹
Less Than 100%	3,970	91	3,879	430	3,448
100-199%	5,352	143	5,209	561	4,648
200% or More	16,308	228	16,080	1,156	14,924
HEALTH INSURANCE²
Private	14,824	213	14,611	1,276	13,335
Medicaid/CHIP	6,131	243	5,889	521	5,368
Other³	8,722	31	8,691	184	8,507
No Coverage	1,828	29	1,799	251	1,548
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.96B – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	9.2	1.8	9.9	6.4	10.4
GEOGRAPHIC REGION
Northeast	8.8	1.2	9.5	6.9	9.9
Midwest	9.4	2.0	10.2	7.3	10.6
South	9.5	1.8	10.3	6.4	10.9
West	8.7	1.9	9.4	5.3	10.0
COUNTY TYPE
Large Metro	8.8	1.7	9.6	6.4	10.0
Small Metro	9.6	2.1	10.4	6.1	11.1
Nonmetro	9.4	1.5	10.2	7.3	10.6
Urbanized	9.0	1.7	9.7	8.7	9.8
Less Urbanized	10.3	1.7	11.2	6.8	11.7
Completely Rural	7.0	0.2	7.6	4.3	8.0
POVERTY LEVEL¹
Less Than 100%	9.2	1.7	10.3	5.1	11.9
100-199%	9.6	2.6	10.4	7.1	11.0
200% or More	9.0	1.5	9.7	6.8	10.0
HEALTH INSURANCE²
Private	8.8	1.5	9.5	6.7	9.8
Medicaid/CHIP	10.8	2.3	12.7	6.2	14.1
Other³	11.4	2.2	11.6	7.3	11.7
No Coverage	6.8	2.1	7.1	5.0	7.6
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.97A – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	3,941	181	3,760	787	2,973
GEOGRAPHIC REGION
Northeast	734	6	729	139	590
Midwest	793	30	763	175	588
South	1,477	71	1,405	304	1,101
West	937	74	863	169	694
COUNTY TYPE
Large Metro	2,299	71	2,229	436	1,793
Small Metro	1,115	91	1,024	220	804
Nonmetro	527	19	507	130	377
Urbanized	218	10	207	62	145
Less Urbanized	277	9	268	61	207
Completely Rural	32	*	32	8	25
POVERTY LEVEL¹
Less Than 100%	615	39	576	126	450
100-199%	977	67	911	232	678
200% or More	2,349	76	2,274	429	1,845
HEALTH INSURANCE²
Private	1,919	64	1,855	438	1,417
Medicaid/CHIP	1,300	132	1,168	215	954
Other³	728	18	710	34	676
No Coverage	440	1	439	123	316
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.97B – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1.4	0.7	1.5	2.4	1.3
GEOGRAPHIC REGION
Northeast	1.5	0.1	1.6	2.4	1.5
Midwest	1.4	0.6	1.5	2.5	1.3
South	1.4	0.7	1.5	2.4	1.3
West	1.4	1.2	1.4	2.1	1.3
COUNTY TYPE
Large Metro	1.5	0.5	1.6	2.4	1.5
Small Metro	1.3	1.2	1.3	2.0	1.2
Nonmetro	1.3	0.5	1.3	2.9	1.1
Urbanized	1.4	0.7	1.4	3.2	1.2
Less Urbanized	1.3	0.4	1.4	2.9	1.2
Completely Rural	0.7	*	0.8	1.7	0.7
POVERTY LEVEL¹
Less Than 100%	1.4	0.7	1.5	1.5	1.5
100-199%	1.8	1.2	1.8	2.9	1.6
200% or More	1.3	0.5	1.4	2.5	1.2
HEALTH INSURANCE²
Private	1.1	0.5	1.2	2.3	1.0
Medicaid/CHIP	2.3	1.3	2.5	2.5	2.5
Other³	0.9	1.2	0.9	1.3	0.9
No Coverage	1.6	0.0	1.7	2.5	1.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.98A – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	71,901	3,342	68,558	6,128	62,430
GEOGRAPHIC REGION
Northeast	10,352	473	9,880	865	9,015
Midwest	15,221	731	14,490	1,345	13,145
South	29,466	1,268	28,198	2,480	25,718
West	16,861	871	15,991	1,439	14,552
COUNTY TYPE
Large Metro	36,973	1,708	35,266	3,084	32,182
Small Metro	22,839	1,092	21,747	2,156	19,591
Nonmetro	12,088	542	11,546	889	10,657
Urbanized	4,502	202	4,300	356	3,943
Less Urbanized	6,176	293	5,884	411	5,473
Completely Rural	1,410	48	1,363	121	1,241
POVERTY LEVEL¹
Less Than 100%	12,591	802	11,789	1,571	10,218
100-199%	15,443	811	14,632	1,544	13,087
200% or More	43,864	1,729	42,134	3,010	39,125
HEALTH INSURANCE²
Private	39,393	1,646	37,746	3,226	34,521
Medicaid/CHIP	18,158	1,510	16,648	1,800	14,848
Other³	24,944	154	24,791	516	24,275
No Coverage	5,702	190	5,512	916	4,595
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Any use of opioids includes the use of heroin or any use of prescription pain relievers. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.98B – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	25.7	12.8	27.0	18.3	28.3
GEOGRAPHIC REGION
Northeast	21.2	11.4	22.1	15.1	23.1
Midwest	26.2	13.3	27.6	18.9	28.9
South	27.6	12.5	29.2	19.5	30.7
West	25.4	14.0	26.6	18.1	27.9
COUNTY TYPE
Large Metro	24.2	11.9	25.5	17.2	26.7
Small Metro	26.7	13.8	28.0	19.7	29.4
Nonmetro	29.1	14.4	30.6	19.7	32.1
Urbanized	28.5	14.1	30.0	18.4	31.8
Less Urbanized	29.1	15.1	30.5	19.4	31.8
Completely Rural	31.7	12.4	33.5	26.8	34.4
POVERTY LEVEL¹
Less Than 100%	29.3	14.9	31.4	18.5	35.1
100-199%	27.7	14.6	29.1	19.5	30.9
200% or More	24.2	11.5	25.4	17.8	26.3
HEALTH INSURANCE²
Private	23.4	11.7	24.4	17.0	25.5
Medicaid/CHIP	31.8	14.3	35.8	21.3	39.0
Other³	32.6	10.6	33.0	20.4	33.4
No Coverage	21.3	13.8	21.7	18.4	22.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Any use of opioids includes the use of heroin or any use of prescription pain relievers. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.99A – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	9,236	497	8,738	1,035	7,703
GEOGRAPHIC REGION
Northeast	1,598	78	1,521	169	1,352
Midwest	1,747	127	1,621	190	1,431
South	3,639	189	3,450	405	3,045
West	2,251	104	2,147	273	1,874
COUNTY TYPE
Large Metro	4,861	286	4,575	537	4,038
Small Metro	3,048	153	2,895	362	2,533
Nonmetro	1,327	59	1,268	137	1,131
Urbanized	503	31	471	59	413
Less Urbanized	690	26	665	63	602
Completely Rural	134	2	132	15	117
POVERTY LEVEL¹
Less Than 100%	2,273	122	2,151	263	1,888
100-199%	2,079	111	1,969	314	1,655
200% or More	4,883	264	4,619	458	4,160
HEALTH INSURANCE²
Private	3,930	216	3,713	452	3,261
Medicaid/CHIP	3,217	240	2,977	322	2,654
Other³	2,133	37	2,096	88	2,008
No Coverage	1,318	38	1,280	209	1,071
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.99B – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	3.3	1.9	3.4	3.1	3.5
GEOGRAPHIC REGION
Northeast	3.3	1.9	3.4	2.9	3.5
Midwest	3.0	2.3	3.1	2.7	3.2
South	3.4	1.9	3.6	3.2	3.6
West	3.4	1.7	3.6	3.4	3.6
COUNTY TYPE
Large Metro	3.2	2.0	3.3	3.0	3.4
Small Metro	3.6	1.9	3.7	3.3	3.8
Nonmetro	3.2	1.6	3.4	3.0	3.4
Urbanized	3.2	2.2	3.3	3.0	3.3
Less Urbanized	3.2	1.3	3.4	3.0	3.5
Completely Rural	3.0	0.5	3.2	3.2	3.3
POVERTY LEVEL¹
Less Than 100%	5.3	2.3	5.7	3.1	6.5
100-199%	3.7	2.0	3.9	4.0	3.9
200% or More	2.7	1.8	2.8	2.7	2.8
HEALTH INSURANCE²
Private	2.3	1.5	2.4	2.4	2.4
Medicaid/CHIP	5.6	2.3	6.4	3.8	7.0
Other³	2.8	2.6	2.8	3.5	2.8
No Coverage	4.9	2.8	5.0	4.2	5.2
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.100A – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	2,791	115	2,676	221	2,456
GEOGRAPHIC REGION
Northeast	648	35	613	25	588
Midwest	491	15	476	41	435
South	976	52	924	77	847
West	676	12	664	77	587
COUNTY TYPE
Large Metro	1,427	59	1,368	99	1,269
Small Metro	1,020	34	986	95	890
Nonmetro	344	22	322	26	296
Urbanized	127	11	115	8	108
Less Urbanized	193	10	182	17	165
Completely Rural	25	*	25	2	23
POVERTY LEVEL¹
Less Than 100%	849	39	810	52	758
100-199%	692	45	648	86	562
200% or More	1,250	31	1,219	83	1,136
HEALTH INSURANCE²
Private	886	33	853	77	776
Medicaid/CHIP	1,246	65	1,182	101	1,081
Other³	776	8	769	12	757
No Coverage	415	14	401	44	357
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.100B – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1.0	0.4	1.1	0.7	1.1
GEOGRAPHIC REGION
Northeast	1.3	0.8	1.4	0.4	1.5
Midwest	0.8	0.3	0.9	0.6	1.0
South	0.9	0.5	1.0	0.6	1.0
West	1.0	0.2	1.1	1.0	1.1
COUNTY TYPE
Large Metro	0.9	0.4	1.0	0.6	1.1
Small Metro	1.2	0.4	1.3	0.9	1.3
Nonmetro	0.8	0.6	0.9	0.6	0.9
Urbanized	0.8	0.8	0.8	0.4	0.9
Less Urbanized	0.9	0.5	0.9	0.8	1.0
Completely Rural	0.6	*	0.6	0.4	0.6
POVERTY LEVEL¹
Less Than 100%	2.0	0.7	2.2	0.6	2.6
100-199%	1.2	0.8	1.3	1.1	1.3
200% or More	0.7	0.2	0.7	0.5	0.8
HEALTH INSURANCE²
Private	0.5	0.2	0.6	0.4	0.6
Medicaid/CHIP	2.2	0.6	2.5	1.2	2.8
Other³	1.0	0.5	1.0	0.5	1.0
No Coverage	1.5	1.0	1.6	0.9	1.7
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.101A – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	21,329	1,841	19,488	4,064	15,424
GEOGRAPHIC REGION
Northeast	3,814	266	3,548	730	2,818
Midwest	4,445	444	4,001	798	3,203
South	7,973	720	7,253	1,461	5,793
West	5,097	411	4,686	1,077	3,610
COUNTY TYPE
Large Metro	11,955	982	10,974	2,209	8,765
Small Metro	6,601	549	6,052	1,366	4,686
Nonmetro	2,773	310	2,463	490	1,973
Urbanized	1,067	148	919	207	712
Less Urbanized	1,393	139	1,255	234	1,020
Completely Rural	313	23	289	49	241
POVERTY LEVEL¹
Less Than 100%	4,189	361	3,828	993	2,835
100-199%	4,374	382	3,992	803	3,189
200% or More	12,760	1,098	11,662	2,263	9,399
HEALTH INSURANCE²
Private	11,853	1,034	10,819	2,629	8,190
Medicaid/CHIP	6,154	772	5,382	811	4,571
Other³	3,579	112	3,467	296	3,171
No Coverage	2,185	90	2,095	498	1,597
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.101B – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	7.6	7.1	7.7	12.1	7.0
GEOGRAPHIC REGION
Northeast	7.8	6.4	7.9	12.8	7.2
Midwest	7.7	8.1	7.6	11.2	7.0
South	7.5	7.1	7.5	11.5	6.9
West	7.7	6.6	7.8	13.6	6.9
COUNTY TYPE
Large Metro	7.8	6.8	7.9	12.3	7.3
Small Metro	7.7	6.9	7.8	12.5	7.0
Nonmetro	6.7	8.2	6.5	10.8	5.9
Urbanized	6.8	10.3	6.4	10.7	5.7
Less Urbanized	6.6	7.1	6.5	11.0	5.9
Completely Rural	7.0	6.0	7.1	10.7	6.7
POVERTY LEVEL¹
Less Than 100%	9.8	6.7	10.2	11.7	9.8
100-199%	7.8	6.9	7.9	10.1	7.5
200% or More	7.1	7.3	7.0	13.4	6.3
HEALTH INSURANCE²
Private	7.0	7.3	7.0	13.8	6.0
Medicaid/CHIP	10.8	7.3	11.6	9.6	12.0
Other³	4.7	7.8	4.6	11.7	4.4
No Coverage	8.1	6.5	8.2	10.0	7.8
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.102A – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	9,177	339	8,838	2,111	6,727
GEOGRAPHIC REGION
Northeast	1,712	52	1,660	359	1,301
Midwest	1,897	88	1,809	420	1,389
South	3,128	105	3,023	669	2,354
West	2,439	94	2,345	662	1,683
COUNTY TYPE
Large Metro	5,193	218	4,975	1,124	3,851
Small Metro	2,725	83	2,642	746	1,896
Nonmetro	1,259	38	1,221	242	980
Urbanized	488	21	467	113	354
Less Urbanized	656	15	641	116	525
Completely Rural	115	2	113	13	100
POVERTY LEVEL¹
Less Than 100%	2,250	57	2,193	543	1,650
100-199%	2,146	68	2,078	465	1,613
200% or More	4,780	213	4,567	1,102	3,465
HEALTH INSURANCE²
Private	4,044	206	3,838	1,315	2,522
Medicaid/CHIP	3,060	101	2,958	406	2,552
Other³	1,371	10	1,361	165	1,196
No Coverage	1,513	41	1,472	305	1,167
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.102B – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	3.3	1.3	3.5	6.3	3.1
GEOGRAPHIC REGION
Northeast	3.5	1.2	3.7	6.3	3.3
Midwest	3.3	1.6	3.4	5.9	3.1
South	2.9	1.0	3.1	5.3	2.8
West	3.7	1.5	3.9	8.3	3.2
COUNTY TYPE
Large Metro	3.4	1.5	3.6	6.2	3.2
Small Metro	3.2	1.1	3.4	6.8	2.8
Nonmetro	3.0	1.0	3.2	5.3	3.0
Urbanized	3.1	1.4	3.3	5.8	2.9
Less Urbanized	3.1	0.8	3.3	5.5	3.1
Completely Rural	2.6	0.4	2.8	2.9	2.8
POVERTY LEVEL¹
Less Than 100%	5.2	1.1	5.8	6.4	5.7
100-199%	3.8	1.2	4.1	5.9	3.8
200% or More	2.6	1.4	2.8	6.5	2.3
HEALTH INSURANCE²
Private	2.4	1.5	2.5	6.9	1.9
Medicaid/CHIP	5.4	1.0	6.4	4.8	6.7
Other³	1.8	0.7	1.8	6.5	1.6
No Coverage	5.6	3.0	5.8	6.1	5.7
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.103A – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	4,126	92	4,034	669	3,365
GEOGRAPHIC REGION
Northeast	814	23	791	146	645
Midwest	828	14	815	131	683
South	1,265	26	1,239	153	1,085
West	1,219	29	1,190	239	951
COUNTY TYPE
Large Metro	2,371	63	2,308	388	1,920
Small Metro	1,154	16	1,138	210	928
Nonmetro	601	12	589	72	517
Urbanized	259	6	253	37	216
Less Urbanized	285	6	279	32	248
Completely Rural	56	*	56	4	53
POVERTY LEVEL¹
Less Than 100%	1,075	14	1,061	180	881
100-199%	1,019	29	990	160	831
200% or More	2,032	49	1,983	329	1,653
HEALTH INSURANCE²
Private	1,362	48	1,314	392	921
Medicaid/CHIP	1,646	33	1,613	143	1,470
Other³	746	2	744	49	695
No Coverage	755	*	745	101	644
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.103B – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	1.5	0.4	1.6	2.0	1.5
GEOGRAPHIC REGION
Northeast	1.7	0.5	1.8	2.5	1.7
Midwest	1.4	0.2	1.6	1.8	1.5
South	1.2	0.3	1.3	1.2	1.3
West	1.8	0.5	2.0	3.0	1.8
COUNTY TYPE
Large Metro	1.6	0.4	1.7	2.2	1.6
Small Metro	1.3	0.2	1.5	1.9	1.4
Nonmetro	1.4	0.3	1.6	1.6	1.6
Urbanized	1.6	0.4	1.8	1.9	1.7
Less Urbanized	1.3	0.3	1.4	1.5	1.4
Completely Rural	1.3	*	1.4	0.8	1.5
POVERTY LEVEL¹
Less Than 100%	2.5	0.3	2.8	2.1	3.0
100-199%	1.8	0.5	2.0	2.0	2.0
200% or More	1.1	0.3	1.2	1.9	1.1
HEALTH INSURANCE²
Private	0.8	0.3	0.9	2.1	0.7
Medicaid/CHIP	2.9	0.3	3.5	1.7	3.9
Other³	1.0	0.2	1.0	1.9	1.0
No Coverage	2.8	*	2.9	2.0	3.1
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.104A – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	23,249	1,562	21,687	4,614	17,073
GEOGRAPHIC REGION
Northeast	3,979	181	3,799	712	3,087
Midwest	4,441	341	4,101	1,043	3,057
South	8,218	576	7,642	1,567	6,075
West	6,610	464	6,145	1,292	4,854
COUNTY TYPE
Large Metro	13,205	872	12,332	2,485	9,848
Small Metro	6,997	507	6,491	1,523	4,968
Nonmetro	3,046	183	2,864	606	2,258
Urbanized	1,296	100	1,196	299	896
Less Urbanized	1,497	75	1,422	271	1,151
Completely Rural	254	8	246	36	210
POVERTY LEVEL¹
Less Than 100%	4,759	291	4,469	1,121	3,348
100-199%	5,175	341	4,835	1,226	3,608
200% or More	13,314	931	12,383	2,266	10,117
HEALTH INSURANCE²
Private	11,632	848	10,783	2,697	8,086
Medicaid/CHIP	6,987	675	6,312	1,016	5,297
Other³	4,074	77	3,997	357	3,640
No Coverage	3,106	86	3,020	705	2,314
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.104B – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	8.3	6.0	8.5	13.8	7.7
GEOGRAPHIC REGION
Northeast	8.1	4.4	8.5	12.4	7.9
Midwest	7.7	6.2	7.8	14.7	6.7
South	7.7	5.7	7.9	12.3	7.3
West	10.0	7.4	10.2	16.3	9.3
COUNTY TYPE
Large Metro	8.6	6.1	8.9	13.8	8.2
Small Metro	8.2	6.4	8.4	13.9	7.5
Nonmetro	7.3	4.9	7.6	13.4	6.8
Urbanized	8.2	7.0	8.3	15.4	7.2
Less Urbanized	7.0	3.8	7.4	12.8	6.7
Completely Rural	5.7	2.1	6.1	7.8	5.8
POVERTY LEVEL¹
Less Than 100%	11.1	5.4	11.9	13.2	11.5
100-199%	9.3	6.1	9.6	15.5	8.5
200% or More	7.4	6.2	7.5	13.4	6.8
HEALTH INSURANCE²
Private	6.9	6.0	7.0	14.2	6.0
Medicaid/CHIP	12.3	6.4	13.6	12.0	13.9
Other³	5.3	5.3	5.3	14.1	5.0
No Coverage	11.6	6.3	11.9	14.2	11.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.105A – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	9,030	476	8,554	1,361	7,193
GEOGRAPHIC REGION
Northeast	1,735	73	1,662	251	1,411
Midwest	1,732	90	1,642	297	1,345
South	2,905	171	2,733	376	2,357
West	2,658	142	2,517	437	2,079
COUNTY TYPE
Large Metro	5,069	244	4,825	750	4,075
Small Metro	2,794	155	2,639	462	2,176
Nonmetro	1,167	77	1,090	149	942
Urbanized	539	41	499	80	419
Less Urbanized	520	33	487	58	429
Completely Rural	107	3	104	10	94
POVERTY LEVEL¹
Less Than 100%	2,007	84	1,923	341	1,582
100-199%	2,088	128	1,960	389	1,571
200% or More	4,935	264	4,671	631	4,040
HEALTH INSURANCE²
Private	3,737	236	3,501	770	2,731
Medicaid/CHIP	3,135	229	2,906	343	2,562
Other³	1,774	17	1,758	90	1,667
No Coverage	1,437	22	1,416	200	1,216
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.105B – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic Characteristic	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
TOTAL	3.2	1.8	3.4	4.1	3.3
GEOGRAPHIC REGION
Northeast	3.5	1.8	3.7	4.4	3.6
Midwest	3.0	1.6	3.1	4.2	3.0
South	2.7	1.7	2.8	3.0	2.8
West	4.0	2.3	4.2	5.5	4.0
COUNTY TYPE
Large Metro	3.3	1.7	3.5	4.2	3.4
Small Metro	3.3	2.0	3.4	4.2	3.3
Nonmetro	2.8	2.0	2.9	3.3	2.8
Urbanized	3.4	2.8	3.5	4.1	3.4
Less Urbanized	2.4	1.7	2.5	2.8	2.5
Completely Rural	2.4	0.9	2.6	2.2	2.6
POVERTY LEVEL¹
Less Than 100%	4.7	1.6	5.1	4.0	5.4
100-199%	3.7	2.3	3.9	4.9	3.7
200% or More	2.7	1.8	2.8	3.7	2.7
HEALTH INSURANCE²
Private	2.2	1.7	2.3	4.1	2.0
Medicaid/CHIP	5.5	2.2	6.2	4.1	6.7
Other³	2.3	1.2	2.3	3.6	2.3
No Coverage	5.4	1.6	5.6	4.0	5.9
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.106A – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2021
Drug or Method of Administration	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
HALLUCINOGENS	45,826	591	45,235	5,154	40,081
PCP	6,464	30	6,434	230	6,204
LSD	29,502	419	29,082	3,173	25,909
Peyote¹	5,216	23	5,193	118	5,076
Mescaline¹	6,982	17	6,965	91	6,874
Psilocybin/Mushrooms¹	28,590	274	28,316	3,433	24,883
Ecstasy	21,122	146	20,976	2,658	18,318
Ketamine	4,537	52	4,485	508	3,977
DMT, AMT, or 5-MeO-DIPT/Foxy	3,538	51	3,487	486	3,001
Salvia divinorum	4,966	22	4,944	382	4,561
INHALANTS	25,596	2,294	23,302	2,770	20,532
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush¹	7,931	162	7,769	576	7,193
Correction Fluid, Degreaser, or Cleaning Fluid¹	1,371	229	1,142	108	1,034
Gasoline or Lighter Fluid¹	2,789	537	2,253	292	1,960
Glue, Shoe Polish, or Toluene¹	3,148	510	2,638	319	2,319
Halothane, Ether, or Other Anesthetics¹	626	53	572	24	548
Lacquer Thinner or Other Paint Solvents¹	1,209	173	1,037	139	898
Lighter Gases¹	739	146	593	49	545
Nitrous Oxide or Whippits¹	12,305	152	12,153	904	11,249
Felt-Tip Pens or Felt-Tip/Magic Markers¹	6,920	1,696	5,223	1,404	3,820
Spray Paints¹	1,929	461	1,468	262	1,206
Computer Cleaner/Air Duster¹	2,701	172	2,529	278	2,251
Other Aerosol Sprays¹	1,136	139	997	108	889
NEEDLE USE¹	5,748	19	5,729	200	5,529
Heroin Needle Use¹	3,168	3	3,165	121	3,044
Cocaine Needle Use¹	2,585	2	2,583	44	2,538
Methamphetamine Needle Use¹	3,057	2	3,055	84	2,970
HEROIN	6,635	6	6,629	327	6,302
Smoke Heroin¹	3,127	2	3,125	191	2,934
Sniff or Snort Heroin¹	4,546	*	4,545	217	4,328
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown specific drug information were excluded from the respective analyses. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.106B – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime: Among People Aged 12 or Older; by Age Group, Percentages, 2021
Drug or Method of Administration	Aged 12+ (2021)	Aged 12-17 (2021)	Aged 18+ (2021)	Aged 18-25 (2021)	Aged 26+ (2021)
HALLUCINOGENS	16.4	2.3	17.8	15.4	18.2
PCP	2.3	0.1	2.5	0.7	2.8
LSD	10.5	1.6	11.5	9.5	11.8
Peyote¹	1.9	0.1	2.0	0.4	2.3
Mescaline¹	2.5	0.1	2.7	0.3	3.1
Psilocybin/Mushrooms¹	10.2	1.1	11.2	10.3	11.3
Ecstasy	7.5	0.6	8.3	7.9	8.3
Ketamine	1.6	0.2	1.8	1.5	1.8
DMT, AMT, or 5-MeO-DIPT/Foxy	1.3	0.2	1.4	1.5	1.4
Salvia divinorum	1.8	0.1	1.9	1.1	2.1
INHALANTS	9.1	8.8	9.2	8.3	9.3
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush¹	2.8	0.6	3.1	1.7	3.3
Correction Fluid, Degreaser, or Cleaning Fluid¹	0.5	0.9	0.4	0.3	0.5
Gasoline or Lighter Fluid¹	1.0	2.1	0.9	0.9	0.9
Glue, Shoe Polish, or Toluene¹	1.1	2.0	1.0	1.0	1.1
Halothane, Ether, or Other Anesthetics¹	0.2	0.2	0.2	0.1	0.2
Lacquer Thinner or Other Paint Solvents¹	0.4	0.7	0.4	0.4	0.4
Lighter Gases¹	0.3	0.6	0.2	0.1	0.2
Nitrous Oxide or Whippits¹	4.4	0.6	4.8	2.7	5.1
Felt-Tip Pens or Felt-Tip/Magic Markers¹	2.5	6.5	2.1	4.2	1.7
Spray Paints¹	0.7	1.8	0.6	0.8	0.5
Computer Cleaner/Air Duster¹	1.0	0.7	1.0	0.8	1.0
Other Aerosol Sprays¹	0.4	0.5	0.4	0.3	0.4
NEEDLE USE¹	2.1	0.1	2.3	0.6	2.5
Heroin Needle Use¹	1.1	0.0	1.2	0.4	1.4
Cocaine Needle Use¹	0.9	0.0	1.0	0.1	1.2
Methamphetamine Needle Use¹	1.1	0.0	1.2	0.3	1.3
HEROIN	2.4	0.0	2.6	1.0	2.9
Smoke Heroin¹	1.1	0.0	1.2	0.6	1.3
Sniff or Snort Heroin¹	1.6	*	1.8	0.6	2.0
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown specific drug information were excluded from the respective analyses. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.107A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2021
Pain Reliever Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2021)
ANY PRESCRIPTION PAIN RELIEVER	71,688	8,711	12.2
Hydrocodone Products¹	35,521	4,049	11.4
Zohydro^® ER¹	529	87	*
Oxycodone Products¹	20,471	2,605	12.8
OxyContin^®	6,791	938	13.8
Tramadol Products¹	14,331	1,385	9.7
Codeine Products¹	19,751	2,256	11.5
Morphine Products¹	4,844	420	8.7
Fentanyl Products	2,578	539	20.9
Buprenorphine Products¹	3,487	771	22.2
Oxymorphone Products¹	994	156	15.9
Demerol^®1	496	61	*
Hydromorphone Products¹	1,620	190	11.8
Methadone¹	1,723	316	*
Any Other Prescription Pain Reliever^1,2	20,321	519	2.6
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.107B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 12 or Older; Percentages, 2021
Pain Reliever Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2021)
ANY PRESCRIPTION PAIN RELIEVER	25.6	3.1	12.2
Hydrocodone Products¹	12.7	1.4	11.4
Zohydro^® ER¹	0.2	0.0	*
Oxycodone Products¹	7.3	0.9	12.8
OxyContin^®	2.4	0.3	13.8
Tramadol Products¹	5.1	0.5	9.7
Codeine Products¹	7.1	0.8	11.5
Morphine Products¹	1.7	0.2	8.7
Fentanyl Products	0.9	0.2	20.9
Buprenorphine Products¹	1.2	0.3	22.2
Oxymorphone Products¹	0.4	0.1	15.9
Demerol^®1	0.2	0.0	*
Hydromorphone Products¹	0.6	0.1	11.8
Methadone¹	0.6	0.1	*
Any Other Prescription Pain Reliever^1,2	7.3	0.2	2.6
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.108A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2021
Pain Reliever Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2021)
ANY PRESCRIPTION PAIN RELIEVER	3,342	497	14.9
Hydrocodone Products¹	671	86	12.9
Zohydro^® ER¹	56	7	*
Oxycodone Products¹	600	118	19.9
OxyContin^®	232	51	*
Tramadol Products¹	286	28	*
Codeine Products¹	1,279	261	20.5
Morphine Products¹	269	7	2.6
Fentanyl Products	66	15	*
Buprenorphine Products¹	71	7	*
Oxymorphone Products¹	51	*	*
Demerol^®1	10	*	*
Hydromorphone Products¹	52	21	*
Methadone¹	43	1	*
Any Other Prescription Pain Reliever^1,2	1,443	48	3.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.108B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 12 to 17; Percentages, 2021
Pain Reliever Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2021)
ANY PRESCRIPTION PAIN RELIEVER	12.8	1.9	14.9
Hydrocodone Products¹	2.6	0.3	12.9
Zohydro^® ER¹	0.2	0.0	*
Oxycodone Products¹	2.3	0.5	19.9
OxyContin^®	0.9	0.2	*
Tramadol Products¹	1.1	0.1	*
Codeine Products¹	4.9	1.0	20.5
Morphine Products¹	1.0	0.0	2.6
Fentanyl Products	0.3	0.1	*
Buprenorphine Products¹	0.3	0.0	*
Oxymorphone Products¹	0.2	*	*
Demerol^®1	0.0	*	*
Hydromorphone Products¹	0.2	0.1	*
Methadone¹	0.2	0.0	*
Any Other Prescription Pain Reliever^1,2	5.6	0.2	3.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.109A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2021
Pain Reliever Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2021)
ANY PRESCRIPTION PAIN RELIEVER	68,346	8,213	12.0
Hydrocodone Products¹	34,851	3,962	11.4
Zohydro^® ER¹	474	80	*
Oxycodone Products¹	19,871	2,487	12.5
OxyContin^®	6,559	886	13.5
Tramadol Products¹	14,045	1,358	9.7
Codeine Products¹	18,472	1,995	10.8
Morphine Products¹	4,576	414	9.0
Fentanyl Products	2,513	524	20.9
Buprenorphine Products¹	3,416	764	22.4
Oxymorphone Products¹	942	155	16.6
Demerol^®1	486	61	*
Hydromorphone Products¹	1,568	169	10.9
Methadone¹	1,681	315	*
Any Other Prescription Pain Reliever^1,2	18,878	471	2.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.109B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 18 or Older; Percentages, 2021
Pain Reliever Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2021)
ANY PRESCRIPTION PAIN RELIEVER	26.9	3.2	12.0
Hydrocodone Products¹	13.8	1.6	11.4
Zohydro^® ER¹	0.2	0.0	*
Oxycodone Products¹	7.8	1.0	12.5
OxyContin^®	2.6	0.3	13.5
Tramadol Products¹	5.5	0.5	9.7
Codeine Products¹	7.3	0.8	10.8
Morphine Products¹	1.8	0.2	9.0
Fentanyl Products	1.0	0.2	20.9
Buprenorphine Products¹	1.3	0.3	22.4
Oxymorphone Products¹	0.4	0.1	16.6
Demerol^®1	0.2	0.0	*
Hydromorphone Products¹	0.6	0.1	10.9
Methadone¹	0.7	0.1	*
Any Other Prescription Pain Reliever^1,2	7.4	0.2	2.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.110A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2021
Pain Reliever Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2021)
ANY PRESCRIPTION PAIN RELIEVER	6,119	1,018	16.6
Hydrocodone Products¹	2,466	386	15.7
Zohydro^® ER¹	40	8	*
Oxycodone Products¹	1,896	465	24.6
OxyContin^®	645	150	23.3
Tramadol Products¹	838	135	16.2
Codeine Products¹	1,748	214	12.2
Morphine Products¹	539	92	17.0
Fentanyl Products	322	75	*
Buprenorphine Products¹	213	50	*
Oxymorphone Products¹	116	22	*
Demerol^®1	41	6	*
Hydromorphone Products¹	85	27	*
Methadone¹	87	19	*
Any Other Prescription Pain Reliever^1,2	1,889	59	3.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.110B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 18 to 25; Percentages, 2021
Pain Reliever Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2021)
ANY PRESCRIPTION PAIN RELIEVER	18.3	3.0	16.6
Hydrocodone Products¹	7.4	1.2	15.7
Zohydro^® ER¹	0.1	0.0	*
Oxycodone Products¹	5.7	1.4	24.6
OxyContin^®	1.9	0.4	23.3
Tramadol Products¹	2.5	0.4	16.2
Codeine Products¹	5.2	0.6	12.2
Morphine Products¹	1.6	0.3	17.0
Fentanyl Products	1.0	0.2	*
Buprenorphine Products¹	0.6	0.1	*
Oxymorphone Products¹	0.3	0.1	*
Demerol^®1	0.1	0.0	*
Hydromorphone Products¹	0.3	0.1	*
Methadone¹	0.3	0.1	*
Any Other Prescription Pain Reliever^1,2	5.6	0.2	3.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.111A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2021
Pain Reliever Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2021)
ANY PRESCRIPTION PAIN RELIEVER	62,227	7,195	11.6
Hydrocodone Products¹	32,385	3,576	11.1
Zohydro^® ER¹	434	72	*
Oxycodone Products¹	17,974	2,022	11.3
OxyContin^®	5,914	736	12.5
Tramadol Products¹	13,208	1,223	9.3
Codeine Products¹	16,723	1,781	10.7
Morphine Products¹	4,036	322	8.0
Fentanyl Products	2,191	449	20.5
Buprenorphine Products¹	3,203	714	22.4
Oxymorphone Products¹	826	133	*
Demerol^®1	445	55	*
Hydromorphone Products¹	1,482	142	9.6
Methadone¹	1,593	296	*
Any Other Prescription Pain Reliever^1,2	16,989	411	2.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.111B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 26 or Older; Percentages, 2021
Pain Reliever Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2021)
ANY PRESCRIPTION PAIN RELIEVER	28.2	3.3	11.6
Hydrocodone Products¹	14.7	1.6	11.1
Zohydro^® ER¹	0.2	0.0	*
Oxycodone Products¹	8.2	0.9	11.3
OxyContin^®	2.7	0.3	12.5
Tramadol Products¹	6.0	0.6	9.3
Codeine Products¹	7.6	0.8	10.7
Morphine Products¹	1.8	0.1	8.0
Fentanyl Products	1.0	0.2	20.5
Buprenorphine Products¹	1.5	0.3	22.4
Oxymorphone Products¹	0.4	0.1	*
Demerol^®1	0.2	0.0	*
Hydromorphone Products¹	0.7	0.1	9.6
Methadone¹	0.7	0.1	*
Any Other Prescription Pain Reliever^1,2	7.7	0.2	2.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.112A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2021
Stimulant Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2021)
ANY PRESCRIPTION STIMULANT	16,630	3,733	22.4
Amphetamines or Methylphenidate Products¹	12,749	3,447	27.1
Amphetamines¹	11,038	3,210	29.1
Methylphenidate Products¹	3,335	536	16.3
Anorectic (Weight-Loss) Stimulants¹	2,587	225	8.7
Provigil^®1	364	100	*
Any Other Prescription Stimulant^1,2	2,228	24	1.1
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.112B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 or Older; Percentages, 2021
Stimulant Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2021)
ANY PRESCRIPTION STIMULANT	5.9	1.3	22.4
Amphetamines or Methylphenidate Products¹	4.6	1.2	27.1
Amphetamines¹	3.9	1.1	29.1
Methylphenidate Products¹	1.2	0.2	16.3
Anorectic (Weight-Loss) Stimulants¹	0.9	0.1	8.7
Provigil^®1	0.1	0.0	*
Any Other Prescription Stimulant^1,2	0.8	0.0	1.1
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.113A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2021
Stimulant Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2021)
ANY PRESCRIPTION STIMULANT	1,821	304	16.7
Amphetamines or Methylphenidate Products¹	1,621	285	17.6
Amphetamines¹	1,209	226	18.7
Methylphenidate Products¹	660	68	10.4
Anorectic (Weight-Loss) Stimulants¹	88	16	*
Provigil^®1	27	3	*
Any Other Prescription Stimulant^1,2	287	*	*
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.113B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 to 17; Percentages, 2021
Stimulant Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2021)
ANY PRESCRIPTION STIMULANT	7.0	1.2	16.7
Amphetamines or Methylphenidate Products¹	6.2	1.1	17.6
Amphetamines¹	4.6	0.9	18.7
Methylphenidate Products¹	2.5	0.3	10.4
Anorectic (Weight-Loss) Stimulants¹	0.3	0.1	*
Provigil^®1	0.1	0.0	*
Any Other Prescription Stimulant^1,2	1.1	*	*
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.114A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2021
Stimulant Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2021)
ANY PRESCRIPTION STIMULANT	14,808	3,429	23.2
Amphetamines or Methylphenidate Products¹	11,128	3,162	28.5
Amphetamines¹	9,830	2,984	30.4
Methylphenidate Products¹	2,675	468	17.7
Anorectic (Weight-Loss) Stimulants¹	2,499	209	8.4
Provigil^®1	337	97	*
Any Other Prescription Stimulant^1,2	1,941	24	1.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.114B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 or Older; Percentages, 2021
Stimulant Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2021)
ANY PRESCRIPTION STIMULANT	5.8	1.4	23.2
Amphetamines or Methylphenidate Products¹	4.4	1.2	28.5
Amphetamines¹	3.9	1.2	30.4
Methylphenidate Products¹	1.1	0.2	17.7
Anorectic (Weight-Loss) Stimulants¹	1.0	0.1	8.4
Provigil^®1	0.1	0.0	*
Any Other Prescription Stimulant^1,2	0.8	0.0	1.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.115A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2021
Stimulant Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2021)
ANY PRESCRIPTION STIMULANT	3,354	1,244	37.1
Amphetamines or Methylphenidate Products¹	3,112	1,218	39.2
Amphetamines¹	2,733	1,151	42.1
Methylphenidate Products¹	816	201	24.7
Anorectic (Weight-Loss) Stimulants¹	164	35	*
Provigil^®1	25	16	*
Any Other Prescription Stimulant^1,2	199	8	*
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.115B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 to 25; Percentages, 2021
Stimulant Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2021)
ANY PRESCRIPTION STIMULANT	10.0	3.7	37.1
Amphetamines or Methylphenidate Products¹	9.3	3.6	39.2
Amphetamines¹	8.2	3.4	42.1
Methylphenidate Products¹	2.4	0.6	24.7
Anorectic (Weight-Loss) Stimulants¹	0.5	0.1	*
Provigil^®1	0.1	0.0	*
Any Other Prescription Stimulant^1,2	0.6	0.0	*
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.116A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2021
Stimulant Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2021)
ANY PRESCRIPTION STIMULANT	11,454	2,184	19.1
Amphetamines or Methylphenidate Products¹	8,017	1,943	24.4
Amphetamines¹	7,097	1,833	25.9
Methylphenidate Products¹	1,859	266	14.6
Anorectic (Weight-Loss) Stimulants¹	2,336	174	7.5
Provigil^®1	312	81	*
Any Other Prescription Stimulant^1,2	1,741	16	1.0
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.116B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 26 or Older; Percentages, 2021
Stimulant Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2021)
ANY PRESCRIPTION STIMULANT	5.2	1.0	19.1
Amphetamines or Methylphenidate Products¹	3.6	0.9	24.4
Amphetamines¹	3.2	0.8	25.9
Methylphenidate Products¹	0.8	0.1	14.6
Anorectic (Weight-Loss) Stimulants¹	1.1	0.1	7.5
Provigil^®1	0.1	0.0	*
Any Other Prescription Stimulant^1,2	0.8	0.0	1.0
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.117A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2021
Tranquilizer Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2021)
ANY PRESCRIPTION TRANQUILIZER	32,735	4,317	13.2
Benzodiazepine Tranquilizers¹	24,488	3,838	15.7
Alprazolam Products¹	13,968	2,737	19.6
Lorazepam Products¹	6,956	655	9.4
Clonazepam Products¹	5,394	949	17.7
Diazepam Products¹	4,994	637	12.8
Muscle Relaxants¹	6,876	539	7.9
Cyclobenzaprine¹	6,236	327	5.3
Soma^®1	880	235	*
Any Other Prescription Tranquilizer^1,2	5,721	78	1.4
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.117B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 or Older; Percentages, 2021
Tranquilizer Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2021)
ANY PRESCRIPTION TRANQUILIZER	11.7	1.5	13.2
Benzodiazepine Tranquilizers¹	8.8	1.4	15.7
Alprazolam Products¹	5.0	1.0	19.6
Lorazepam Products¹	2.5	0.2	9.4
Clonazepam Products¹	1.9	0.3	17.7
Diazepam Products¹	1.8	0.2	12.8
Muscle Relaxants¹	2.5	0.2	7.9
Cyclobenzaprine¹	2.2	0.1	5.3
Soma^®1	0.3	0.1	*
Any Other Prescription Tranquilizer^1,2	2.0	0.0	1.4
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.118A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2021
Tranquilizer Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2021)
ANY PRESCRIPTION TRANQUILIZER	737	198	26.9
Benzodiazepine Tranquilizers¹	421	177	*
Alprazolam Products¹	344	165	*
Lorazepam Products¹	66	8	*
Clonazepam Products¹	52	9	*
Diazepam Products¹	95	34	*
Muscle Relaxants¹	56	11	*
Cyclobenzaprine¹	45	10	*
Soma^®1	11	*	*
Any Other Prescription Tranquilizer^1,2	311	10	*
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.118B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 to 17; Percentages, 2021
Tranquilizer Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2021)
ANY PRESCRIPTION TRANQUILIZER	2.8	0.8	26.9
Benzodiazepine Tranquilizers¹	1.6	0.7	*
Alprazolam Products¹	1.3	0.6	*
Lorazepam Products¹	0.3	0.0	*
Clonazepam Products¹	0.2	0.0	*
Diazepam Products¹	0.4	0.1	*
Muscle Relaxants¹	0.2	0.0	*
Cyclobenzaprine¹	0.2	0.0	*
Soma^®1	0.0	*	*
Any Other Prescription Tranquilizer^1,2	1.2	0.0	*
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.119A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2021
Tranquilizer Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2021)
ANY PRESCRIPTION TRANQUILIZER	31,998	4,119	12.9
Benzodiazepine Tranquilizers¹	24,067	3,662	15.2
Alprazolam Products¹	13,624	2,572	18.9
Lorazepam Products¹	6,890	647	9.4
Clonazepam Products¹	5,342	940	17.7
Diazepam Products¹	4,899	603	12.4
Muscle Relaxants¹	6,820	528	7.8
Cyclobenzaprine¹	6,191	317	5.1
Soma^®1	869	234	*
Any Other Prescription Tranquilizer^1,2	5,409	69	1.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.119B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 or Older; Percentages, 2021
Tranquilizer Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2021)
ANY PRESCRIPTION TRANQUILIZER	12.6	1.6	12.9
Benzodiazepine Tranquilizers¹	9.5	1.4	15.2
Alprazolam Products¹	5.4	1.0	18.9
Lorazepam Products¹	2.7	0.3	9.4
Clonazepam Products¹	2.1	0.4	17.7
Diazepam Products¹	1.9	0.2	12.4
Muscle Relaxants¹	2.7	0.2	7.8
Cyclobenzaprine¹	2.4	0.1	5.1
Soma^®1	0.3	0.1	*
Any Other Prescription Tranquilizer^1,2	2.1	0.0	1.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.120A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2021
Tranquilizer Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2021)
ANY PRESCRIPTION TRANQUILIZER	2,449	810	33.1
Benzodiazepine Tranquilizers¹	2,084	772	37.1
Alprazolam Products¹	1,403	665	47.7
Lorazepam Products¹	539	100	18.7
Clonazepam Products¹	510	164	32.3
Diazepam Products¹	329	67	*
Muscle Relaxants¹	257	54	*
Cyclobenzaprine¹	213	23	*
Soma^®1	52	35	*
Any Other Prescription Tranquilizer^1,2	358	25	*
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.120B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 to 25; Percentages, 2021
Tranquilizer Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2021)
ANY PRESCRIPTION TRANQUILIZER	7.3	2.4	33.1
Benzodiazepine Tranquilizers¹	6.2	2.3	37.1
Alprazolam Products¹	4.2	2.0	47.7
Lorazepam Products¹	1.6	0.3	18.7
Clonazepam Products¹	1.5	0.5	32.3
Diazepam Products¹	1.0	0.2	*
Muscle Relaxants¹	0.8	0.2	*
Cyclobenzaprine¹	0.6	0.1	*
Soma^®1	0.2	0.1	*
Any Other Prescription Tranquilizer^1,2	1.1	0.1	*
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.121A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2021
Tranquilizer Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2021)
ANY PRESCRIPTION TRANQUILIZER	29,549	3,309	11.2
Benzodiazepine Tranquilizers¹	21,982	2,890	13.2
Alprazolam Products¹	12,222	1,907	15.6
Lorazepam Products¹	6,351	547	8.6
Clonazepam Products¹	4,832	776	16.1
Diazepam Products¹	4,569	536	11.8
Muscle Relaxants¹	6,563	473	7.2
Cyclobenzaprine¹	5,978	294	4.9
Soma^®1	817	198	*
Any Other Prescription Tranquilizer^1,2	5,052	44	0.9
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.121B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 26 or Older; Percentages, 2021
Tranquilizer Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2021)
ANY PRESCRIPTION TRANQUILIZER	13.4	1.5	11.2
Benzodiazepine Tranquilizers¹	10.0	1.3	13.2
Alprazolam Products¹	5.5	0.9	15.6
Lorazepam Products¹	2.9	0.2	8.6
Clonazepam Products¹	2.2	0.4	16.1
Diazepam Products¹	2.1	0.2	11.8
Muscle Relaxants¹	3.0	0.2	7.2
Cyclobenzaprine¹	2.7	0.1	4.9
Soma^®1	0.4	0.1	*
Any Other Prescription Tranquilizer^1,2	2.3	0.0	0.9
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.122A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2021
Sedative Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2021)
ANY PRESCRIPTION SEDATIVE	14,548	923	6.3
Zolpidem Products¹	7,023	706	10.0
Eszopiclone Products¹	1,120	34	3.0
Zaleplon Products¹	404	16	*
Benzodiazepine Sedatives¹	1,758	103	5.9
Flurazepam¹	89	*	*
Temazepam Products¹	993	60	6.1
Triazolam Products¹	700	38	5.5
Barbiturates¹	756	51	6.8
Any Other Prescription Sedative^1,2	5,912	86	1.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.122B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 or Older; Percentages, 2021
Sedative Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2021)
ANY PRESCRIPTION SEDATIVE	5.2	0.3	6.3
Zolpidem Products¹	2.5	0.3	10.0
Eszopiclone Products¹	0.4	0.0	3.0
Zaleplon Products¹	0.1	0.0	*
Benzodiazepine Sedatives¹	0.6	0.0	5.9
Flurazepam¹	0.0	*	*
Temazepam Products¹	0.4	0.0	6.1
Triazolam Products¹	0.3	0.0	5.5
Barbiturates¹	0.3	0.0	6.8
Any Other Prescription Sedative^1,2	2.1	0.0	1.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.123A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2021
Sedative Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2021)
ANY PRESCRIPTION SEDATIVE	408	41	10.2
Zolpidem Products¹	102	11	*
Eszopiclone Products¹	17	*	*
Zaleplon Products¹	16	2	*
Benzodiazepine Sedatives¹	55	5	*
Flurazepam¹	17	*	*
Temazepam Products¹	14	*	*
Triazolam Products¹	26	4	*
Barbiturates¹	43	3	*
Any Other Prescription Sedative^1,2	266	15	*
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.123B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 to 17; Percentages, 2021
Sedative Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2021)
ANY PRESCRIPTION SEDATIVE	1.6	0.2	10.2
Zolpidem Products¹	0.4	0.0	*
Eszopiclone Products¹	0.1	*	*
Zaleplon Products¹	0.1	0.0	*
Benzodiazepine Sedatives¹	0.2	0.0	*
Flurazepam¹	0.1	*	*
Temazepam Products¹	0.1	*	*
Triazolam Products¹	0.1	0.0	*
Barbiturates¹	0.2	0.0	*
Any Other Prescription Sedative^1,2	1.0	0.1	*
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.124A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2021
Sedative Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2021)
ANY PRESCRIPTION SEDATIVE	14,140	881	6.2
Zolpidem Products¹	6,921	695	10.0
Eszopiclone Products¹	1,104	33	3.0
Zaleplon Products¹	388	15	*
Benzodiazepine Sedatives¹	1,704	98	5.8
Flurazepam¹	72	*	*
Temazepam Products¹	979	59	6.1
Triazolam Products¹	674	35	5.2
Barbiturates¹	713	49	6.8
Any Other Prescription Sedative^1,2	5,646	71	1.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.124B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 or Older; Percentages, 2021
Sedative Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2021)
ANY PRESCRIPTION SEDATIVE	5.6	0.3	6.2
Zolpidem Products¹	2.7	0.3	10.0
Eszopiclone Products¹	0.4	0.0	3.0
Zaleplon Products¹	0.2	0.0	*
Benzodiazepine Sedatives¹	0.7	0.0	5.8
Flurazepam¹	0.0	*	*
Temazepam Products¹	0.4	0.0	6.1
Triazolam Products¹	0.3	0.0	5.2
Barbiturates¹	0.3	0.0	6.8
Any Other Prescription Sedative^1,2	2.2	0.0	1.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.125A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2021
Sedative Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2021)
ANY PRESCRIPTION SEDATIVE	846	141	16.7
Zolpidem Products¹	326	78	24.0
Eszopiclone Products¹	58	*	*
Zaleplon Products¹	22	15	*
Benzodiazepine Sedatives¹	115	16	*
Flurazepam¹	25	*	*
Temazepam Products¹	44	14	*
Triazolam Products¹	50	2	*
Barbiturates¹	66	11	*
Any Other Prescription Sedative^1,2	449	44	10.0
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.125B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 to 25; Percentages, 2021
Sedative Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2021)
ANY PRESCRIPTION SEDATIVE	2.5	0.4	16.7
Zolpidem Products¹	1.0	0.2	24.0
Eszopiclone Products¹	0.2	*	*
Zaleplon Products¹	0.1	0.0	*
Benzodiazepine Sedatives¹	0.3	0.0	*
Flurazepam¹	0.1	*	*
Temazepam Products¹	0.1	0.0	*
Triazolam Products¹	0.1	0.0	*
Barbiturates¹	0.2	0.0	*
Any Other Prescription Sedative^1,2	1.3	0.1	10.0
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.126A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2021
Sedative Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2021)
ANY PRESCRIPTION SEDATIVE	13,295	740	5.6
Zolpidem Products¹	6,595	617	9.3
Eszopiclone Products¹	1,046	32	3.1
Zaleplon Products¹	366	*	*
Benzodiazepine Sedatives¹	1,589	83	5.2
Flurazepam¹	47	*	*
Temazepam Products¹	935	45	4.8
Triazolam Products¹	624	32	5.2
Barbiturates¹	647	37	*
Any Other Prescription Sedative^1,2	5,197	27	0.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.126B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 26 or Older; Percentages, 2021
Sedative Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2021)
ANY PRESCRIPTION SEDATIVE	6.0	0.3	5.6
Zolpidem Products¹	3.0	0.3	9.3
Eszopiclone Products¹	0.5	0.0	3.1
Zaleplon Products¹	0.2	*	*
Benzodiazepine Sedatives¹	0.7	0.0	5.2
Flurazepam¹	0.0	*	*
Temazepam Products¹	0.4	0.0	4.8
Triazolam Products¹	0.3	0.0	5.2
Barbiturates¹	0.3	0.0	*
Any Other Prescription Sedative^1,2	2.4	0.0	0.5
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.127A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2021
Benzodiazepine Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2021)
ANY PRESCRIPTION BENZODIAZEPINE	25,630	3,941	15.4
Benzodiazepine Tranquilizers¹	24,488	3,838	15.7
Alprazolam Products¹	13,968	2,737	19.6
Lorazepam Products¹	6,956	655	9.4
Clonazepam Products¹	5,394	949	17.7
Diazepam Products¹	4,994	637	12.8
Benzodiazepine Sedatives¹	1,758	103	5.9
Flurazepam¹	89	*	*
Temazepam Products¹	993	60	6.1
Triazolam Products¹	700	38	5.5
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	20	da
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.127B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 or Older; Percentages, 2021
Benzodiazepine Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2021)
ANY PRESCRIPTION BENZODIAZEPINE	9.2	1.4	15.4
Benzodiazepine Tranquilizers¹	8.8	1.4	15.7
Alprazolam Products¹	5.0	1.0	19.6
Lorazepam Products¹	2.5	0.2	9.4
Clonazepam Products¹	1.9	0.3	17.7
Diazepam Products¹	1.8	0.2	12.8
Benzodiazepine Sedatives¹	0.6	0.0	5.9
Flurazepam¹	0.0	*	*
Temazepam Products¹	0.4	0.0	6.1
Triazolam Products¹	0.3	0.0	5.5
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	0.0	da
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.128A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2021
Benzodiazepine Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2021)
ANY PRESCRIPTION BENZODIAZEPINE	462	181	*
Benzodiazepine Tranquilizers¹	421	177	*
Alprazolam Products¹	344	165	*
Lorazepam Products¹	66	8	*
Clonazepam Products¹	52	9	*
Diazepam Products¹	95	34	*
Benzodiazepine Sedatives¹	55	5	*
Flurazepam¹	17	*	*
Temazepam Products¹	14	*	*
Triazolam Products¹	26	4	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	*	da
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.128B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 to 17; Percentages, 2021
Benzodiazepine Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2021)
ANY PRESCRIPTION BENZODIAZEPINE	1.8	0.7	*
Benzodiazepine Tranquilizers¹	1.6	0.7	*
Alprazolam Products¹	1.3	0.6	*
Lorazepam Products¹	0.3	0.0	*
Clonazepam Products¹	0.2	0.0	*
Diazepam Products¹	0.4	0.1	*
Benzodiazepine Sedatives¹	0.2	0.0	*
Flurazepam¹	0.1	*	*
Temazepam Products¹	0.1	*	*
Triazolam Products¹	0.1	0.0	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	*	da
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.129A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2021
Benzodiazepine Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2021)
ANY PRESCRIPTION BENZODIAZEPINE	25,168	3,760	14.9
Benzodiazepine Tranquilizers¹	24,067	3,662	15.2
Alprazolam Products¹	13,624	2,572	18.9
Lorazepam Products¹	6,890	647	9.4
Clonazepam Products¹	5,342	940	17.7
Diazepam Products¹	4,899	603	12.4
Benzodiazepine Sedatives¹	1,704	98	5.8
Flurazepam¹	72	*	*
Temazepam Products¹	979	59	6.1
Triazolam Products¹	674	35	5.2
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	20	da
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.129B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 or Older; Percentages, 2021
Benzodiazepine Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2021)
ANY PRESCRIPTION BENZODIAZEPINE	9.9	1.5	14.9
Benzodiazepine Tranquilizers¹	9.5	1.4	15.2
Alprazolam Products¹	5.4	1.0	18.9
Lorazepam Products¹	2.7	0.3	9.4
Clonazepam Products¹	2.1	0.4	17.7
Diazepam Products¹	1.9	0.2	12.4
Benzodiazepine Sedatives¹	0.7	0.0	5.8
Flurazepam¹	0.0	*	*
Temazepam Products¹	0.4	0.0	6.1
Triazolam Products¹	0.3	0.0	5.2
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	0.0	da
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.130A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2021
Benzodiazepine Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2021)
ANY PRESCRIPTION BENZODIAZEPINE	2,147	787	36.6
Benzodiazepine Tranquilizers¹	2,084	772	37.1
Alprazolam Products¹	1,403	665	47.7
Lorazepam Products¹	539	100	18.7
Clonazepam Products¹	510	164	32.3
Diazepam Products¹	329	67	*
Benzodiazepine Sedatives¹	115	16	*
Flurazepam¹	25	*	*
Temazepam Products¹	44	14	*
Triazolam Products¹	50	2	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	8	da
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.130B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 to 25; Percentages, 2021
Benzodiazepine Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2021)
ANY PRESCRIPTION BENZODIAZEPINE	6.4	2.4	36.6
Benzodiazepine Tranquilizers¹	6.2	2.3	37.1
Alprazolam Products¹	4.2	2.0	47.7
Lorazepam Products¹	1.6	0.3	18.7
Clonazepam Products¹	1.5	0.5	32.3
Diazepam Products¹	1.0	0.2	*
Benzodiazepine Sedatives¹	0.3	0.0	*
Flurazepam¹	0.1	*	*
Temazepam Products¹	0.1	0.0	*
Triazolam Products¹	0.1	0.0	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	0.0	da
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.131A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2021
Benzodiazepine Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2021)
ANY PRESCRIPTION BENZODIAZEPINE	23,021	2,973	12.9
Benzodiazepine Tranquilizers¹	21,982	2,890	13.2
Alprazolam Products¹	12,222	1,907	15.6
Lorazepam Products¹	6,351	547	8.6
Clonazepam Products¹	4,832	776	16.1
Diazepam Products¹	4,569	536	11.8
Benzodiazepine Sedatives¹	1,589	83	5.2
Flurazepam¹	47	*	*
Temazepam Products¹	935	45	4.8
Triazolam Products¹	624	32	5.2
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	12	da
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

220623

Table 1.131B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 26 or Older; Percentages, 2021
Benzodiazepine Subtype	Any Use in Past Year (2021)	Misuse in Past Year among Total Population (2021)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2021)
ANY PRESCRIPTION BENZODIAZEPINE	10.4	1.3	12.9
Benzodiazepine Tranquilizers¹	10.0	1.3	13.2
Alprazolam Products¹	5.5	0.9	15.6
Lorazepam Products¹	2.9	0.2	8.6
Clonazepam Products¹	2.2	0.4	16.1
Diazepam Products¹	2.1	0.2	11.8
Benzodiazepine Sedatives¹	0.7	0.0	5.2
Flurazepam¹	0.0	*	*
Temazepam Products¹	0.4	0.0	4.8
Triazolam Products¹	0.3	0.0	5.2
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	0.0	da
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.